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 I  
Abstract  
Diffusion-weighted magnetic resonance imaging (DW-MRI) has rapidly become an 
important part of cancer patient management. In this thesis, challenges in the analysis 
and interpretation of DW-MRI data are investigated with focus on the intravoxel 
incoherent motion (IVIM) model, and its applications to childhood cancers. Using 
guidelines for validation of potential imaging biomarkers, technical and biological 
investigation of IVIM was undertaken using a combination of model simulations and in 
vivo data. To reduce the translational gap between the research and clinical use of IVIM, 
the model was implemented into an in-house built clinical decision support system. 
Technical validation was performed with assessment of accuracy, precision and bias of 
the estimated IVIM parameters. Best performance was achieved with a constrained 
IVIM fitting approach. The optimal use of b-values was dependent on the tissue 
characteristics and a compromise between bias and variability. Reliable data analysis 
was strongly dependent on the data quality and particularly the signal-to-noise ratio. 
IVIM perfusion fraction (f) was generally found to correlate with dynamic susceptibility 
contrast imaging derived cerebral blood volume. IVIM-f also presented as a potential 
diagnostic biomarker in discriminating between malignant retroperitoneal tumour 
types. Overall, the results encourage the use of IVIM parameters as potential imaging 
biomarkers. 
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1. Introduction 
This Chapter introduces the role of non-invasive imaging in the clinical management of 
childhood cancers. The focus is on magnetic resonance imaging (MRI), how it has 
contributed towards the improvements seen in patient care and what challenges remain 
today. The concept of imaging biomarkers is then introduced and tied to the aims and 
objectives of this thesis. 
1.1 Importance of MR Imaging in Childhood Cancers 
More than 1,800 new cases of childhood cancers are diagnosed every year in the United 
Kingdom (1). Cancer is the leading cause of disease related deaths in children aged 1-14, 
and the highest incidence rates are observed for ages 0-4. Brain and other central 
nervous system (CNS) tumours (Figure 1.1) are the principal cause of children’s cancer 
death, accounting for 32 % of cases (2). However, with improvements made in the last 50 
years, the survival rates for CNS tumours have doubled to 70 % at five years. 
Nevertheless, brain tumours present a diverse group of tumours, and the survival rates 
remain very tumour specific. Overall, the survival rates for childhood cancers stand at 
approximately 82 % over five or more years (1). 
MR imaging is a non-invasive imaging method, which is increasingly used and has led to 
improvements in clinical management of childhood cancers (3, 4). Depending on the 
location and type of tumour, MR imaging is performed at diagnosis, prior to and after 
surgery, during treatment and at the end of the treatment for tumour surveillance (5). 
The standard clinical imaging includes conventional MR imaging protocols, which 
provide excellent structural detail in millimetre resolution, but are limited in measuring 
quantitative tissue properties. 
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Figure 1.1 Childhood cancer types. A chart demonstrating the incidence of childhood 
cancers in the UK and Ireland (source: CCLG, 2017 (6)). 
MR imaging is used in the diagnosis of both brain and body tumours, although 
histopathological diagnosis following biopsy or surgical resection remains the gold 
standard. Diagnosis based on MR imaging involves the qualitative assessment of the 
appearance of the tumour on the resulting MR images. However, some childhood 
tumours, such as CNS tumours, are very diverse in their pathology (Figure 1.2) and 
some tumour types, in both the brain and abdomen, are known to have overlapping 
imaging characteristics (4, 7). Therefore, diagnosis of tumours is often not possible and 
thus rarely based on conventional MR imaging alone.  
Based on the most recent World Health Organization (WHO) classification (2016), there 
are now more than 50 different brain tumour types and subtypes (8). Previous brain 
studies have demonstrated that conventional MR imaging alone is not tumour grade or 
type specific (9, 10), while separate challenges remain with procedures required for 
histopathological diagnosis. For example, some brain tumours occur in regions that are 
not surgically accessible, which means that the diagnosis and choice of treatment will be 
based solely on the qualitative inspection of images. In the abdomen, tumours are often 
large and heterogeneous in nature, which means that the biopsy might not be obtained 
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from a region that is very characteristic of the tumour type. These challenges highlight 
the need for more advanced quantitative imaging methods, in particular for cases where 
biopsy might not be possible. 
Conventional MR imaging has also been used for the assessment of treatment response. 
This relies on the measurement of tumour volume changes, often only based on the 
largest tumour diameter on a single image slice. However, with the low specificity of MR 
imaging in biological tissue, the differentiation of tumours from pseudoprogression or 
pseudoresponse can be difficult (11). Pseudoprogression and pseudoresponse correspond 
to an apparent false increase and decrease in tumour size, respectively, assuming a 
contrast agent is used for an enhancement. For example, differentiation of 
pseudoresponse from true tumour response can be difficult, when a decrease in the 
enhancement indicates a response to a treatment, but could result from changes in the 
vascular permeability. Changes in the vascular permeability are often a result of certain 
chemotherapy drugs, and the effect may be readily reversible when the drug is stopped. 
Therefore, while conventional MR imaging has become an important technique in the 
assessment of tumours, new quantitative MR imaging methods are required to improve 
its specificity in characterising tissues. 
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Figure 1.2 Childhood brain cancer types. A chart demonstrating the incidence of 
different childhood brain cancers in the UK and Ireland (source: CCLG, 2017 (6)). 
1.2 Diffusion-weighted MR Imaging of Childhood Cancers 
The development of new MR imaging techniques, such as diffusion- and perfusion-
weighted imaging and MR spectroscopy, has made it possible to probe the underlying 
tissue properties and characteristics. These methods have the potential to provide 
clinically relevant and complementary information, far extending the information 
provided by conventional MR imaging. A range of these advanced imaging methods are 
already being implemented in clinical practice, further increasing the role of MR 
imaging in clinical management of childhood cancers (3, 12). 
Diffusion-weighted MR imaging (DW-MRI) is one of the most widely accepted non-
conventional MR imaging methods, where the MR signal is attenuated by the movement 
of water molecules. DW-MRI initially gained a lot of attention in the imaging of acute 
stroke, where it was able to detect a 30-50 % decrease in the water signal during the 
very early phase of acute brain ischemia (13). Conventional MR imaging on the same 
cases showed no apparent differences. These observations led to the development of DW-
MRI as a clinical tool, formally only considered a pure research tool, and to its 
implementation on most clinical systems today as a standard protocol. 
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DW-MRI has been applied as both a diagnostic and prognostic technique. The commonly 
derived quantitative parameter from DW-MRI is the apparent diffusion coefficient 
(ADC), which measures the apparent magnitude of diffusion within tissue. In clinical 
practice, the ADC is often determined using two b-values, which correspond to the 
degree of diffusion-weighting applied in the MR imaging. The ADC (in units of mm2/s) 
can then be calculated from the fitting gradient of the diffusion-weighted signal 
measured at the corresponding b-values. Although ADC provides a quantitative 
measure, it is generally only used by qualitative review of the ADC maps in clinical 
practice. ADC has been associated with an inverse relationship to extracellular density 
in many previous studies, including paediatric studies (14-20). However, other 
biophysical processes relating to the different environments of the water molecules have 
the potential to increase the apparent water diffusion, including perfusion, bulk 
movement such as cardiac and respiratory motion, necrosis and nuclei to cytoplasm ratio 
(19, 21-23).  
The effect of perfusion on ADC and the diffusion signal attenuation has been 
demonstrated in previous studies using multiple b-values (23-26). The use of multiple b-
values allows the detection of faster and slower diffusion components at low and high b-
values, respectively. Using this concept, Le Bihan et al. (24, 25) proposed the intravoxel 
incoherent motion (IVIM) model, which accounts for the perfusion effect in the modelling 
of diffusion-weighted MR signal. The model has been applied in an increasing number of 
adult studies (27-30), but only a few studies have reported its use in paediatrics (31-34). 
A more thorough introduction to the IVIM model is given in the following Chapter. 
A large number of studies have been reported on paediatric brain tumours and their 
characterisation with ADC (35-40). These include classification of cerebellar tumours 
and tumour grading, although overlapping ADC values of some of these tumours limit 
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its diagnostic performance (35-38, 40). Some of the most cited articles include a study by 
Bull et al. (35), who showed a 74.1 % success rate in discrimination of paediatric brain 
tumours, and a study by Rodriguez et al. (39), who reported a 91.4 % success rate for 
posterior fossa tumours. Both studies used a histogram analysis, which accounted for the 
tumour heterogeneity. 
Only a few studies have reported the characterisation of childhood abdominal tumours 
with ADC (32, 41-43) and most of these studies focused on discriminating between 
benign and malignant abdominal lesions. For example, a study by Kocaoglu et al. (41) 
demonstrated a significantly lower ADC for malignant tumours compared to benign 
cases, and a cut-off value 1.11 × 10-3 mm2/s was determined. However, in some cases, 
ADC was not predictive of the benign nature of lesions, possibly due to the influence 
from other underlying tissue properties such as vascularity, which is not accounted for 
by the ADC.  
Although promising results have been reported for the use of ADC in the 
characterisation of paediatric tumours, limitations exist in its methodology. The 
qualitative use of ADC in clinical practice restricts its potential, though slow movement 
towards using quantitative information as part of clinical management is taking place. 
Some of these methodological limitations are discussed in the following Chapter 2, 
together with alternative approaches and models for the diffusion-weighted signal. 
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1.3 Imaging Biomarkers 
A biomarker is defined as “a characteristic that is measured as an indicator of normal 
biological processes, pathogenic processes or responses to an exposure or intervention, 
including therapeutic interventions” (44). According to the most recent consensus 
statement from the FDA-NIH Biomarker Working Group, a biomarker can be a 
molecular, histologic, radiographic or physiologic characteristic (45). Both imaging and 
biospecimen-derived biomarkers have been widely studied in oncology, and include 
biomarkers for many different purposes. For example, biomarkers have been used in the 
diagnosis and prognosis of cancer, staging of cancer, and assessment of therapeutic 
efficacy or toxicity (46).  
New imaging biomarkers are increasingly needed to test research hypotheses in clinical 
trials and research studies, and to utilise them as clinical decision-making tools. To 
accelerate this process, a recent consensus paper for cancer studies introduced guidelines 
for the clinical translation of imaging biomarkers (47). The process requires validation 
and quantification by crossing the two translational gaps, as described in Figure 1.3. 
These gaps represent the key points in the evaluation of biomarkers, and are defined as 
the stage when the imaging biomarker can be reliably used to test medical hypotheses, 
and the final stage, when it can be used as a tool for clinical-decision making.  
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Figure 1.3 Summary of the imaging biomarker evaluation and development. The 
development of imaging biomarkers includes two key translational gaps. Gap 1: to become a 
robust medical research tool, and Gap 2: to be integrated into a routine patient care. The 
figure is adapted from the consensus study by Cancer Research UK (CRUK) and the 
European Organisation for Research and Treatment of Cancer (EORTC) (47). 
The technical and biological validation of imaging biomarkers run in a parallel fashion, 
together with considerations for the cost effectiveness. The technical validation of 
imaging biomarkers involves the assessment of precision and accuracy, and whether the 
biomarker (and hence imaging method) is accessible in different geographical locations. 
The biological and clinical validation determines whether the biomarker can measure a 
relevant biological property or predict a clinical outcome. The processes also include an 
assessment of uncertainty and risk in using the biomarker for clinical-decision making. 
Finally, cost effectiveness has a key role in later aspects such as large multi-centre 
reproducibility studies and clinical trials.  
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As part of the consensus study (47), four key attributes were suggested for all imaging 
biomarkers: 
I. The imaging biomarker is a subset of all biomarkers 
II. The imaging biomarker is either quantitative or qualitative (categorical) 
III. The imaging biomarker is derived from imaging modality, technique or signal, 
but is a distinct entity 
IV. One imaging measurement can support multiple distinct imaging biomarkers. 
Imaging biomarkers also have some additional considerations in comparison to 
biospecimen-derived biomarkers. These include the performance of the imaging device, 
which might vary across different clinical centres and manufacturers. Innovation in 
manufacturing tends to focus on the image quality and user interface, while the effects of 
quantification of imaging biomarkers remain secondary. Furthermore, the validation of 
imaging biomarkers is not aligned with biospecimen-derived biomarkers. An important 
part of biospecimen-derived biomarker validation is to assess the biophysical stability 
and reliability of the analytes. However, this is not possible with image analysis and the 
validity of the measurement mainly remains at the point of patient imaging. A detailed 
roadmap proposed for the development of imaging biomarkers is presented in Figure 1.4 
(47). 
The current practice of medicine has transformed with the introduction and development 
of new imaging methods (48). Imaging biomarkers have an immense potential in further 
improving the clinical management of cancer by addressing different clinical questions 
from diagnosis to assessing treatment effects. However, as suggested by the guidelines, 
careful validation and quantification is essential to ensure that informed decisions can 
be made based on the imaging biomarkers. 
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Figure 1.4 The imaging biomarker roadmap. A schematic roadmap produced for 
imaging biomarker evaluation in cancer studies. Technical and clinical validation run 
parallel, and important technical validation e.g. multicentre reproducibility occurs later in 
the evaluation after which definitive clinical validation in terms of clinical trials can take 
place. At each stage, cost effectiveness impacts the roadmap. (source: O’Connor, JPB. et al. 
(2016) Imaging biomarker roadmap for cancer studies Nat. Rev. Clin. Oncol. 
doi:10.1038/nrclinonc.2016.162, ref (47), under Creative Commons licence v.4.0) 
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1.4 Aims and Objectives 
The overall aim of this work was to investigate diffusion-weighted MR imaging and the 
application of intravoxel incoherent motion (IVIM) model in childhood cancers. The 
study focuses on the post-processing aspects of IVIM and its technical and biological 
validation as a potential imaging biomarker. 
Objectives: 
I. To investigate the robustness of IVIM fitting methods and parameters in low-
perfused tissues observed in the brain and childhood brain tumours 
II. To establish the reliability of IVIM parameters based on a rapid MR imaging 
protocol for tissues in the brain and abdomen 
III. To investigate the biophysical origin of IVIM perfusion fraction parameter by 
comparison to dynamic susceptibility contrast (DSC) MR imaging derived 
cerebral blood volume parameter, in healthy and pathological brain tissue 
IV. To integrate the IVIM application into an in-house built clinical decision support 
system, MIROR. 
V. To evaluate the use of IVIM as potential diagnostic biomarker in a cohort of 
childhood abdominal lesions 
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1.5 Thesis Structure 
This Chapter provided background to the clinical motivation behind the presented work 
and introduced the concept of imaging biomarkers. The content of the following Chapters 
is summarised below: 
Chapter 2: Diffusion-Weighted MR Imaging and Modelling of the Diffusion Signal 
Chapter 2 provides the theoretical background on the principles of MR imaging, with 
focus on diffusion-weighted MRI (DW-MRI). The physical phenomenon of apparent 
diffusion, how it appears in biological tissues, how it can be measured and modelled are 
discussed. A more thorough review is given on the concepts of intravoxel incoherent 
motion (IVIM) model, its implementation, biophysical origins and clinical applications. 
Chapter 3: Investigation of IVIM Fitting Methods in Low-Perfused Tissues 
In this Chapter, the robustness of constrained and simultaneous IVIM fitting methods 
are investigated using model simulations based on low-perfused tissues as part of the 
technical validation of IVIM. Previous simulation studies have included higher perfusion 
scenarios, which differ from what is observed in many of the childhood brain tumours. 
Evaluation of the uniqueness of IVIM parameters is also performed to assess their 
clinical reliability. 
Chapter 4: Rapid Measurement of IVIM Perfusion Fraction for use in Clinical MR 
Imaging 
Chapter 4 continues with the technical validation of IVIM and investigates the 
dependency between estimated IVIM parameters and the acquired data i.e. b-values. 
While many studies have focused on increasing the number of b-values, here we assess 
the use of simple three b-value acquisition to determine the IVIM diffusion coefficient 
and perfusion fraction, which have previously shown promising clinical value. The 
reliability of the IVIM parameters is assessed in terms of bias, accuracy and 
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reproducibility for different perfusion scenarios, including tissue models relevant to 
brain, kidney and liver. Based on the model simulations, the optimal use of b-values is 
suggested for different tissue types, including discussion on common pathologies and 
interpretation of differences seen between IVIM parameters from previous studies. A 
comparison of the model data to in vivo brain DW-MRI data is used to validate the 
results. 
Chapter 5: Comparison Study of IVIM and DSC Perfusion Parameters in Childhood 
Brain Tumours 
In Chapter 5, the focus is on the biological validation of the IVIM perfusion fraction 
parameter. The physical origins of the perfusion fraction are investigated with 
comparison to the “gold standard” dynamic susceptibility contrast (DSC) derived 
cerebral blood volume (CBV). Although this comparison has been performed previously 
in adult brain tumours, here we look at childhood low-grade gliomas, which commonly 
have low perfusion, to assess whether IVIM could provide an alternative non-invasive 
measure of vascularity. The similarities and differences of IVIM perfusion fraction and 
DSC-CBV parameters are discussed. 
Chapter 6: MIROR Clinical Decision Support System: Implementation of Diffusion 
Module and Investigation of Childhood Solid Tumours 
Chapter 6 describes the implementation of a diffusion module, including ADC and IVIM 
modules, to an in-house built clinical decision support system, MIROR. The implemented 
diffusion module is applied to a cohort of childhood abdominal lesions to validate its use 
and to evaluate the potential of IVIM parameters as diagnostic biomarkers. The purpose 
of the module was to develop an adaptable MR analysis tool for clinicians, and to provide 
a framework for its use as part of the evidence-adaptive clinical decision support system 
at a later stage.  
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Chapter 7: Conclusions and Further Work 
The final Chapter provides a summary of the results presented in this thesis and the 
conclusion drawn from this study. Suggestions for future work and directions are also 
proposed.
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2. Diffusion-Weighted MR Imaging and Modelling of 
the Diffusion Signal 
This Chapter provides a background to MR imaging. The focus is on diffusion-weighted 
MR imaging and how it can be modelled to provide information about the underlying 
tissue microstructure and microenvironment. For a more in-depth description of MR 
imaging, please refer to textbooks by Brown et al. (49) and Freeman (50). 
2.1 MR Imaging 
MR imaging is derived from the physical phenomenon known as nuclear magnetic 
resonance (NMR). Here the principles of NMR and the idea of nuclear spin are 
introduced using the classical physics and the quantum mechanical models, respectively. 
The focus in this section is on the 1H protons of water, which constitutes approximately 
70 % (51) of the adult human body. Because of this, the protons are the most commonly 
used nuclei in clinical MR imaging. 
2.1.1 Nuclear Magnetic Resonance 
Nuclei that possess nuclear spin are said to be NMR active. Nuclear spin is a property of 
a nucleus, which contains unpaired nucleons comprising of neutrons and protons, each 
with a nuclear spin of a half. Therefore, an NMR active nucleus always has a non-zero 
spin quantum number, I, and for the case of 1H, I = ½, corresponding to the single proton 
in the nucleus. Another property of a nucleus possessing a nuclear spin is the spin 
angular momentum, P, which is defined as 2 I + 1. This defines the number of possible 
orientations of the spin along a given axis. For the 1H nucleus, this results in two 
possible spin states, + ½ and - ½. The two spin states (m = + ½ and m = - ½) are 
degenerate in the absence of an external magnetic field (Figure 2.1). However, when the 
nucleus is placed in a magnetic field, the interactions between the magnetic moment and
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Figure 2.1 Energy levels of a proton nucleus. Diagram of the energy levels of a proton 
nucleus in the absence of a magnetic field (B0 = 0) and the splitting of the spin states in an 
applied magnetic field (B0 ≠ 0). 
the static magnetic field result in splitting of the spin states. The magnetic moment of a 
nucleus is related to its spin angular momentum with a proportionality constant γ, the 
gyromagnetic ratio: 
𝝁 = γ𝑷 [2.1] 
The gyromagnetic ratio for a 1H nucleus is γ = 2.68 × 108 rad s-1 T-1, which is defined as 
the ratio of its magnetic moment to its angular momentum. 
 
The precession of spins is often described using classical physics. The nuclear spins start 
to precess due to torque imposed on the magnetic moments by the applied magnetic field 
(Figure 2.2). The precession occurs in the direction of B0 and the rate of this precession is 
called the Larmor frequency (in s-1). The precession is proportional to γ and the strength 
of the magnetic field: 
𝜔 =
γ𝑩𝟎
2π
 
[2.2] 
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Figure 2.2 Precession of a nucleus. Diagram of the precession of a nucleus in an applied 
magnetic field. 
The nuclear spins that align parallel (+ ½) to the external field are in a lower energy 
state compared to those that align anti-parallel (- ½) (Figure 2.1). The energy gap 
between the two states can be defined as:  
Δ𝐸 = h𝜐 =  
hγ𝑩0
2π
 [2.3] 
where h is the Planck’s constant and v is the frequency. 
In NMR experiments, the focus is on the ensemble of spins, rather than the behaviour of 
the individual spins. This is described by the macroscopic magnetisation vector, M0 
(Figure 2.3), which is the sum of all the individual spin vectors. At the thermal 
equilibrium, the spins are distributed per the Boltzmann distribution and the difference 
between the spin populations is extremely small, with a small excess in the lower energy 
state. This means that at the equilibrium, the macroscopic magnetisation vector M0 
aligns along the direction of the applied field. The ratio of the spin populations is 
governed by the Boltzmann equation: 
𝑁+
𝑁−
=  exp (
−Δ𝐸
k𝐵𝑇
) [2.4] 
where N+ and N- are the number of spins aligning parallel and anti-parallel to the field, 
respectively, kB is the Boltzmann constant and T is the temperature. 
The magnetisation vector, M0, is what is being manipulated in MR imaging and forms 
the basis of all experiments. 
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Figure 2.3 Macroscopic magnetisation vector, M0. Diagram of the vector presentation of 
the spin ensemble and the resulting macroscopic magnetisation vector, M0 aligning along the 
direction of the applied magnetic field. 
2.1.2 Radio frequency Pulses 
Radio frequency (rf) pulses can be used to manipulate the M0 vector. This results in 
transitions between the spin-states, when the energy of radiation is equal to ∆E and 
matches the Larmor frequency. The NMR signal may be measured when the M0 vector 
precesses orthogonally to the applied field and the precession induces an oscillating 
current within the receiver coil. The maximum NMR signal can be produced by an rf 
pulse that brings the M0 vector to the xy transverse plane (Figure 2.4). This corresponds 
to an rf pulse with an intensity and duration that result in a rotation of 90 degrees. The 
angle of rotation is called the flip angle (θ), which can be calculated using: 
𝜃 = γ𝑩1𝑡𝑝 [2.5] 
where B1 is the generated rf field and tp is the time duration of the applied pulse. 
After an rf pulse, the magnetisation vector will return to its thermal equilibrium over 
time due to two relaxation processes, the longitudinal and transverse relaxation. The 
signal decay over time is called the free induction decay (FID). The combination of 
measured MR signals (a series of damped sine waves) can be separated by a Fourier 
transformation, which converts the time domain signal to a frequency domain (Figure 
2.5). 
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Figure 2.4 Application of a radio frequency pulse. Diagram of the application of a 90- 
degree pulse to bring the magnetisation vector, M0, to the xy transverse plane, where it can 
produce the maximum NMR signal. 
The complex motion of spins is often simplified by using a rotating frame of reference. 
This means that the xy plane (the reference frame) is assumed to rotate around the z-
axis at the Larmor frequency. After a 90 degree rf pulse, the magnetisation vector and 
the applied field will then appear stationary and the system can be referred to as on-
resonance. This simplifies the description of any deviations from the Larmor frequency. 
 
 
Figure 2.5 Free induction decay (FID). Diagram of the acquired free induction decay 
signal in the time domain, and the conversion to frequency domain by application of a 
Fourier transformation. 
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2.1.3 Relaxation Processes 
The return of the spins to thermal equilibrium after an rf pulse happens via spin-lattice 
(T1) and spin-spin (T2) relaxation processes (Figure 2.6). The T1 relaxation, also known 
as longitudinal relaxation, corresponds to the process of spins moving between the 
energy levels to restore the thermal equilibrium. This causes the release of energy from 
spins to the surrounding environment, the lattice. The T1 is the time constant defined as 
the time it takes for a signal to recover back to 63 % of its original value and is described 
by (52): 
𝑴𝑧 = 𝑴0(1 − exp
−𝑡/𝑇1) [2.6] 
where Mz is the component of the bulk magnetisation vector in the z-direction, and t is 
the time delay allowed for longitudinal relaxation (Mz = 0 at t = 0 returns to Mz ≠ 0).  
The T2 relaxation, also known as transverse relaxation, is the time it takes for a system 
to lose its phase coherence on the xy plane. After a 90-degree rf pulse, the spins have 
phase coherence by alignment in the transverse plane, but due to inter-and intra-
molecular interactions, the phase coherence is lost. The T2 relaxation can be described by 
(52): 
𝑴𝑧 = 𝑴0 ∙ exp
−𝑡/𝑇2 [2.7] 
where t is the time delay. 
The measurement of T2 relaxation is sensitive to any microscopic diffusion taking place 
during the MR acquisition and the presence of inhomogeneities in the applied magnetic 
field (B0). This causes the incomplete refocusing of the magnetisation vector (in gradient-
echo imaging), which results in a significantly shorter T2 compared to the real T2 
relaxation time. The measured T2 is then referred to as the T2* relaxation time. 
However, the real T2 relaxation time can be measured with spin-echo imaging, which 
eliminates the field inhomogeneity and diffusion effects by an application of a 180-degree  
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Figure 2.6 Return of the system back to thermal equilibrium via relaxation 
processes. Recovery of the magnetisation vector, M0, with (a) longitudinal relaxation and (b) 
transverse relaxation over time. The T1 relaxation time is defined as the 63 % (1 × T1) 
recovery of the maximum value of M0, with full recovery reached at approximately 5 × T1. 
Similarly, the T2 relaxation is the time defined as reduction of the Mxy to 37 % of its initial 
value after rf excitation. 
rf pulse, and refocuses the signal on a timescale, where the diffusion effects are kept 
minimal. 
2.1.4 Magnetic Field Gradients and Image Acquisition 
Magnetic field gradients are used in MR imaging to localise the MR signal. The 
gradients are applied in a controlled manner and are used to construct pulse sequences 
together with rf pulses and the constantly present static magnetic field, B0. Gradients 
apply spatially linear variation to the static magnetic field, e.g. a gradient Gx will add or 
subtract from the magnitude of B0 in different points along the x-direction, as described 
in Figure 2.7. The precession of the spins will linearly decrease or increase depending on 
their position. At the centre (x = 0) the spins will precess at the Larmor frequency as the 
total magnetic field equals B0.  
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Figure 2.7 Application of magnetic field gradients. (a) No gradients are applied and the 
spins precess at the same frequency and (b) application of a magnetic field gradient Gx in x 
direction, introducing spatial dependency to the magnetic field (in z direction) with position 
along x. 
An example of a basic gradient-echo (GRE) pulse sequence is shown in Figure 2.8, which 
describes how the MR signal is encoded for position using three orthogonal magnetic 
field gradients. The sequence starts with a slice selection by simultaneous application of 
a frequency selective rf pulse, containing a narrow band of frequencies and a linear slice 
selective gradient Gss gradient (also known as Gz), applied along the direction of the 
selected slice. This results in an excitation of a thin section, where the object has a 
resonance frequency (or Larmor frequency) within the bandwidth of the applied rf pulse. 
The thickness of the slice is determined by the effective bandwidth of the rf pulse and 
the magnitude of the applied gradient. The application of a negative Gss gradient after 
the slice selection is to re-focus the spins within the selected slice in preparation for the 
following gradients. 
The next part of the GRE sequence involves the application of phase (PE) and frequency 
(FE) encoding gradients to determine the spin density within the selected slice. The PE 
gradient is applied for a fixed time period prior to signal acquisition and affects the 
phase of the spins. After the gradient is switched off, the frequencies of the spins become 
similar, but with a phase difference dependent on their position. This is repeated until 
all possible spatial frequencies are interrogated in the phase-encoding direction. 
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Figure 2.8 Gradient-echo MR imaging pulse sequence. Diagram of a basic gradient-
echo MR imaging pulse sequence, which includes the simultaneous application of an rf pulse 
and a slice selective gradient (Gss), followed by the application of phase and frequency 
encoding (GPE and GFE) gradients and the signal acquisition. TE and TR correspond to the 
sequence echo time and repetition time. 
The FE gradient consists of bipolar gradient pulses to generate a gradient echo, which is 
required for the data sampling as there are no refocusing rf pulses. A negative FE 
gradient is first applied to dephase the signal, after which the positive FE gradient is 
used as a readout gradient during the acquisition. The signal is acquired at fixed time 
intervals, encoding the signal for position in terms of the frequency. The pulse sequence 
is then repeated to collect all the data within the user-defined region. 
The GRE pulse sequence in Figure 2.8 also features the basic pulse sequence 
parameters: echo time (TE) and repetition time (TR). The TE defines the time between 
the excitation rf pulse and the maximum of the signal echo, and TR the time between the 
consecutive excitation rf pulses. Both parameters are typically measured in milliseconds. 
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Figure 2.9 Generating the MR image. Conversion of raw k-space data to image space 
data by a 2D Fourier transform. The presented example is from a T2-weighted imaging 
sequence with a Cartesian k-space trajectory. 
The collected raw data is stored as a matrix called the k-space, where kPE and kFE 
represent the signal from the phase and frequency encoding directions. Each point in k-
space determines a single measurement of the entire MR signal, and therefore each 
point in k-space contributes information to all pixels in the image space (Figure 2.9). The 
k-space data is converted to image space using a two-dimensional Fourier transform. 
Different anatomical planes can be studied with MR imaging by acquisition of data in 
different imaging planes. This does not involve the moving of a patient, but can be 
performed by simply changing the magnetic field gradients. The commonly used imaging 
planes include axial, sagittal and coronal, as presented in Figure 2.10. 
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Figure 2.10 Common imaging planes used in clinical MR imaging. The imaging 
planes from left: axial, coronal and sagittal. The post-contrast T1-weighted images are from a 
patient with optic pathway glioma. 
2.1.5 Image Quality 
Image quality is an important factor for any quantitative analysis based on the image 
data. Random or systematic noise is included in all physical measurements, which 
affects the accuracy of the quantitative analysis (49). Generally, the noise in MR imaging 
arises from random thermal fluctuations of the voltage in the receiver coil and the 
patient. The fluctuations in the measured signal are “white”, meaning the noise is 
characterised by equal intensities at different frequencies and can be described as 
Gaussian.  
The construction of the magnitude images from the complex raw data is performed using 
non-linear mapping, which means that the noise distribution is no longer Gaussian (53). 
The noise in MR magnitude images can be modelled by the Rician distribution, which 
has a non-zero mean. However, at signal-to-noise ratio (SNR) levels > 3, the Rician 
distribution approximates to a Gaussian (53, 54). In regions where there is only noise 
and no signal, the Rician distribution approximates to a Rayleigh distribution.  
The differentiation of structures and tissue types from MR images depends on three key 
factors: the spatial resolution, image contrast and SNR. The spatial resolution of the 
resulting MR image is determined by the matrix size, field-of-view (FOV) and slice 
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thickness. The matrix size is controlled by the number of frequency and phase encoding 
steps. However, only the increase in PE matrix size results in a direct increase in the 
scan time for most practical applications. This is due to the phase relationships 
requiring multiple signals, each with a different phase-encoding step. In most cases the 
matrix size is kept equal in both directions as the formation of non-isotropic voxels 
within a plane is not preferable.  
The SNR and contrast are both affected by the voxel size. A larger voxel results in a 
higher SNR level, but poorer contrast due to reduction in the spatial resolution. The 
larger voxel size results in partial volume effects, where a combination of signal from 
different tissues such as a lesion and healthy tissues are mixed. In order to improve 
contrast yet acquire sufficient SNR level, a smaller voxel size can be used with a higher 
number of signal averages (NSA or NEX). The signal increases in proportion to √NSA due 
to the randomness of noise, meaning that if the NSA is doubled, the SNR is increased by 
a factor of √2. However, the use of higher NSA leads to longer acquisition times, and 
therefore there is often a need to decide on the trade-off between SNR and the 
acquisition duration.  
2.1.6 Basic Brain and Body Anatomy with MR Imaging 
This section briefly outlines the basic anatomy seen on MR images of both brain and the 
abdomen.  
2.1.6.1 Central Nervous System 
The nervous system of the body is composed of central and peripheral systems. The 
central nervous system (CNS) is formed of two components: the brain and the spinal 
cord, with its main purpose to receive, process and store information, and to direct any 
activity of the body. Three main parts compose the brain, including the cerebrum, 
cerebellum and brainstem, which are protected within the skull, as shown in Figure 
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2.11a. The cerebrum is divided into four lobes: frontal, parietal, temporal and occipital, 
forming the largest part of the brain. Higher functions such as vision, hearing, reasoning 
and learning originate from the cerebrum. The cerebellum is located underneath the 
cerebrum, and is responsible for functions such as muscle movement and balance. 
Finally, the cerebrum and cerebellum are connected to the spinal cord via the brainstem, 
which acts as a relay centre. The functions of the brainstem include many automatic 
processes such as breathing, body temperature, digestion and heart rate. 
The surface of the cerebrum has a folded appearance, called the cortex. The cortex 
contains about 70 % of the 100 billion nerve cells in the human brain and appears grey-
brown in colour, lending to its name the grey matter. Beneath the grey matter, long 
connecting fibres between neurons form the white matter. Fluid-filled cavities in the 
brain are called ventricles, which are filled with cerebrospinal fluid (CSF). The CSF is 
made in the choroid plexus, and is responsible for cushioning the brain and spinal cord 
from injury. The CSF flows within and around the brain, and the circulating fluid is 
constantly absorbed and replenished. Segmented regions of CSF, cortical grey matter 
and white matter are presented in Figure 2.11. 
 
Figure 2.11 The main brain structures and regions. MR images of the brain (a) main 
structures: cerebrum, cerebellum and brainstem and regions of the brain on (b) T2-weighted 
image and the segmented regions of (c) cerebrospinal fluid, (d) grey matter and (e) white 
matter. 
Chapter 2. Diffusion-Weighted MR Imaging and Modelling of the Diffusion Signal 
 30  
2.1.6.2 Abdominal Organs 
MR imaging of the body is an important part of clinical practice for many abdominal 
diseases. Here, the locations of the organs in MR images are briefly familiarised with. 
MR images of the abdominal region are shown in Figure 2.12 for coronal and axial 
planes. Looking at the coronal image (Figure 2.12a), the liver and spleen are located on 
the top, with kidneys directly below. The same organs can be observed in the axial MR 
image (Figure 2.12b), which also shows the location of the gall bladder and the bowel at 
the top right of the image.  
 
 
Figure 2.12 Abdominal MR imaging. Abdominal MR T2-weighted images in (a) coronal 
and (b) axial planes. Locations of the large abdominal organs are indicated with numbers: 1. 
liver, 2. kidney, 3. spleen, and 4. gall bladder. 
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2.2 Diffusion MR Imaging 
Many areas of research have contributed towards the success of diffusion-weighted MR 
imaging (DW-MRI) (13, 55, 56). In clinical applications, the technique has resulted in 
significant improvements in stroke patient management from diagnosis (57) to 
predicting clinical outcome (58). Following on, the technique has rapidly become an 
important part of cancer patient management (59). In this section, the underlying 
principles of the diffusion phenomenon and the measurement of diffusion with MR 
imaging are described. 
2.2.1 Physical and Biological Origins of Diffusion 
The diffusion phenomenon arises from the random translational motion of molecules 
within a fluid suspension (60). It is caused by the thermal energy possessed by the 
molecules and results in molecular or particle mixing. Unlike other transport 
mechanisms, diffusion does not require bulk motion. The mixing process was first 
explained by Fick’s first law (61), which related the diffusive flux to particle 
concentration and the diffusion coefficient. It embodied the idea that the diffusion 
coefficient is an intrinsic property of the medium, depending on the size of molecules, 
temperature and microstructure. Although the work by Fick suggested that no net flux 
occurs at thermodynamic equilibrium, it was later discovered that microscopic random 
motion still exists. This is now commonly known as Brownian motion, named after 
Robert Brown (62). 
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Later on, a displacement distribution function was introduced by Albert Einstein (63), 
quantifying the fraction of particles that traverse a certain distance within a time frame. 
He derived that motion can be quantitatively defined as the diffusion coefficient, D, 
given in units of mm2/s as the mean displacement, d within a time τ: 
〈𝑑2〉 =  6 ∙ 𝐷 ∙ 𝜏 [2.8] 
The Einstein equation (Eq. 2.8) describes diffusion as a Gaussian function, where the 
width of the distribution is determined by the diffusion coefficient. It assumes that 
diffusion is free, with the self-diffusion coefficient of free water approximately measured 
at 3.0 × 10-3 mm2/s (37 °C). However, diffusion in biological tissue is rarely free due to 
the presence of different barriers and obstacles including macromolecules, cell 
membranes and fibres. Therefore, deviation occurs from the Gaussian behaviour and the 
molecular displacement distribution becomes sharper, as described in Figure 2.13  (64).  
Water molecules within tissues are often considered to be in intracellular and 
extracellular compartments (65). Those found in the extracellular compartment are 
hindered by cell membranes, but can travel longer distances compared to water 
molecules within the intracellular compartment. Depending on the cell shape, the 
intracellular water diffusion might be restricted to a different extent in different 
directions. For example, in elongated cells such as axons and dendrites, the water is 
more restricted in the perpendicular direction. Cell permeability is another important 
factor, usually determined by the cell type.  Cells such as astrocytes can facilitate water 
transfer between the intra- and extracellular compartments, whereas myelinated axonal 
membranes are practically impermeable (66). These structural restrictions mean that 
the diffusion distance of water in biological tissues is in the range of micrometres, in the 
period of typically applied diffusion times (tens of milliseconds) (64). Therefore, within 
any voxel (mm) measured with diffusion-weighted MR imaging, there will be multiple 
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Figure 2.13 Diffusion of water in tissue. Diagram of (a) water displacement function 
when diffusion is free (described by a Gaussian) and restricted as observed in biological 
tissues, (b) depiction of diffusion at the cellular level with water restricted within cells, 
crossing cell membranes and hindered in the extracellular space. 
complex water environments, each with their own apparent water diffusion coefficients. 
2.2.2 Measurement of Diffusion with MR Imaging 
Diffusion MR imaging is based on the concept that molecular diffusion can probe the 
underlying tissue structure on a micrometre scale. It provides a non-invasive measure of 
diffusion in vivo, which can describe changes to tissues due to physiological or 
pathological reasons (67). Other conventional MRI techniques are unable to resolve the 
micrometre detail that characterises diffusion in biological systems. 
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Figure 2.14 PGSE pulse sequence for diffusion-weighted MR imaging. Schematic of 
the pulsed field gradient spin-echo (PGSE) sequence. After a 90-degree pulse, the first 
Gdiffusion gradient acts to label the space along one direction for a finite time interval (δ). The 
180-degree pulse then inverts the phase prior to the second gradient, which encodes any 
displacement of water molecules in that direction, and the diffusion-weighted signal is 
acquired. TE indicates the echo time of the sequence, with the application of the 180-degree 
rf pulse at TE/2. The slice selection and spatial encoding gradients are not included in the 
diagram. 
Many of the diffusion-weighted MR imaging protocols today are based on a sequence 
introduced by Stejskal and Tanner in 1965 (68). The pulsed gradient spin-echo (PGSE) 
sequence is described in Figure 2.14, which shows how the MR signal is sensitised to 
diffusion by additional magnetic field gradients (sometimes known as diffusion 
gradients). The sequence begins with a 90-degree pulse, after which the first gradient 
(duration, δ and strength, G) imposes a spatially dependent phase on the magnetisation 
vectors, encoding them for position. The 180-degree pulse at TE/2 then inverts the phase 
and after a time ∆, the second gradient acts to re-focus the magnetisation vectors. 
Finally, the signal is acquired.  If any incoherent motion occurs during the diffusion time 
(∆), the magnetisation vector will not be fully re-focused and results in an attenuation of 
the signal.  
The diffusion gradient parameters (δ, ∆ and G) have an important role in determining 
the applied diffusion-weighting on the signal. The strength (G) and duration (δ) of the 
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gradient pulse affect the amount of spin dephasing. Therefore, a larger or longer 
gradient leads to a greater signal loss. The time between the pulses (∆) determines how 
long the molecules can diffuse, and longer times lead to a greater mean displacement 
(Eq. 2.8). In clinical practice, these factors are combined into a single value called the b-
value, which determines the diffusion-weighting of the observed signal: 
𝑏 =  γ2𝑮2𝛿2 (Δ −
𝛿
3
) [2.9] 
Most importantly, the diffusion signal attenuation is material or tissue dependent. This 
can be characterised by the diffusion coefficient, D (in mm2/s), with large and small D 
corresponding to faster and slower diffusion, respectively. The relationship between the 
signal and the diffusion coefficient is given by: 
𝑆(𝑏)
𝑆(0)
= exp−𝑏∙𝐷 [2.10] 
where S(b) is the signal at the applied diffusion weighting (determined by the b-value) 
and S(0) the signal with no diffusion weighting (or b = 0). The quantity S(b)/S(0) is called 
the MR signal attenuation, which is solely dependent on diffusion. Any relaxation effects 
are removed by dividing the diffusion-attenuated signal S(b) with signal in the absence 
of gradients S(0). This is based on the relaxation-related signal attenuation being 
approximately independent of the diffusion gradients (60). 
2.3 Modelling of Diffusion-weighted MR Imaging 
The observed DW-MRI signal in complex multi-component systems such as the brain has 
posed a significant challenge for the analysis and interpretation of the data (65). The 
previously introduced idea of two water compartments, extra- and intracellular, in 
biological tissue has been one of the more controversial topics in diffusion MR imaging 
(69). The diffusion MR signal curve is characterised by a faster decay at lower b-values 
(≤ 2000 s/mm2) and slower decay at higher b-values (≥ 2000 s/mm2). The relative 
Chapter 2. Diffusion-Weighted MR Imaging and Modelling of the Diffusion Signal 
 36  
fractions of these diffusion components in the brain have been found to be around 0.7 
and 0.3, corresponding to the fast and slow components, respectively (70, 71). As a 
result, some studies have considered the fast and slow components to relate to the 
extracellular and intracellular compartments, respectively (72, 73). However, the 
measured water fractions in typical brain tissue have been measured at 0.2 for 
extracellular and 0.8 for intracellular compartments (74), and thus approximately the 
opposite of what is expected. 
Different solutions have been suggested to account for the above behaviour, including a 
difference in T2 values of the intracellular and extracellular compartments (69). 
However, no distinction between water T2 values of the two compartments have been 
inferred from T2 measurements to date (75, 76). A different approach was taken by 
Jespersen et al. (77), who suggested a model based on neural cytoarchitecture. In this 
model, the two diffusion components arise from dendrites and axons (modelled as long 
cylinders) and the isotropic component of water within and across other structures e.g. 
extracellular space and non-cylindrical cells. Physiologically reasonable estimates were 
derived in this study for both white and grey matter (77). These studies suggest that the 
interpretation of extracellular and intracellular compartments is unlikely to fully 
account for the observed behaviour in diffusion measurements. Therefore, models 
including geometrical features of tissue microstructure might provide a reasonable 
compromise for the interpretation of the MR signal at the higher b-values. 
The focus in this thesis is at the lower b-value region (0 - 1000 s/mm2), where two 
distinct diffusion components can also be observed. The very fast diffusion signal decay 
(b ≤ 200 s/mm2) is often thought to be influenced by perfusion (24, 25), which is described 
by the intravoxel incoherent motion (IVIM) model, introduced in the following section. 
Other models used to interpret the diffusion-weighted signal are also briefly introduced, 
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including the simplistic ADC model, and the kurtosis, Gaussian and stretched-
exponential models. 
2.3.1 Apparent Diffusion Coefficient (ADC) 
The first diffusion-weighted images of the human brain were introduced in 1985 by Le 
Bihan et al. (25) together with the idea of apparent diffusion coefficient (ADC). ADC was 
proposed to avoid the challenges of non-Gaussian diffusion and to promote the technique 
as a clinical application (78). The ADC concept utilises the previously introduced 
Gaussian diffusion (Eq. 2.10), but underlines the differences to free water diffusion, and 
is hence called the “apparent” diffusion coefficient: 
𝑆(𝑏)
𝑆(0)
= exp−𝑏∙𝐴𝐷𝐶 [2.11] 
Diffusion-weighted MR imaging is commonly performed with diffusion gradients applied 
in three orthogonal directions. The diffusion-weighted images from these directions are 
averaged (known as geometrical average or trace) and the resultant diffusion-weighted 
images are then used to compute the ADC map. This is to minimise any anisotropic 
tissues producing artificially low or high ADC values, which might present if a diffusion 
gradient is only applied in one direction. The ADC can be calculated from at least two b-
values, where one of them is commonly b = 0 (Figure 2.15). The mono-exponential 
relationship (Eq. 2.11) is used in a voxel-by-voxel basis, and the resulting ADC 
parameter is often reported in units of × 10-3 mm2/s or × 10-6 mm2/s in clinical practice. 
Most scanner software packages now provide ADC maps as an automatic output for 
diffusion-weighted MR imaging. 
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Figure 2.15 Diffusion-weighted MR imaging in clinical practice. DW-MRI mages at b-
values (a) b = 0 and (b) b = 1000 s/mm2 and (c) the resulting ADC map (in mm2/s). The 
diffusion signal decay plots shown in (d), correspond to the regions-of-interest shown on the b 
= 0 image for grey matter (yellow), white matter (green) and cerebrospinal fluid (purple). 
The interactions of water molecules within tissue are reflected in the magnitude of ADC, 
and it is highly sensitive to physiologic and pathologic conditions. The ADC values of 
grey and white matter are similar, as shown in Figure 2.15d, and a previous multi-
centre study reported these to be 0.83  0.02 and 0.70  0.02 (× 10-3 mm2/s), respectively 
(79). Areas of fluid, e.g. cerebrospinal fluid (CSF) and cysts, present highly diffused areas 
in the ADC map due to the greater mean displacement of water. This results in greater 
dephasing of the magnetisation vector during acquisition and causes the fluid to appear 
dark (e.g. CSF in Figure 2.15b). The ADC of CSF in the lateral ventricles has been 
reported to be in the range of 2.73 – 3.02 (× 10-3 mm2/s) for a healthy adult brain (80). 
Although simplistic, ADC remains the most used diffusion model in clinical practice. 
However, the quantitative information is still often overlooked in preference to visual 
inspection of the parametric maps 
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2.3.2 Intravoxel Incoherent Motion (IVIM) Model 
The intravoxel incoherent motion (IVIM) model was introduced in 1986 by Le Bihan et 
al. (25) to describe the multi-exponential diffusion signal decay observed with the 
acquisition of multiple b-values. The model has gained more interest in the recent years, 
with its idea that diffusion-weighted MR imaging can also provide information about 
tissue perfusion, and thus vascularity.  
The IVIM model considers perfusion as a form of incoherent motion, which contributes 
towards the observed diffusion signal attenuation (81). The incoherent motion is thought 
to arise from the microcirculation of blood in the capillary network, with its magnitude 
depicted by the volume fraction (IVIM-f parameter). The flow of blood water (IVIM-D* 
parameter) in the randomly oriented capillaries mimics a random walk, and contributes 
to the signal attenuation during the application of diffusion gradients. This can only be 
observed at low b-values, as the pseudodiffusion coefficient, D*, is greater than the 
tissue water diffusion coefficient, D. The difference of the diffusion coefficients is 
approximately an order of a magnitude, allowing the separation of the two effects. The 
multi b-value DW-MRI and the fitting of the diffusion signal with IVIM is described in 
Figure 2.16, which also shows how the fitting with the ADC model is unable to account 
for the multi-exponential diffusion signal decay. 
The IVIM model uses a bi-exponential approach to derive the two diffusion coefficients 
and their relative fractions: 
𝑆(𝑏)
𝑆(0)
= 𝑓 ∙ exp−𝑏∙𝐷
∗
+ (1 − 𝑓) ∙ exp−𝑏∙𝐷 [2.12] 
where f is the perfusion fraction, D* the pseudodiffusion coefficient and D the tissue 
diffusion coefficient. These parameters can be derived on a voxel-by-voxel basis and 
presented as quantitative parameter maps (Figure 2.17).  
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Figure 2.16 Multi b-value diffusion-weighted MR imaging. (a) DW-MR images showing 
the attenuation of signal towards high b-values and (b) fitting of the multi b-value diffusion-
weighted signal with ADC and IVIM models. 
2.3.2.1 Implementation of IVIM 
The use of IVIM or any quantitative technique as a clinical application requires it to be 
sufficiently robust in the process of image acquisition, image processing, data fitting and 
analysis of the resulting parametric maps (82). Such technical challenges also form an 
important part of the validation process for potential imaging biomarkers (47). Previous 
studies have investigated the optimisation and effect of b-values and the use of different 
fitting algorithms on the estimated IVIM parameters (83-88). These studies have clearly 
demonstrated that the reliable derivation of IVIM parameters depends on the chosen 
DW-MRI protocol and the subsequent post-processing of the image data.  
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Figure 2.17 Intravoxel incoherent motion (IVIM) parameter maps. Diffusion-
weighted MR images of (a) b = 0, (b) b = 1000 s/mm2 and the IVIM parameter maps of (c) D, 
(d) D* and (e) f presented for a case of optic pathway glioma (indicated by the arrow on b0 
image). 
The most commonly used IVIM fitting algorithms include the non-linear least-squares, 
and more recently the Bayesian probability methods (85, 88). The least-squares fitting 
can be constrained to different extents, as described in Figure 2.18. In a non-constrained 
approach, the fitting can be performed simultaneously and all three parameters are 
fitted at once. However, as most image data is influenced by noise, this approach is 
rarely feasible due to its high degree of freedom in the fitting algorithm. Therefore, and 
to overcome this mathematical instability, constrained least-squares fitting approaches 
have been introduced.  
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Figure 2.18 IVIM least-squares fitting algorithms. (a) Descriptions of the commonly 
used IVIM fitting methods. * indicates a step in the method, where the commonly proposed 
threshold is b = 200 s/mm2; however this is user and sometimes tissue dependent. (b) 
Visualisation of the regions of signal where the IVIM parameters are derived. 
Two constrained approaches have been previously reported: the so-called segmented 
method (88, 89) and its less constrained variant the two-step method (28). In all cases, 
the S(0) is set to the b = 0 image. Both approaches assume that at the higher b-values, 
the effect of pseudodiffusion can be neglected (D* ≫ D) and the tissue coefficient, D, can 
be estimated by linear fitting to the log of the high b-value data, normalised to the S(0) 
(Eq. 2.10). In the segmented method, the f parameter is approximated from the y-
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intercept of the same linear fit (Eq. 2.13), after which the D* parameter is estimated by 
non-linear fitting with the bi-exponential equation over all b-values (Eq. 2.12), again 
normalised to the S(0). In the two-step model, both f and D* parameters are estimated 
from the previously described non-linear fitting over all b-values.  
𝑓 =
(𝑆(0) − 𝑆(𝑖𝑛𝑡))
𝑆(0)
 [2.13] 
The constrained methods have been shown to produce more robust IVIM parameters 
with higher accuracy and reproducibility, although previous studies have mostly focused 
on the abdominal organs (88, 90, 91). Perfusion in the abdomen is relatively higher 
compared to the brain (92). This results in a more challenging scenario for the IVIM 
fitting in the brain, which assumes that the given signal data is bi-exponential (24, 25). 
A few studies have reported simulations based on a healthy brain (87, 92), however these 
studies did not consider regions of very low perfusion, such as observed in acute ischemic 
stroke (28, 93), brain injury (94) and some of the low-grade brain tumours (27, 95). The 
previous brain studies have also only focused on single fitting methods, not accounting 
for the differences that might arise due to the use of fitting constraints.  
Recently, the Bayesian probability method for estimation of IVIM parameters has also 
been of interest (85, 96). This approach does not require the user to define parameters or 
their variability, but they can be derived from the data itself. The Bayesian studies have 
shown cleaner and more visually pleasing IVIM parameter maps due to smaller 
estimation uncertainties in heterogeneous tissue regions. However, a recent study 
suggested that some of the features in heterogeneous tissue regions were masked 
completely (97). Therefore, the implementation of Bayesian method, although more 
visually pleasing, might lead to underestimation of the heterogeneity of tumours, which 
can be vital in clinical applications.  
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The other challenge with the use of IVIM is the number and magnitude of b-values used 
in the data acquisition, which have a direct impact on the computation of IVIM 
parameters (83, 88, 90). For IVIM, the low b-value region (0 – 200 s/mm2) is critical for 
the evaluation of the perfusion characteristics. However, most studies to date have 
utilised different sets of b-values, although a recent consensus study was reported for 
IVIM in the body (98). The use of a larger number of b-values can aid to stabilise the 
data fitting, but becomes clinically less appealing due to longer acquisition times. 
Therefore, a common theme in the clinical research studies has been to utilise a set of b-
values (often between six to ten) and introduce a higher number of signal averages. This 
results in improvement of the image SNR, which has been shown to be more important 
than the use of additional b-values for accurate data fitting (92). 
Optimisation of b-values for IVIM has been reported in many previous studies (83, 92, 
99, 100). However, these studies report optimisation for specific organs or tissue types 
and therefore one cannot generalise their use for standard clinical imaging. The choice of 
b-values is important for data fitting, especially when a pre-defined threshold is chosen 
to separate the perfusion and diffusion components (constrained fitting). For this 
purpose, thresholds of b = 100 and 200 s/mm2 have been suggested for body (101) and 
brain (102), respectively. The effect of the threshold b-value was also reported in an 
abdominal study by Wurnig et al. (103). Their study showed that the estimated IVIM 
parameters were dependent on the chosen threshold, which also varied depending on the 
region of abdomen. Therefore, for the implementation of IVIM, it is vital to consider and 
assess the choice of b-values, the fitting algorithm and the data quality (SNR), to ensure 
the best yield of clinically meaningful results.  
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2.3.2.2 IVIM Parameter Reproducibility 
Reproducibility of IVIM parameters is particularly important for the clinical uptake of 
the method for practice. It describes the ability of a method to give similar results from 
repeated measurements, and the variability between them. It is not to be confused with 
the term repeatability, which describes the consistency of the quantitative parameter of 
the same imaging test on the same object, performed at short intervals on the same 
scanner and the same operator.  
Multiple sources of variance can influence the overall reproducibility. These include 
biological properties (e.g. heterogeneity of tissue, patient size), hardware (e.g. MRI 
system, pulse sequence), MR operator and data analysis (e.g. algorithms for quantitative 
analysis). Only one multi-centre, multi-scanner brain study on reproducibility of IVIM 
has been reported (79), while other multi-centre studies have covered the use of ADC 
(79, 104) and diffusion tensor imaging (DTI) derived parameters (105-107). The IVIM-D 
parameter was reported to have good reproducibility with coefficient of variation (CV) < 
4 % for grey and white matter (accounts for inter-scanner, inter-volunteer and intra-
scanner reproducibility). The f parameter had a good overall reproducibility with CV = 
5.3 and 8.5 % in grey and white matter, respectively. No values were reported for the D* 
parameter. Interestingly, the protocols used across the different centres were not 
precisely matched, which suggests that IVIM parameters D and f are quantitatively 
robust. 
Reproducibility has also been examined in previous single-centre liver (84, 99, 108, 109), 
and simulation based studies including various tissue types (85, 88, 92). For example, in 
a study by Kakite et al. (110), the reproducibility (CV) in healthy liver was reported to be 
13.2 % (range: 1.2-28.5 %) for D, 25.3 % (range: 9.3-84.9 %) for f, and 59.0 % (range: 2.4-
121.3 %) for D*. Another study by Andreou et al. (108) reported the 95 % confidence 
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intervals of the percentage difference between paired measurements in the liver to be -
5.12 to 8.09 % for D, -24.3 to 25.1 % for f and -31.2 to 59.1 % for D*. The overall findings 
suggest that while D and f are sufficiently reproducible for clinical use, the 
reproducibility of D* parameter is relatively poor. However, the use of D* has shown 
potential in clinical diagnosis, e.g. for liver cirrhosis (89, 111). Therefore, further studies 
are needed to improve the robustness of D* parameter to justify its use for clinical 
applications. 
2.3.2.3 Biophysical Origins of IVIM Parameters and Perfusion 
The idea of using diffusion-weighted MR imaging for derivation of quantitative 
parameters of both diffusion and perfusion has its advantages. The gold standard MR 
perfusion imaging method: dynamic susceptibility contrast (DSC) requires the use of a 
contrast agent, which is often not possible in patients with renal failure and can be 
difficult in younger patients. Recent reports of gadolinium deposits in the brain, from 
DSC contrast agents, have also posed questions on the safety of the agents (112, 113). 
Measurement of perfusion has shown promise in various aspects of clinical management 
of cancer, including tumour grading (114, 115), differentiation (116), treatment planning 
(117) and predicting long-term outcome (118). Perfusion of blood in tissue is responsible 
for the delivery of oxygen and nutrients to cells (119). This occurs via a capillary network 
that allows blood-tissue exchange through the capillary walls. Similarly, the waste 
products of tissue metabolism are transported through the capillary network. The 
overall process is affected by many physiological parameters such as blood pressure, 
velocity and microstructure. In clinical environment, the term perfusion is often loosely 
described as the degree of microvasculature of a tissue.  
Measurement of perfusion with DSC-MRI relies on the regional susceptibility induced 
signal loss caused by the first passing of paramagnetic contrast bolus (120). The contrast 
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is injected intravenously, after which imaging is performed rapidly and repeatedly to 
acquire the MR signal, which relates to the concentration of the contrast agent in tissue. 
A curve of the signal intensity as a function of time for each voxel can be converted to 
tracer tissue concentration-time data using a well-known relationship between T2 or T2* 
signal intensity and tracer tissue concentration. The principles of a kinetic model can be 
used to estimate the perfusion parameters: cerebral blood volume (CBV), cerebral blood 
flow (CBF) and mean transit time (MTT), as described in Figure 2.19. More information 
on DSC-MRI can be found on references (120, 121). 
 
 
Figure 2.19 DSC-MR imaging and the computation of DSC perfusion parameters. 
(a) Diagram showing the processing required to estimate the DSC parameters. This involves 
signal data conversion to tracer tissue concentration, from which CBV can be determined. An 
arterial input function (AIF) can be determined from the image data and is a function 
describing the time-dependent concentration input to tissue. The AIF is deconvolved from 
the tissue concentration-time curve resulting in the tissue response function. From this, 
parameters of CBF and MTT can be determined. An example case of optic pathway glioma 
shown on (b) T2-weighted image (tumour indicated by the arrow) and (c) the DSC parameter 
maps. 
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A study linking the DSC parameters to the IVIM parameters was reported by Le Bihan 
and Turner (119). The IVIM perfusion fraction, f, or the fractional volume (%) of 
capillary blood can be thought as the ratio of the volume of water flowing in the capillary 
compartment (Vd) to the total water volume (VH2O) within a voxel. This can be converted 
to the volume of capillary blood per 100 g of tissue (DSC-CBV), if the water content 
fraction (fw = VH2O/ Vd) is known and assuming tissue density unity: 
𝑓 =
Vd
VH2O
=
Vd
𝑓wV
=
CBV
𝑓𝑤
 
[2.14] 
The study also suggested the relation of IVIM D* parameter to the average blood 
velocity and the mean capillary segment length. This results in an inverse relationship 
of D* to the DSC-MTT parameter. The product of fD* was related to the measure of CBF 
on the basis that the link between the IVIM and classical perfusion is in the capillary 
geometry. 
The idea of a link between the IVIM and DSC perfusion parameters has been 
investigated in previous correlation studies (Table 2.1). Moderate to strong correlation 
between IVIM-f and DSC-CBV has been demonstrated in healthy grey matter (87) and 
pathological tissues including low- and high-grade gliomas (27, 28, 93) and glioblastomas 
(122, 123). The comparison of D* and fD* to perfusion parameters has been more 
inconclusive. Only one study reported the comparison of IVIM-D* and DSC-MTT, which 
did not demonstrate significant correlation but indicated negative association of the 
parameters (28). The same study also reported comparison of fD* to DSC-CBF, which 
showed moderately positive correlation. Although a mixture of different tumours has 
been studied, the correlation has not been assessed in low-perfused tumours, such as 
presented in some paediatric brain tumours (124). 
The comparison of IVIM and DSC parameters is difficult, as both methods provide 
separate challenges in the acquisition and analysis of the data, as well as some inherent 
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differences in what they are able to measure. The IVIM-f parameter has previously been 
reported to be approximately 0.10 and 0.08 in grey and white matter, respectively (79, 
125), whereas the CBV fractions have been reported to be approximately 5.2 % in grey 
matter and 2.7 % in white matter (126). Although these f values have not been converted 
to the CBV equivalent values using Eq. 2.14, it is unlikely that IVIM-f provides a direct 
measure of CBV. The IVIM has been shown to be more sensitive to the perfusion in the 
microcapillary network (127, 128), with a smaller contribution, if any, resulting from the 
larger arteries containing faster blood flow. This contrasts with DSC, where larger 
arteries provide a major contribution to the DSC signal (27, 28, 93). 
For the other DSC parameters CBF and MTT, the measurement of the arterial input 
function (AIF) can be difficult and is often not even performed in clinical practice (121). 
The AIF is required to remove variations in the supply of the contrast agent to the 
tissue, because of changes in the physiology and the administration of the contrast agent 
(129). The measurement of AIF is optimally performed using a vessel close to the tissue 
of interest, which needs to be included within the MR field-of-view. Conversely, the AIF 
is often measured using larger feeding vessels rather than direct smaller vessels. This is 
due to the tumour potentially influencing the blood supply of the nearby vessels, as well 
as possible issues with partial volume effects. However, the use of larger vessels can also 
lead to erroneous measures of AIF due to dispersion of the bolus, thereby leading to 
inaccuracies in the estimation of the CBF and MTT parameters.  
Evidence of tissue perfusion detected with IVIM has been provided from a few studies 
using purpose-built model phantoms. The first IVIM phantom was introduced together 
with the IVIM model by Le Bihan et al. (24). This involved a chromatographic column 
packed with resin microspheres, through which water drains under gravity (replicating 
microcapillary perfusion). In their experiments, a series of water flow rates were applied 
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and a reduced flow rate was observed as a decrease in the perfusion fraction. Another 
phantom study using different area fractions of flowing water compartments reported 
significant positive correlation between the flow rate and f and D* (91). Similar findings 
were reported by Cho et al. (130), who used a complex flow phantom mimicking tumour 
microenvironment. These studies suggest that the DW-MRI is sensitive to flow effects 
and support the IVIM model. However, further evaluation of the underlying principles 
and the association of these parameters with the tissue microstructure would be 
beneficial to demonstrate the full potential of IVIM for clinical applications. 
 
Table 2.1 Previous literature on comparison of IVIM and DSC-MRI perfusion parameters. 
Author  Year Study region Parameters 
compared 
Correlation 
coefficient 
P-value 
Wirestam (125) 2001 Grey matter 
White matter 
IVIM-f - DSC-CBV 
IVIM-f - DSC-CBV 
r = 0.44 
r = 0.44 
0.001 
0.001 
Federau (27) 2014 Glioma IVIM-f - DSC-rCBV* r = 0.59 - 
Federau (28) 2014 Mixture of 
brain 
pathologies 
IVIM-fr - DSC-rCBV, 
IVIM-D*r - DSC-rMTT-1, 
IVIM-fD*r - DSC-rCBF* 
r = 0.75 
r = - 0.27 
r = 0.65 
- 
- 
- 
Kim (122) 2014 Glioblastoma IVIM-f - DSC-rCBV* r = 0.674 < 0.001 
Puig (123) 2016 Glioblastoma IVIM-f - DSC-rCBV* 
IVIM-D* - DSC-rCBF* 
r = 0.49 
r = 0.71 
0.04 
< 0.001 
Wu (87) 2015 Grey matter 
White matter 
IVIM-f - DSC-CBV† 
IVIM-f - DSC-CBV† 
r = 0.48 
r = 0.02 
< 0.001 
0.58 
Conklin (93) 2016 Glioma IVIM-f - DSC-rCBV r = 0.49 - 
*rCBV, rCBF and rMTT are relative values calculated by dividing the mean tumour 
perfusion value by normal appearing white matter perfusion value. Similarly, fr, D*r and fD*r 
are relative values (tumour region/white matter region).  
† value in units of ml/100 ml 
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2.3.2.4 IVIM in Clinical Studies 
Despite the uncertainties with regards to the biophysical origins of the IVIM 
parameters, an increasing number of studies have investigated the use of IVIM for 
clinical applications. A summary of some of these studies can be found in Table 2.2, 
including the type of pathology and the derived IVIM parameters.  
A study that led to a surge of studies exploring IVIM in clinical applications was by 
Luciani et al. (81), who investigated the use of IVIM for diagnosis of cirrhotic liver (111). 
Their study showed that the pseudodiffusion coefficient was lower in cirrhotic liver 
compared to normal healthy liver, and thereby likely contributing towards the restricted 
diffusion seen in cirrhosis. Following this, many studies in the intra-abdominal organs 
(liver, spleen, kidneys, pancreas) have revealed the presence of a strong bi-exponential 
diffusion signal attenuation (82, 131). This has allowed the utilisation of the perfusion-
sensitive diffusion component, in particularly for the abdomen.  
Interesting abdominal studies have included types of liver and pancreatic cancers (30, 
132-135). A study looking at differentiation of low- and high-grade hepatocellular 
carcinoma found that the D parameter had significantly better diagnostic performance 
compared to ADC (30). This study also reported significant correlation of f to the 
percentage of arterial enhancement. Another study including common pancreatic 
tumours and chronic pancreatitis, demonstrated that D* and f were more valuable than 
ADC or D in their differentiation (132).  
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Table 2.2 Previously reported examples of IVIM parameters in different pathologies (no 
studies of healthy tissues are included). 
Author et al. Year Pathology Cases D D* f 
Bisdas (136) 2013 Low-grade glioma 7 0.52 10.8 0.06 
  High-grade glioma 15 0.76 41.6 0.11 
Federau (27) 2014 Low-grade glioma 5 1.00 11.4 0.08 
  High-grade glioma 16 2.00 11.7 0.13 
Hu (137) 2014 Low-grade glioma 13 0.76 2.15 0.48 
  High-grade glioma 29 0.51 2.71 0.29 
Lin (138) 2015 Low-grade glioma 13 0.81 2.77 0.49 
  High-grade glioma 11 0.69 5.10 0.40 
Freiman (31)  2013 Crohn’s disease non-enhancing 13 1.70 18.5 0.59 
  Crohn’s disease enhancing 11 1.30 51.9 0.27 
Suo (139) 2016 Ischemic stroke 101 0.42 10.2 0.04 
Cho (90) 2015 Breast cancer 14 1.40 15.0 0.13 
Sigmund (140) 2015 Breast cancer 27 2.36 15.1 0.10 
Hayashi (141) 2013 Cirrhotic liver 29 0.87 25.0 0.24 
Luciani (111) 2008 Cirrhotic liver 12 1.19 61.0 0.30 
Patel (89) 2010 Cirrhotic liver 14 1.04 27.9 0.25 
Shinmoto (142) 2008 Prostate cancer 12 0.30 1.70 0.50 
Kuru (143) 2014 Prostate cancer 27 1.04 31.1 0.10 
Ueda (144) 2016 Prostate cancer 63 0.65 7.48 0.23 
Hectors (133) 2015 Hepatocellular carcinoma 25 1.36 64.1 0.18 
Woo (30) 2014 Low-grade hepatocellular carcinoma 24 1.18 36.8 0.22 
  High-grade hepatocellular carcinoma 18 0.99 32.2 0.19 
Lemke (135) 2009 Pancreatic adenocarcinoma  23 1.15 20.0† 0.09 
Kang (132) 2014 Chronic pancreatitis  7 1.41 40.8 0.19 
  Neuroendocrine tumour  17 1.11 43.7 0.30 
  Pancreatic adenocarcinoma  39 1.14 22.3 0.12 
  Intraductal papillary mucinous neoplasm 37 2.84 15.6 0.10 
Klauss (134) 2011 Chronic pancreatitis  9 1.07 20.0† 0.16 
  Pancreatic adenocarcinoma 15 1.09 20.0† 0.08 
† D* fixed in fitting. D and D* values are reported in units of × 10-3 mm2/s. 
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More recently, IVIM brain applications have been reported for the differentiation of low- 
and high-grade gliomas (27, 136-138) and the assessment of stroke (139). The glioma 
studies have showed promising results for the use of perfusion fraction, f, in the grading 
of tumours. However, the agreement of the perfusion fraction values has been poor. A 
range of values for low- (f = 0.06 – 0.49) and high-grade (f = 0.11 – 0.40) gliomas have 
been reported. Higher f values (> 0.29) were reported in studies, which included b-values 
≥ 1500 s/mm2 (137, 138), compared to studies with lower b-values ≤ 1300 s/mm2 (f ≤ 
0.13).  
Previous simulation studies have indicated that the IVIM analysis in the brain is much 
more demanding in terms of the data quality and SNR level (87, 92). This is partially 
due to the relatively low perfusion in the brain compared to the abdomen, leading to a 
lower degree or subtler bi-exponential signal behaviour. The low-perfused scenario is 
more challenging for the IVIM model, in particular with regards to data fitting. 
Therefore, consideration of factors such as the choice of b-values, pre-defined thresholds 
and fitting algorithms (section 2.3.2.1) becomes even more essential for IVIM analysis in 
the brain. 
The previous IVIM studies have shown interesting and promising results for its use in 
clinical applications, although challenges remain with its methodology. The 
discrepancies seen in the previous glioma studies make it difficult to assess the accuracy 
of the IVIM parameters, and raise the need for guidelines to aid in interpretation of 
these differences. Further technical validation in terms of the assessment of data quality 
and the reliability of the IVIM parameters, need addressing before the method can be 
truly applied in clinical practice.  
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2.3.3 Other Mathematical Models for Diffusion MR Imaging 
Other mathematical models have been proposed to describe the attenuation of diffusion 
signal at multiple b-values. These include the stretched exponential (145), Gaussian or 
statistical (146) and kurtosis (147) models. These models introduce additional 
parameters, which are not of specific physiologic basis. They do however consider the 
non-mono-exponential behaviour of diffusion signal seen in tissues. Here, a brief 
summary is given of these models. 
The stretched-exponential model was introduced by Bennett et al. (145) to account for 
the microscopic heterogeneity seen in cerebral cortex, with no assumptions made on the 
number of diffusing components: 
𝑆(𝑏)
𝑆(0)
= exp [(−𝑏 ∙ 𝐷)α] [2.15] 
where D (in mm2/s) is the distributed diffusion coefficient and α (no units) the 
heterogeneity index between 0 and 1. The D can be simply interpreted as the diffusion 
coefficient, but the interpretation of α is more challenging with no clear link between the 
parameter and a physiological origin. In the original study, the model was found to 
provide a better fit for 20 % of the voxels in comparison to the IVIM model. However, 
only voxels from the cerebral cortex were included and therefore its use for other brain 
tissues was not justified. 
Another mathematical model, the Gaussian model, was proposed by Yablonskiy et al. 
(146). The model accounts for within-voxel heterogeneity and assumes a Gaussian 
distribution of diffusion coefficients, P(D). 
𝑆(𝑏)
𝑆(0)
= ∫ 𝑑𝐷𝑃(𝐷)exp (−𝑏𝐷)
∞
0
 [2.16] 
The fitting with this model provides a truncated Gaussian distribution with mode ∆ 
(mm2/s) and spread σ (mm2/s). The proposed model provides a framework for analysis of 
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complex diffusion, although the use of such a complex model itself can be rather slow 
and complicated for clinical use.  
Finally, the kurtosis model was introduced by Jensen et al. (147) to quantify the degree 
of non-Gaussian water diffusion (Eq. 2.17). This is measured by the kurtosis term, K, 
which estimates the excess kurtosis of the diffusion displacement probability 
distribution. The method uses a quadratic function, therefore allowing the estimation of 
both diffusion coefficient and diffusional kurtosis: 
𝑆(𝑏)
𝑆(0)
= exp (−𝑏 ∙ 𝐷 + 𝑏2𝐷2𝐾/6) [2.17] 
Promising results were reported in the original kurtosis study, which demonstrated a 
significantly higher kurtosis in white matter compared to grey matter, potentially 
reflecting the structural differences between these tissues. While the kurtosis model is 
relatively simple to apply, it does require the acquisition of higher b-values (> 1000), 
currently not part of most clinical protocols. 
The mathematical models described here can provide additional parameters as potential 
statistical biomarkers of disease. They might also provide better mathematical fits 
compared to models such as IVIM (148). However, the biological basis of these 
parameters remains uncertain and therefore the clinical value of these models is yet to 
be established.  
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2.4 Summary 
This chapter introduced the basic principles and theory behind MR imaging. This was 
followed by background on the physical phenomenon of diffusion, how it can be 
measured, and what it can tell us about the underlying tissue microenvironment. 
Consideration of these aspects is important to understand the challenges and 
restrictions posed for acquisition of high quality data, a necessity for robust data 
analysis, and the interpretation of results based on phenomenological models such as the 
IVIM. 
The second part of this chapter introduced the models used to describe the diffusion-
weighted MR signal. Focus was on the IVIM model, which includes the perfusion 
component into the modelling of the diffusion signal. The technical challenges in the 
implementation of IVIM in low-perfused tissues and the lack of studies thereof in 
assessing its reliability for such regions was covered to highlight the need for validation 
for its potential clinical use. A second limitation in the current literature is the 
continuous drive for increasing the number of b-values, rather than the use of higher 
NSA to improve the data quality and hence the IVIM parameter estimation. Therefore, 
the importance of data quality for reliable IVIM analysis should be further assessed. In 
this thesis, these limitations are addressed to advance the technical and clinical 
validation of IVIM, and to reduce the translational gap between its research and clinical 
use. 
 
 
 
 
 
  57  
 
 
 
Chapter 3 
Investigation of IVIM Fitting Methods in Low-
Perfused Tissues 
 
 
 
 
 
 
 
 
 
  58  
3. Investigation of IVIM Fitting Methods in Low-
Perfused Tissues 
Some aspects of the work presented here were published in [P01] and [P05]. 
3.1 Introduction 
The intravoxel incoherent motion (IVIM) model is based on the estimation of two 
diffusion components in tissue. One from the molecular diffusion of water and one from 
the blood perfusion in the microcapillary network (24, 25). Promising results have been 
reported for its use in clinical applications, yet challenges remain with its data 
acquisition and analysis, which have a direct effect on whether the IVIM parameters can 
be derived reliably (84, 85, 88, 92). 
The image quality, and the number and magnitude of b-values (Chapter 4) are 
important considerations for IVIM data acquisition. The data quality is often assessed in 
terms of signal-to-noise ratio (SNR), which determines the ratio of level of signal to the 
level of background noise. Requirements for sufficient SNR levels for different tissue 
types have been reported in previous IVIM studies (87, 88, 92). For the brain, a 
requirement of at least SNR = 30 or 50 has been proposed, with lower requirements 
suggested for the abdominal organs (87, 92). Although these studies provided 
recommendations for the sufficient SNR levels for IVIM, the in vivo SNR measurements 
were most commonly performed with the b = 0 images, apart from Wu et al. (87) who 
reported SNR ≈ 30 in the brain for b = 1000 s/mm2. However, the SNR at b = 0 might not 
correctly reflect the SNR at the higher b-values with lower signal intensities, and hence 
the data quality. Therefore, it is important to consider the SNR at the higher b-values to 
determine whether the IVIM parameters can be estimated in a robust manner.  
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Previous IVIM data fitting studies have mainly focused on the abdominal regions, which 
are relatively high perfused compared to the brain (84, 85, 88). In a comprehensive study 
by Barbieri et al. (85), variability was shown between the fitting algorithms depending 
on the abdominal region alone. This suggests that the performance of the fitting methods 
is highly dependent on the underlying tissue perfusion characteristics, and thus the 
degree of bi-exponential behaviour of the diffusion signal. 
As mentioned above, the application of IVIM in the brain differs from the abdominal 
organs in terms of the degree of perfusion (28). Perfusion in the brain is generally lower, 
which poses a greater challenge for the IVIM fitting, which assumes a bi-exponential 
signal (92). The brain also includes regions that exhibit mono-exponential signal 
behaviour e.g. cerebrospinal fluid (CSF), although this might not be the case for CSF in 
lateral ventricles due to pulsatile flow (149). While the use of IVIM in such regions is 
generally not problematic, the regions around the edges of CSF can produce artificially 
high degrees of bi-exponential or multi-exponential behaviour due to partial volume 
effects. This is picked up by the IVIM model, resulting in particularly high values for 
IVIM perfusion fraction. Thresholding methods have been commonly applied to remove 
such values (27, 28, 87, 93).  
Although the brain provides a relatively low-perfused region itself, even lower perfused 
tissues can exist in acute ischemic stroke (28), traumatic brain injury (94) and both adult 
and paediatric low-grade brain tumours (27, 95). As shown in previous studies, tissue 
characteristics are important for the evaluation of IVIM fitting methods, yet low-
perfused pathological brain tissues have not been reported to date. Therefore, this 
Chapter aims to assess and compare the constrained and simultaneous IVIM fitting 
methods in low-perfused tissues to evaluate its use for clinical applications in such 
regions. 
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3.2 Methods 
3.2.1 Data Simulations  
Model simulations were performed to investigate the influence of constraints on fitting 
algorithms and the resulting accuracy and precision (or reproducibility) of the estimated 
IVIM parameters. All simulations and data analysis were implemented using in-house 
Python software (Anaconda, Continuum Analytics, v. 2.7.1.0) with the LmFit library 
(150) and MATLAB (MathWorks, Natick, MA, v.2016b). The model data signal values 
were generated with Eq. 2.12 (Chapter 2) using b-value distribution: 0, 20, 40, 80, 110, 
140, 170, 200, 300, 500, 1000 s/mm2. The distribution was chosen based on the MR 
protocol used in the local institution. The IVIM parameters used for the grey matter 
(GM) and low-grade glioma tumour models were based on preliminary measurements 
performed with a paediatric brain tumour patient cohort (Table 3.1), presented in 
Chapter 5.  
Table 3.1 Tissue models and IVIM parameters used in the simulations. 
Tissue Model D (× 10-3 mm2/s) D* (× 10-3 mm2/s) f 
Grey Matter 0.83 20.8 0.115 
Tumour 1.63 7.23 0.095 
 
Random white Gaussian noise was introduced to the modelled data to simulate the 
Rician distribution of noise found in MR images using the in-built MATLAB function 
(Communications System toolbox, awgn() function). This was based on the Rician 
distribution equalling to Gaussian distribution for SNR levels > 3 (53). SNR levels of 20, 
30, 40, 50, 60 and 70, simulated with Gaussian noise, were used to study the influence of 
noise on the estimated parameters. SNR levels were selected based on previous brain 
DW-MRI publications (87, 151, 152) and SNR measurements performed with the DW-
MRI data from the local institution at b = 1000 s/mm2 (Chapter 4).  
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Figure 3.1 Simulated diffusion signal data for grey matter and low-perfused 
tumour models. Examples of grey matter (a-c) and tumour (d-f) diffusion signals generated 
at SNR = 70 (a,d), 50 (b,e) and 30 (c,f). 
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Examples of grey matter and tumour diffusion signal data generated based on in vivo 
DWI data are presented in Figure 3.1.  
Data simulations were performed using 1,000 random data iterations for each model and 
SNR level. Data iterations were defined as outliers if the standard error of the individual 
parameters was higher than 30 % for the bi-exponential fitting step. The standard errors 
for each parameter were determined by taking the square root of the diagonal elements 
in the variance-covariance matrix.  
3.2.2 Data Analysis 
Non-linear least-squares minimisation was performed with the Levenberg-Marquardt 
(153) algorithm for the IVIM fitting. The fitting was performed on a voxel-by-voxel basis 
using the bi-exponential methods outlined in Figure 2.18 and section 2.3.2.1. The fitting 
methods varied from a non-constrained simultaneous fitting to a more constrained step-
wise fitting with fixed IVIM parameters. 
For the two-step and segmented fitting methods, an assumption was made that the 
perfusion effects are negligible at high b-values > 200 s/mm2 (27, 28, 154). Based on this 
assumption, the mono-exponential relationship (linear fitting) was applied to the log of 
the high b-value data to define the diffusion coefficient D (Eq. 2.10). The segmented 
fitting includes an additional constraint with the derivation of perfusion fraction f from 
the same linear fit (Eq. 2.13), by extrapolating the fit to the y-intercept, S(int). If no 
vascular component is present, S(int) = S(0), where S(0) is the image data at b = 0. The 
final fitting step was performed with the non-linear bi-exponential fitting (Eq. 2.12), 
which for the case of simultaneous fitting was the only fitting step. 
A few constraints were used in the data fitting. The following boundaries were applied to 
the IVIM parameters: 0 < D < 0.1 mm2/s, 0 < D* 1 mm2/s and 0 < f < 1.  These boundaries 
were chosen to eliminate any non-physiological results (88).  
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3.2.3 Statistical Analysis 
Statistical analysis was performed in SPSS Statistics (IBM, Chicago, IL, v.22), unless 
stated otherwise. 
The following statistics were calculated for the estimated parameters D, D* and f. 
Accuracy was determined using the true IVIM values (used in signal data generation) 
and the measured mean values estimated from fitting of the simulated data. The 
reproducibility of the estimated parameters was determined as a coefficient of variation 
(CV%), expressed as the percentage of the ratio of the standard deviation to the mean. 
Additionally, confidence intervals and 2D error norm plots (LmFit library (150)) were 
used to analyse the estimation of IVIM parameters for data with a great amount of 
random noise and where data fitting was poor. The method used an F-test to compare 
the null model (best fit) with an alternate model where one parameter was fixed. 
Analysis of variance (ANOVA) was performed for the repeated IVIM model data 
simulations and the estimated parameters derived using the different fitting methods. 
This was to test if the estimated parameters differed significantly between the fitting 
algorithms. The Tukey post-hoc analysis was used to define which algorithms differed 
significantly. P-value < 0.05 was considered to indicate significant difference. 
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3.3 Results 
3.3.1 Model Data Simulations 
The accuracy of the fitting methods and hence the estimated IVIM parameters are 
described in Figures 3.2 and 3.3 for grey matter and tumour models, respectively. The 
estimation of D was robust for both the constrained and simultaneous fitting methods. 
At lower SNR levels, the mean D value decreased, which led to an increase in both f and 
D* mean values. While an increasing variance was observed for all the IVIM parameters 
at decreasing SNR levels, the variance was comparatively reduced for D and f. 
Significant differences between the fitting algorithms were observed for the grey matter 
model (Table 3.2) and the estimation of D (SNR 20-40; P 0.001 – 0.007), D* (SNR 20-70; 
P < 0.001 – 0.005) and f (SNR 20-40; P 0.001 – 0.013). The post-hoc test attributed this to 
the differences between the constrained fitting methods and the simultaneous fitting. 
Differences between the two constrained fitting methods were observed for D* and f at 
SNR 20-40.  
For the tumour model (Table 3.3), significant differences were observed for the 
estimation of D (SNR 20-60; P < 0.001 – 0.046), D* (SNR 20-50; P < 0.001 – 0.001) and f 
(SNR 20-60; P < 0.001 – 0.008). Similarly to the grey matter model, the differences were 
found to be between the constrained and simultaneous fitting methods.  
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Figure 3.2 The accuracy results for IVIM fitting methods using the grey matter 
model. Data simulation results for IVIM D (a-c), D* (d-f) and f (g-i) using the segmented, 
two-step and simultaneous fitting. 
 
Figure 3.3 The accuracy results for IVIM fitting methods using the tumour model. 
Data simulation results for IVIM D (a-c), D* (d-f) and f (g-i) using the segmented, two-step 
and simultaneous fitting.
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Table 3.2 ANOVA results for the comparison of the estimated IVIM parameters among the different fitting algorithms for the grey 
matter model. 
 P-value Tukey post-hoc (P-value) 
SNR D D* f  D D* f 
70 0.944 0.100 0.735  - - - 
60 0.089 < 0.001 0.211  - Seg-Sim < 0.001 - 
50 0.400 < 0.001 0.147  - Seg-Sim 0.02 - 
40 0.007 < 0.001 0.001  Seg-Sim 0.018 
2Step-Sim 0.018 
Seg-Sim < 0.001 Seg-Sim < 0.001 
Seg-2Step 0.014 
30 < 0.001 < 0.001 0.001  Seg-Sim < 0.001 
2Step-Sim < 0.001 
Seg-Sim < 0.001 
Seg-2Step < 0.001 
Seg-Sim < 0.001 
Seg-2Step 0.002 
2Step-Sim <0.001 
20 < 0.001 0.005 0.013  Seg-Sim < 0.001 
2Step-Sim < 0.001 
Seg-Sim < 0.001 
Seg-2Step < 0.001 
Seg-2Step <0.001 
2Step-Sim <0.001 
* Seg = segmented, 2Step = two-step, Sim = simultaneous fitting. 
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Table 3.3 ANOVA results for the comparison of the estimated IVIM parameters among the different fitting algorithms for the simulated 
tumour model. 
 P-value Tukey post-hoc (P-value) 
SNR D D* f  D D* f 
70 0.132 0.374 0.121  - - - 
60 0.004 0.785 < 0.001  Seg-Sim 0.006 
2Step-Sim 0.017 
- Seg-Sim < 0.001 
2Step-Sim < 0.001 
50 < 0.001 < 0.001 < 0.001  Seg-Sim < 0.001 
2Step-Sim < 0.001 
Seg-2Step 0.006 
Seg-Sim < 0.001 
Seg-Sim < 0.001 
2Step-Sim < 0.001 
40 0.046 0.067 0.008  Seg-Sim 0.07 
2Step-Sim 0.067 
- Seg-Sim < 0.001 
2Step-Sim < 0.001 
30 < 0.001 0.001 0.005  Seg-Sim 0.001 
2Step-Sim < 0.001 
Seg-Sim 0.001 
2Step-Sim 0.018 
Seg-2Step < 0.001 
Seg-Sim < 0.001 
2Step-Sim < 0.001 
20 < 0.001 < 0.001 0.001  Seg-Sim <0.001 
2Step-Sim 0.001 
Seg-Sim < 0.001 Seg-2Step < 0.001 
Seg-Sim < 0.001 
2Step-Sim < 0.001 
* Seg = segmented, 2Step = two-step, Sim = simultaneous fitting. 
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The IVIM parameter precision (or reproducibility) in terms of coefficient of variation 
(CV%) are reported in Tables 3.4 and 3.5 for the fitting of grey matter and tumour 
models, respectively. The number of outliers from the fittings methods are reported in 
Table 3.6. 
The grey matter model resulted in better precision and a smaller number of outliers 
compared to the tumour model. The simultaneous fitting was the most reproducible for 
the grey matter model, although not to a great extent. However, the simultaneous fitting 
was found to result in a large number of outliers.  
The precision of the tumour model was found to be poor especially at low SNR levels for 
the IVIM perfusion parameters D* and f. The precision of D was similar for both models. 
The estimation of D* and f was more variable across all SNR levels, and in particular at 
SNR 20-40.  The more constrained fitting methods improved the precision compared to 
the simultaneous fitting. The segmented fitting of the constrained methods was found to 
be the most reproducible with the lowest number of outliers. 
Overall, the segmented fitting approach estimated the most accurate and precise D, D* 
and f values, without excluding a great amount of the data. This was more pronounced 
for the low-perfused tumour model. At SNR 40, the mean error % / precision (CV%) for 
D, D* and f were -0.30/4.23, 8.91/32.8, and 1.68/15.6 for the grey matter model, and -
1.57/3.95, 64.9/64.2, and 10.4/33.4 for the tumour model, respectively. 
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Table 3.4 Reproducibility (CV%) results of the grey matter model. 
 Segmented  Two-step  Simultaneous 
SNR D D* f  D D* f  D D* f 
70 0.13 0.98 0.49  0.13 0.73 0.36  0.10 0.67 0.29 
60 0.41 3.20 1.54  0.41 2.37 1.12  0.31 2.21 0.90 
50 1.37 10.3 5.07  1.37 7.54 3.66  0.99 7.04 2.91 
40 4.23 32.8 15.6  4.23 23.2 11.4  3.31 21.8 9.21 
30 11.3 68.7 38.3  12.4 73.9 34.2  12.6 80.0 31.4 
20 27.9 147 45.8  41.5 122 58.1  39.5 112 59.3 
 
Table 3.5 Reproducibility (CV%) results of the tumour model. 
 Segmented  Two-step  Simultaneous 
SNR D D* f  D D* f  D D* f 
70 0.13 1.04 1.08  0.13 1.39 1.41  0.21 2.04 2.24 
60 0.40 3.29 3.33  0.40 4.45 4.38  0.68 6.59 7.23 
50 1.26 11.8 10.6  1.26 14.3 13.6  2.29 20.7 25.5 
40 3.95 64.2 33.4  4.11 60.6 41.6  6.00 74.8 60.2 
30 9.51 128 55.2  10.1 136 61.8  8.47 181 66.9 
20 22.1 158 56.3  22.2 155 65.5  18.6 204 73.8 
 
Table 3.6 Number of outliers (%) from the data fitting. 
 Grey Matter  Tumour 
SNR Seg Two-step Sim  Seg Two-step Sim 
70 9.10 10.2 19.6  11.3 21.7 30.1 
60 11.5 12.6 22.4  12.9 23.6 49.2 
50 18.5 24.5 35.7  20.5 29.9 54.9 
40 23.3 28.7 43.7  26.7 42.0 65.6 
30 27.7 31.5 54.6  28.4 49.9 70.1 
20 31.8 37.3 55.7  34.2 54.7 73.0 
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3.3.2 Uniqueness of IVIM Parameters 
Confidence intervals were computed for the IVIM parameters at different SNR levels to 
investigate their uniqueness, focusing on cases that resulted in ill-conditioned data 
fitting. In this context, uniqueness was used to describe whether the IVIM parameters 
are unique of one another in their estimation.  
Example cases of 2D-confidence interval or error-norm plots at SNR = 40 and 20 with 
grey matter and tumour models are shown in Figure 3.4 and 3.5, respectively. The plots 
represent signal data, where data fitting was starting to fail due to a greater amount of 
random noise or at the so-called “worst case scenario”. The D and f were the most robust 
parameters, varying little within the 95 % confidence regions. The D* was increasingly 
overestimated at decreasing f or increasing D values, which corresponded to decreasing 
bi-exponential behaviour of the signal. Similar behaviour was observed across all three 
bi-exponential fitting methods, whether constrained or not, although slightly more 
elongated confidence regions were observed for the simultaneous fitting.  
The error norm plots for the tumour model showed similar behaviour to the grey matter 
model, although the 95 % confidence regions appeared relatively more elongated for each 
IVIM parameter (Figure 3.5). No multiple minima were observed for either of the tissue 
models, meaning that the Levenberg-Marquardt fitting algorithm was appropriate for 
the use of IVIM in the brain, as only a global minimum was observed. 
The distributions of the estimated IVIM parameters at increasing SNR levels are shown 
for segmented and simultaneous fitting methods in Figure 3.6. The estimation of D 
values was robust with a few outliers, while a wider spread of values was observed for 
both D* and f. The f value distributions were found positively skewed towards the higher 
values at the reducing SNR levels, and the median gave a better measure of the central 
tendency. This was also seen in Figure 3.4 as the elongation of the confidence levels 
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towards greater f values. The estimation of D* had limited robustness even at the higher 
SNR levels. 
 
Figure 3.4 Error norm plots for the grey matter model. Examples of segmented fitting 
and the resulting error normal plots at SNR = 40 (left) and SNR = 20 (right), where the data 
fitting was starting to fail due to a greater amount of random noise. The plots were computed 
for all three IVIM parameter combinations f-D* (a-b), f-D (c-d), and D-D*(e-f). The contour 
colours describe the percentage confidence as shown by the colour bar. 
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Figure 3.5 Error norm plots for the tumour model. Examples of segmented fitting and 
the resulting error normal plots at SNR = 40 (left) and SNR = 20 (right), where the data 
fitting was starting to fail due to a greater amount of random noise. The plots were computed 
for all three IVIM parameter combinations f-D* (a-b), f-D (c-d), and D-D*(e-f). The contour 
colours describe the percentage confidence as shown by the colour bar. 
 
Chapter 3. Investigation of IVIM Fitting Methods in Low-Perfused Tissues 
 73  
 
 
Figure 3.6 Boxplots of estimated IVIM parameters for the grey matter model. 
Boxplots of D (a-b), D* (c-d) and f (e-f) value distributions with segmented (left) and 
simultaneous (right) fitting methods for the grey matter model. The y-axis describes the 
percentage error (%) to the true value, the pink lines describe the medians and notches 
describe the 95 % confidence levels of the median. The box edges are the first (Q1) and the 
third (Q3) quartiles, with whiskers showing the more extreme data points not considered 
outliers. 
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3.4 Discussion 
In this Chapter, simulated multi b-value DW-MRI data for the determination of IVIM 
parameters was used to investigate the robustness of the fitting methods in low-perfused 
brain tissues. The model simulations suggested that the constrained segmented and two-
step methods performed similarly but better than simultaneous fitting. At the lower 
SNR levels, the estimated parameters from the constrained methods differed 
significantly to the ones derived with simultaneous fitting. The use of constrained fitting 
methods reduced the number of outliers and provided more reproducible estimation of 
IVIM parameters. Overall, the more constrained approaches provided more robust 
results compared with the simultaneous fitting, in particular at the lower SNR level.   
The segmented fitting has often been used to increase the reliability of the D* parameter 
in abdominal or body IVIM studies (84, 89, 90, 111). However, the precision of D* in the 
relatively low-perfused grey matter model was found similar across the three fitting 
methods, although better accuracy was achieved with the segmented method. In this 
study, the constrained fitting methods and especially the segmented fitting were found 
to produce more reliable results for the tumour model with the subtle bi-exponential 
signal data. This was observed with the estimation of D* and to a lesser extent with f. 
Therefore, tissues of low perfusion can also benefit from the use of more constrained 
fitting methods.  
The results from the data simulations showed that the estimation of D and f was more 
robust and reliable compared to D*. Both f and D* were affected by the degree of 
perfusion or bi-exponential behaviour, which resulted in a greater variance for the low-
perfused tumour model. However, f was still estimated with good accuracy at lower SNR 
levels using the segmented fitting method. A similar perfusion-related influence was 
observed in a study by Wu et al. (87), where model simulations based on a healthy brain 
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showed greater variance for the less-perfused white matter compared to the grey matter. 
Therefore, the low-perfused tissues are likely to have a higher SNR requirement for the 
computation of reliable IVIM derived parameters. Overall, our simulations suggest that 
the use of segmented fitting is beneficial, providing more reliable results with the 
smallest number of outliers, followed by the two-step fitting, which has been the more 
commonly applied method in the brain (27, 28). 
The uniqueness of the estimated IVIM parameters was investigated using error norm 
plots. For models such as the bi-exponential, the approximation of the standard error 
from the covariance matrix can begin to fail, and confidence intervals can provide a 
better measure of robustness of the parameters. Most of the grey matter and tumour 
model iterations produced symmetrical uncertainties and the standard errors derived 
from the covariance matrix produced sufficient approximates of the uncertainties. 
Therefore, the presented error norm plots of grey matter and tumour model cases did not 
reflect most of the data observed at the corresponding SNR levels, but rather indicated 
the behaviour of the models at higher random noise levels. 
Previous studies, such as one by Jelescu et al. (155), have shown that multiple minima 
can occur in application of multi-compartmental models to diffusion-weighted data. 
Depending on factors such as the initial parameter value (set for the fitting algorithm), 
the minimisation process might converge in a local minimum and hence lead to incorrect 
estimation of the parameter value. However, in our study, no such cases were observed, 
meaning that the chosen algorithm was feasible for the convergence of the algorithm to 
the global minimum. This is important for the clinical reliability of the model. 
The results from the grey matter model suggested that the estimation of D and f was 
still robust in the presence of noise. A loss in uniqueness of D* was observed, with a 
range of D* values estimated for the fixed D and f values. This was also illustrated as 
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the large number of outliers for the D* parameter. In comparison to the other fitting 
methods, the segmented fitting provided the best estimate of D*. With the limited 
robustness and loss in uniqueness of D*, our study suggests that the fitting methods 
utilised here cannot provide a reliable measure of microvascular diffusion, specifically 
the parameter D*, for the low-perfused brain tissue. An increase in SNR or the number 
of low b-values could potentially increase the robustness of D*, which was previously 
shown in a liver study by Cohen et al. (84). Also, as previously mentioned, an increase in 
the number of averages would improve the fitting and hence the robustness of the D* 
and f.  
3.5 Study Limitations 
A key limitation in this study was the use of fitting methods that assume the signal bi-
exponential. In regions where the signal decay approaches mono-exponential behaviour, 
such as for the tumour model, the accuracy and precision of the estimated f and D* 
parameters was decreased. The f parameter was affected to a lesser degree than the D*, 
which performed poorly in the model simulations. In scenarios where the signal might be 
mono-exponential, the D and D* would effectively be the same. This could be 
implemented into the in vivo fitting scenarios as a quality control method to improve the 
robustness and reliability in low-perfused regions. 
 
 
 
 
Chapter 3. Investigation of IVIM Fitting Methods in Low-Perfused Tissues 
 77  
3.6 Conclusion 
The model simulations suggested that the best performance was achieved with the use of 
constrained fitting algorithms. These resulted in the most reliable IVIM parameters, and 
although similar accuracy was achieved with the simultaneous and constrained fitting 
methods, differences were observed in the precision or reproducibility, and the number of 
outliers. Greater variance was demonstrated in the estimation of the IVIM parameters 
in the low-perfused tumour model compared to the grey matter model.  However, the 
estimation of D and f parameters was robust despite the low degree of bi-exponential 
behaviour. The D* parameter was concluded to provide unreliable results in such regions 
with the fitting methods studied here. The simulations indicated that there is an 
important SNR requirement for reliable IVIM data analysis in the very low-perfused 
tissues. In our study, this was approximately SNR > 40. Overall, this study showed that 
the constrained fitting of the IVIM model and the D and f parameters can be used to 
assess low-perfused tissue regions. 
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4. Rapid Measurement of IVIM Perfusion Fraction 
for Use in Clinical MR Imaging 
Some aspects of the work presented here were published in [P02] and [P06]. 
4.1 Introduction 
The clinical adoption of the intravoxel incoherent motion (IVIM) model has been 
hindered by practical issues, such as the lack of consensus for the number and choice of 
b-values, and the requirements for sufficient signal-to-noise ratio (SNR) levels for 
accurate and reproducible post-processing (84, 85, 92). As a potential consequence, 
variability has been observed in the previously reported perfusion fraction f values, as 
summarised in Table 2.2, in both the brain and the abdomen. The variability of 
parameters can also be related to their reproducibility. However, previous studies have 
shown that the IVIM D and f are reproducible to a clinical standard, but greater 
variability has been observed with the pseudo-diffusion coefficient D* (79, 85, 90, 156). 
Therefore, the variability resulting from the use of different b-value distributions should 
be addressed to estimate its contribution to the differences seen in previous studies. 
As mentioned above, the poor precision and reproducibility of the D* parameter has 
hindered its clinical value, particularly for the low-perfused brain tissues (28, 93, 156). 
This has meant that the IVIM brain applications have mainly focused on the D and f 
parameters, with clinical value demonstrated in brain tumour grading (27, 93, 137) and 
stroke imaging (93, 139). The application of IVIM and D* has been more established in 
the abdominal organs such as the liver (84, 109, 111) and kidneys (157). However, the 
reproducibility of D* is still reduced relative to the D and f parameters, and commonly 
produces very heterogeneous appearing maps (109). The application of IVIM in the 
abdomen is also subject to respiratory and cardiac motion artifacts. 
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While different challenges exist for the applications of IVIM in different tissues, the 
same practical issues related to the requirements for data quality and acquisition 
remain.  
The translation of IVIM to clinical practice requires a DW-MRI protocol with a short 
acquisition time. One way to reduce the scanning time is to decrease the total number of 
b-values. Previously, the most robust IVIM parameters in many tissue types (85, 88, 
156), including low-perfused tissues presented in Chapter 3, have been achieved with the 
use of segmented IVIM fitting. Using this methodology, the D and f parameters can be 
computed using the linear fit of high b-values and b = 0. Although this method does not 
allow the computation of the D* parameter, the challenges with its reproducibility 
suggest that further evaluation is required to demonstrate its clinical reliability. 
Therefore, if only D and f are of clinical interest, the IVIM could be performed using a set 
of high b-values, thereby minimising the time required for data acquisition. 
A series of high b-value combinations for brain tumour and stroke patients were used for 
the estimation of f with the segmented fitting in a study by Conklin et al. (93). The 
recommended b-value distribution was chosen by comparison to the more commonly 
used less constrained two-step fitting method in the brain. Although the similarity of the 
two fitting methods can indicate how many b-values are required for comparable results, 
it was unable to assess the accuracy and reliability of the estimated IVIM parameters.  
In this Chapter, the aim is to evaluate the application of a rapid three b-value protocol 
for the estimation of clinically valuable D and f parameters, using tissue models 
accounting for diffusion in the brain and the abdomen, and to investigate the influence of 
different b-values in the parameter estimation. To relate and validate the results back to 
in vivo data, comparison of the model data to brain DW-MRI data is performed. 
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4.2 Methods 
4.2.1 Data Simulations  
 
Figure 4.1 Description of the IVIM data generation and fitting method. A schematic 
(a) of the mono-exponential fitting of the high b-value diffusion signal to derive the D and f 
parameters from the fit gradient and off-set of the intercept to S(0), respectively. Plots (b) 
describing the data signal decay at varying f values for the diffusion in low-perfusion model 
(brain) and (c) comparison of the signal decays for the different tissue models, respectively. 
All simulations and data analysis were implemented in MATLAB v.2016b (MathWorks, 
Natick, MA). The model data signal values were generated with the bi-exponential Eq. 
2.12, using b-value distribution: 0, 200, 300, 400, 500, 600, 700, 800, 900, 1000 s/mm2. 
The data generation and analysis are described in Figure 4.1. 
Signal data sets were generated using a range of f values (0.06 to 0.30 in increments of 
0.02) and three different D*/D ratios, corresponding to previously reported ratios 
observed in brain, kidney and liver (10, 20 and 70, respectively (92)). The D parameter 
was fixed at 0.7  10-3 mm2/s and D* parameter was 7  10-3, 14  10-3 and 49  10-3 
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mm2/s for the brain, kidney and liver models, respectively. In this chapter, these models 
are also referred to as low-, medium- and high-perfusion models, respectively. Signal 
data for the different diffusion scenarios and a series of f values is presented in Figure 
4.1b and 4.1c.  
Gaussian noise was introduced to the modelled data to simulate the Rician distribution 
of noise found in MR images using the in-built MATLAB function (Communications 
Systems toolbox). Signal to noise ratio (SNR) levels of 40, 55 and 80, based on Gaussian 
noise, were used to study the influence of noise on the estimated parameters. SNR = 40 
was representative of the SNR levels measured in our volunteer cohort (b = 1000 s/mm2) 
and the higher SNR levels corresponded to increasing the number of averages (NSA) 
from one to two and four, respectively. The data simulations were performed using N = 
1,000 random data iterations for each set of IVIM parameters. 
4.2.2 MR Imaging 
All MR imaging was performed on a Philips Achieva 3.0 Tesla (T) TX (Philips 
Healthcare, Best, the Netherlands) MRI scanner with a 32-multichannel receive head 
coil at Birmingham Children’s Hospital.   
The diffusion MR protocol used a sensitivity-encoded (SENSE) approach with single-
shot, spin-echo (EPI) sequence, with diffusion-weighted gradients applied in three 
orthogonal directions, of which a geometrical average (or trace) diffusion-weighted image 
was derived. The protocol used TR/TE = 4,000/91 ms, 30 contiguous 3.5 mm thick axial 
slices, field-of-view (FOV) 240  240 mm and matrix size 96  96, which resulted in in-
plane resolution of 2.5  2.5 mm. The b-value distribution included values of 0, 300, 500, 
1000 s/mm2 which were used in the analysis (full b-value distribution: 0, 20, 40, 80, 110, 
140, 170, 200, 300, 500, 1000 s/mm2). The spectral presaturation with inversion recovery 
(SPIR) was used for fat suppression and the total scan duration was 2.12 minutes. The 
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T1-weighted scan was performed with a spin-echo sequence with FOV 240  240 mm, 
matrix size 240  240, slice thickness 3.5 mm and TR/TE = 675/10 ms. 
Additionally, four of the volunteer cases (n = 4) were scanned twice with the DW-MRI 
protocol to assess the IVIM parameter repeatability. The volunteers remained on the 
scanner bed for both of the scans. Finally, one volunteer (n = 1) had a separate scan 
acquired with b-values: 0, 200, 300, 400, 500, 600, 700, 800, 900 and 1000 s/mm2 for 
illustrative purposes.  
4.2.2.1 Volunteer Population 
A cohort of healthy young adult volunteers (n = 16, age 25-30, mean age 26 years) was 
scanned with the above MRI protocols (DW-MRI, T1W-MRI). The protocols for this 
retrospective study were approved by the research ethics committee and informed 
consent was gathered from all volunteers. 
4.2.3 Data Analysis 
IVIM data fitting was performed with the segmented method, as described in Chapter 2 
(section 2.3.2.1), and demonstrated in Figure 4.1a, to estimate the IVIM D and f 
parameters. The fitting of generated diffusion-weighted signal was performed with b-
value distributions: [200,1000], [300,1000], [400,1000], [500,1000], [600,1000], 
[700,1000], [800,1000] and [900,1000]. For the volunteer cohort (n = 16), due to the 
retrospective nature of the data, only fitting with [300,1000] and [500,1000] was 
performed, including the scans acquired for repeatability measurements. The IVIM D* 
was estimated with the segmented fitting and the full b-value distribution was used to 
estimate the in vivo IVIM D* in grey matter. 
Grey matter masks were created for each volunteer case with the Brain Extraction Tool 
(BET) and FMRIB’s Automated Segmentation Tool (FAST) in FMRIB Software Library 
package (Analysis Group, FMRIB, Oxford, UK, v. 5.0) using the T1-weighted images 
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(158, 159). The probabilistic tissue segmentation was performed for three classes, 
corresponding to grey matter, white matter or cerebrospinal fluid (CSF). To assess the 
inclusion of only cortical grey matter and exclusion of sulcal CSF in the binary masks, 
partial volume tissue (PVE) segmentation was also performed for eight of the volunteer 
cases (n = 8). The PVE masks provided an estimation of the proportion of grey matter 
within the voxels (scale 0 - 1), and only voxels of value = 1 were included in the analysis, 
which corresponded to tissue fully representing grey matter with no partial volume of 
CSF or white matter (see Figure 4.13).  
The T1-weighted images were acquired using the same spatial geometry as the DWI 
images and no further registration was performed at post-processing. The generated 
masks (mask = 1, background = 0) were adjusted for the size of the acquired DWI images 
using bi-linear interpolation. As the interpolation of the binary masks resulted in a 
range of values (0 to 1) for the mask, a threshold of 0.7 was applied to remove blurring 
effects created around the mask edges (values > 0.7, were made to equal 1). This further 
minimised the number of pixels affected by partial volume effects. For the analysis, the 
D and f values were extracted using the grey matter masks from three slices above the 
lateral ventricles. 
Based on the extracted grey matter values, average histograms were computed for the 
IVIM parameters. The number of bins was based on the square root of the maximum 
number of data values extracted from the regions-of-interests (ROIs). The bin widths 
were computed for a range of zero to the maximum IVIM value. The same number of 
bins was used for all the cases and b-value distributions, as well as for the IVIM values 
extracted with the PVE masks. The same histogram methodology was applied to the 
simulated IVIM parameters. 
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4.2.3.1 Signal-to-Noise Ratio (SNR) of DW-MRI Data 
 
Figure 4.2 The difference images of b-values used for the computation of SNR. The 
diffusion-weighted images (top) and the difference images, [im3], (bottom) for a series of b-
values used in the DW-MRI protocol. 
SNR levels of the DWI data were determined using the standard NEMA method, which 
is the recommended method for computing SNR when parallel imaging such as SENSE 
acceleration is used (160). The method uses subtraction of two repeated signal-
containing images [im1 and im2], providing a difference image [im3], which gives a 
measure of the noise field: 
[im3] = [im1] − [im2] [4.1] 
Examples of the difference images for different b-values are shown in Figure 4.2. 
The standard deviation of noise (σ) was determined from the pixel values within a 
region-of-interest (ROI) in [im3]. Using the same ROI, the average signal is determined 
from the [im1 and im2]. The SNR can then be calculated using (152): 
SNRdiff(im1, im2) =  
𝑆𝑑𝑖𝑓𝑓
𝜎𝑑𝑖𝑓𝑓
=
1
2mean(𝑆𝑁
(𝐫, im1) + 𝑆𝑁(𝐫, im2))
1
√2
stddev((𝑆𝑁(𝐫, im1) − 𝑆𝑁(𝐫, im2))
=
1
2𝑚sum
1
√2
𝑠diff
=
1
√2
𝑚sum
𝑠diff
 [4.2] 
where r = (x,y,z) is the position. 
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The SNR was measured for grey matter regions of five volunteers using ROI size of 3 × 
3. The SNR at b = 1000 s/mm2 was found to be in the range of 45 ± 8. 
4.2.4 Statistical Analysis 
Statistical analysis was performed in SPSS Statistics (IBM, Chicago, IL, v.22) and 
Microsoft Excel (Microsoft, Redmond, WA, v.16.0). 
4.2.4.1 Simulated Model Data 
The following statistics were calculated for the estimated parameters D and f. Relative 
bias was determined from the difference between the true parameter (used in the signal 
data generation) and the estimated parameter (computed from fitting of the signal data) 
values, which was normalised to the true parameter value: 
relative bias =  
1
𝑁
∑ (𝑥𝑖 − 𝑋)
𝑁
𝑖=1
𝑋
 
[4.3] 
where i = number of iterations, xi = estimated parameter and X = true parameter. 
Relative error (σ) was computed as the root mean square of the distance between the 
true parameter to the estimated parameter: 
relative error, σ =  
√1
𝑁
∑ (𝑥𝑖 − 𝑋)2
𝑁
𝑖=1
𝑋
 
[4.4] 
Both relative bias and error were determined individually for each estimated parameter 
(D, f) rather than for the mean values over all data iterations. The overall relative error 
was computed from the individual IVIM parameter errors for each b-value distribution 
using σD+f = σD + σf. The overall error and the σf were used to make recommendations for 
the simulated tissue regions based on the smallest overall relative error.  
The reproducibility of the estimated parameters was determined as a coefficient of 
variation from the ratio of the standard deviation to the mean of the estimated 
parameters: 
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coefficient of variation (%) =
(
 
√1
𝑁
∑ (𝑥𝑖 − ?̅?)2
𝑁
𝑖=1
?̅?
)
 ×  100 [4.5] 
where ?̅? is the mean of the estimated parameter D or f. 
4.2.4.2 In vivo Volunteer Data 
Correlation analysis (n = 16) was performed for the mean D and f parameters of grey 
matter to determine how the values were related between the b-value distributions 
[300,1000] and [500,1000]. This was assessed using the Pearson correlation coefficient, r. 
An analysis of variance (ANOVA) was also performed for the mean grey matter values. 
This was to test if the estimated parameters differed significantly (P < 0.05) between the 
two b-value distributions. The agreement of the estimated IVIM parameters with the 
different b-value distributions was determined with the Bland-Altman analysis. The 
repeatability of the IVIM parameters was tested using within-subject coefficient of 
variation (wCV%), which was the recommended statistic by the Quantitative Imaging 
Biomarkers Alliance (161). The methodology has been applied in previous IVIM studies 
(84, 88, 90). The wCV was computed with the root mean square method (162), using the 
paired DW-MRI data measurements (n = 4) and 4  4 ROIs (two for each measurement 
pair) of the same grey matter regions as used in the above analysis. To assess whether 
the IVIM values were influenced by CSF partial volume, ANOVA was performed for 
IVIM histogram parameters derived with the probabilistic and PVE masks (n = 8) to 
determine any significant difference (P < 0.05). 
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4.3 Results 
4.3.1 Model Data Simulations 
The relative bias results for the estimated f and D parameters from the tissue models 
and the different b-value distributions are presented in Figure 4.3. Noise was found to 
influence the bias at SNR = 40, whereas results at SNR = 55 and 80 resembled one 
another in magnitude and behaviour for all tissue models. The direction of bias was 
different for f and D, with negative and positive bias shown, respectively. At the higher 
SNR levels (55 and 80), the magnitude of the simulated f value was found to not affect 
the bias in estimation of f. However, at SNR = 40, noise had a greater influence on lower 
f values and higher b-values. The similarity of biases at SNR = 55 and 80 suggests that 
these present the intrinsic magnitude of biases from the fitting of the tissue models. 
Higher biases were observed for the lower perfusion models, with lower D*/D ratios 
equating to lower degrees of bi-exponential behaviour. 
The choice of b-value had a noticeable influence on the observed bias. The intrinsic bias 
of the models and the estimated parameters was higher at the low b-value distributions, 
whereas noise affected the high b-value distributions, although only for the f parameter. 
Distributions of the estimated f values with different b-value distributions for the three 
models are presented in Figure 4.4 for SNR = 40. Narrower distributions were observed 
for the lower b-values, whereas the estimation of f with [800,1000] was largely 
influenced by noise. The position of the f value distributions, derived with [200,1000] for 
the lower perfusion models clearly indicated the presence of greater intrinsic negative 
bias. 
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Figure 4.3 Relative bias results for the estimated IVIM parameters as a function of 
b-value. Relative bias results for the (a-c) low-, (d-f) medium- and (g-i) high-perfusion models 
at SNR levels 40, 55 and 80. Results are presented for simulated f values of 0.1, 0.2 and 0.3 
for both D and f. Bias = 0 is indicated by the black dashed line. 
The bias of f for the range of simulated values (f = 0.06 - 0.3) and the low-perfusion 
model at SNR 40 was -35.8 ± 0.3 %, -8.63 ± 0.8 % and -5.77 ± 15.0 % for [200,1000], 
[500,1000] and [800,1000] distributions, respectively. At SNR = 55 the biases were 
similar but with reduced variability: -35.7 ± 0.2 %, 8.48 ± 0.05 % and -2.62 ± 0.32 %. 
Similarly for the D parameter at SNR = 40, the bias was 11.1 ± 5.32 %, 2.72 ± 1.34 % and 
0.61 ± 0.65 % for [200,1000], [500,1000] and [800,1000] distributions, respectively.  For 
the higher perfusion models (medium and high), the bias was < 10 % for f, apart from the 
high b-value distributions (b = 700 – 900 s/mm2) at SNR = 40. The bias for the D 
parameter was < 6 % for both higher perfusion models. 
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Figure 4.4 Distributions of the estimated f values from model simulations and b-value distributions at SNR = 40. 
Distributions based on simulations where f = 0.1 (top) and f = 0.3 (bottom) using b-value distributions b[200,1000], b[500,1000] and 
b[800,1000] for low- (a,d), medium- (b,e) and high-perfusion (c,f) tissue models. 
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Figure 4.5 Reproducibility of perfusion fraction f, as a function of b-value. 
Reproducibility of f in low- (a-c), medium- (d-f) and high-perfusion (g-i) models at SNR levels 
40, 55 and 80 for simulated f values 0.1, 0.2 and 0.3. 
 
Figure 4.6 Reproducibility of diffusion coefficient D, as a function of b-value. 
Reproducibility of D in low- (a-c), medium- (d-f) and high-perfusion (g-i) models at SNR levels 
40, 55 and 80 for simulated f values 0.1, 0.2 and 0.3. 
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The reproducibility results for f and D parameters and the different tissue models are 
presented in Figures 4.5 and 4.6, respectively. The variability of the estimated IVIM 
parameters was largely influenced by noise and dependent on the SNR level. The 
increase from SNR = 40 to SNR = 55 (NSA = 1 to NSA = 2) resulted in a noticeable 
improvement in the reproducibility of D and f, with smaller improvements observed with 
the increase to SNR = 80. The different tissue models did not differ to a great extent in 
terms of their reproducibility for the f parameter, but the D parameter was found to be 
more reproducible with the low-perfusion model. Lower variability of f and D was 
observed with the use of lower b-value distributions. Finally, higher f values had better 
reproducibility compared to low f values. 
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4.3.2 Optimal b-value distributions 
The relative errors of estimating f and D individually are presented in Figures 4.7 and 
4.8, respectively, for the low- and high-perfused tissue models. The relative error of f was 
greater compared to D in all cases. At SNR = 80, the relative errors were higher at low b-
value distributions for the low- and medium-perfusion models because of the influence 
from bias. As shown previously, negligible bias was observed with the high-perfusion 
model. Noise had a larger influence compared to bias at SNR = 40, resulting in higher 
relative errors at high b-values. At SNR = 55 a similar magnitude of contribution from 
bias and noise was seen for the low-perfusion model, whereas noise was the dominant 
contributor for the medium- and high-perfusion models.  
The overall relative errors based on both individual f and D errors are presented in 
Figure 4.9 for b-value distributions that had the lowest overall error. The overall error 
values for all b-value distributions are summarised in Table 4.1. The overall error was 
largely influenced by the relative error of f, with a small contribution from the relative 
error of D. For the low- and medium-perfusion models, a shift to a higher b-value 
distribution was observed at all SNR levels. This is seen on Figure 4.9b and 4.9d, where 
the relative error plots cross for the different b-value distributions.  
Based on the minimal overall and f relative errors, suggestions for optimal b-value 
distributions were derived. The optimal b-value distributions are listed in Table 4.2 for 
each perfusion model. At SNR = 40, the optimal b-value distributions were [500,1000], 
[300,1000] and [200,1000] for the low-, medium, and high-perfusion models, respectively. 
The relative errors of the estimated f parameters for these b-value distributions were < 
20 % at SNR = 40, and < 10 % for SNR = 55 and 80. For the low-perfusion model, a 
higher b-value distribution was required to minimise the influence from bias.  
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Figure 4.7 Relative error of estimating perfusion fraction f. Surface plots describing the relative error of f with different b-value 
distributions and SNR levels for (a-c) low- and (d-f) high-perfused tissue models. The b-value axis (200 to 900 s/mm2) defines the b-value, 
which together with b = 1000 s/mm2 was used to compute the f value. 
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Figure 4.8 Relative error of estimating diffusion coefficient D. Surface plots describing the relative error of D with different b-
value distributions and SNR levels for (a-c) low- and (d-f) high-perfused tissue models. The b-value axis (200 to 900 s/mm2) defines the b-
value, which together with b = 1000 s/mm2 was used to compute the D value. 
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Figure 4.9 The b-value distributions with the lowest overall relative error in 
estimating D and f parameters. Plots representing the optimal b-value distributions with 
lowest overall relative errors (D+f) for low- (a-b), medium- (c-d), and high-perfusion (e-f) 
models. The plots on the right-hand side represent the overall relative errors at SNR = 40, 
for the three best performing b-value distributions as a function of the simulated f value.
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Table 4.1 Overall relative error (± standard deviation) of the estimated D and f parameters. Lowest relative errors are highlighted for 
each SNR level and perfusion model. 
 Low-perfusion  Medium-perfusion  High-perfusion 
b-values SNR = 40 SNR = 55 SNR = 80  SNR = 40 SNR = 55 SNR = 80  SNR = 40 SNR = 55 SNR = 80 
[200,1000] 0.49 ± 0.04 0.47 ± 0.05 0.47 ± 0.05  0.22 ± 0.05 0.12 ± 0.01 0.12 ± 0.01  0.17 ± 0.06 0.03 ± 0.01 0.001 ± 0.0005 
[300,1000] 0.32 ± 0.02 0.29 ± 0.03 0.29 ± 0.03  0.21 ± 0.08 0.05 ± 0.01 0.04 ± 0.004  0.21 ± 0.08 0.04 ± 0.01 0.001 ± 0.0006 
[400,1000] 0.26 ± 0.05 0.18 ± 0.02 0.18 ± 0.02  0.26 ± 0.10 0.05 ± 0.02 0.01 ± 0.001  0.26 ± 0.09 0.05 ± 0.02 0.002 ± 0.0007 
[500,1000] 0.25 ± 0.08 0.12 ± 0.01 0.11 ± 0.01  0.34 ± 0.13 0.06 ± 0.02 0.004 ± 0.0004  0.34 ± 0.13 0.06 ± 0.02 0.002 ± 0.001 
[600,1000] 0.30 ± 0.12 0.09 ± 0.01 0.07 ± 0.01  0.45 ± 0.16 0.08 ± 0.03 0.003 ± 0.002  0.45 ± 0.17 0.08 ± 0.3 0.003 ± 0.001 
[700,1000] 0.40 ± 0.15 0.09 ± 0.03 0.05 ± 0.01  0.61 ± 0.19 0.12 ± 0.05 0.004 ± 0.002  0.64 ± 0.23 0.12 ± 0.05 0.004 ± 0.002 
[800,1000] 0.62 ± 0.23 0.13 ± 0.06 0.03 ± 0.003  0.92 ± 0.33 0.19 ± 0.08 0.007 ± 0.003  0.99 ± 0.33 0.19 ± 0.08 0.007 ± 0.003 
[900,1000] 1.20 ± 0.52 0.26 ± 0.12 0.03 ± 0.003  1.78 ± 0.74 0.40 ± 0.15 0.01 ± 0.007  1.91 ± 0.67 0.41 ± 0.16 0.01 ± 0.007 
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Table 4.2 Recommended b-value distributions for computation of IVIM perfusion fraction, based on relative error of < 10 %. 
Model Recommended b-value distribution Relative error of f Overall relative error 
Low-perfusion SNR = 40; [500,1000] 
SNR = 55; [600,1000], [700,1000] 
SNR = 80; ≥ [500,1000] 
18.7 ± 5.5 %* 
< 10 % 
< 10 % 
24.8 ± 7.6 %* 
< 10 % 
< 10 % 
Medium-perfusion SNR = 40; [300,1000] 
SNR = 55; [300,1000] – [600,1000] 
SNR = 80; ≥ [300,1000] 
15.3 ± 8.3 %* 
< 10 % 
< 10 % 
21.3 ± 7.8 %* 
< 10 % 
< 10 % 
High-perfusion SNR = 40; [200,1000] 
SNR = 55; [200,1000] – [600,1000] 
SNR = 80; ≥ [200,1000] 
12.1 ± 6.8 %* 
< 10 % 
< 10 % 
17.2 ± 6.4 %* 
< 10 % 
< 10 % 
* Lowest relative error. 
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4.3.3 Comparison of Grey Matter IVIM Parameters In vivo 
The b-value distributions [300,1000] and [500,1000] were investigated retrospectively for 
the volunteer cohort. Average IVIM parameters for the grey matter are presented in 
Figure 4.10 for the f and D parameters. The average values of f and D in the grey matter 
were 0.141 ± 0.02 and 0.865 ± 0.05 ( 10-3 mm2/s) with [500,1000], and 0.104 ± 0.01 and 
0.912 ± 0.05 ( 10-3 mm2/s) with [300,1000] distributions, respectively. The f parameters 
were higher and D parameters lower when computed using the [500,1000] distribution, 
agreeing with the observations made with the low-perfusion model. 
 
Figure 4.10 Mean IVIM parameters from in vivo grey matter. Mean f (a) and D (b) 
parameters derived from the volunteer cohort (n = 16). 
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Figure 4.11 Correlation and Bland-Altman plots for f and D parameters estimated 
in grey matter. Results from correlation and Bland-Altman (BA) analysis for (a-b) f and (c-
d) D parameters derived with [500,1000] and [300,1000] b-value distributions for the 
volunteer cohort (n = 16). The red lines in the BA plots describe the mean difference of the 
values and the dashed lines the agreement range (95% confidence intervals). 
The estimated f and D parameters with the [500,1000] and [300,1000] distributions were 
analysed using correlation and Bland-Altman methods (Figure 4.11). Significant 
correlations were established between both IVIM parameters derived with the different 
b-value distributions, which indicated an existence of a linear relationship. Correlation 
of r = 0.770 (P < 0.001) was derived between the f parameters, and r = 0.953 (P < 0.001) 
between the D parameters. However, the estimation of f (P < 0.001) and D (P = 0.029) 
were significantly different between the [500,1000] and [300,1000] distributions. The 
agreement of methods, described by the Bland-Altman plots, showed a bias of -0.037 and 
0.048 ( 10-3 mm2/s) for f and D parameters respectively. However, this only indicated 
the bias of estimating the IVIM parameters with [500,1000] in comparison to [300,1000]. 
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The bias was smaller at the lower f values and greater towards the higher f values. The 
opposite was observed for the D values. In comparison to the simulated f = 0.1 value for 
the low-perfusion model at SNR = 40, the differences between the mean values for 
[300,1000] and [500,1000] were 0.015 ( 10-3 mm2/s) and -0.013 for D and f parameters, 
respectively. At f = 0.2, the differences were increased to 0.030 ( 10-3 mm2/s) and -0.025, 
although the relative bias remained the same. 
Average in vivo grey matter histograms and low-perfusion model histograms (where f = 
0.1 at SNR = 40) were derived for the IVIM parameters (Figure 4.12).  Similar behaviour 
was observed between the in vivo and simulated data histograms. As depicted by the 
simulated data histograms, the in vivo histograms based on the [300,100] distribution 
were narrower in shape and the histograms based on the [500,1000] distributions were 
shifted to higher f values compared to the [300,1000] distribution.  
 
 
Figure 4.12 Histograms of IVIM perfusion fraction and diffusion coefficient. 
Histograms for in vivo (a-b) and simulated (c-d) data with b-value distributions [500,1000] 
and [300,1000]. The in-vivo histograms are the average histograms derived for the grey 
matter regions of the volunteer cohort (n = 16) and the simulated histograms correspond to 
the estimated values from the low-perfusion model at SNR = 40 and f = 0.1. 
Chapter 4. Rapid Measurement of IVIM Perfusion Fraction for Use in Clinical MR Imaging 
 102  
 
Figure 4.13 Grey matter segmentation. An example volunteer case with (a) T1-weighted 
image and overlaid binary grey matter mask regions showing the exclusion of CSF, (b) the 
binary mask, (c) the original PVE mask (with values 0 to 1) and (d) the final (binary) PVE 
mask. 
The wCV was used to assess the repeatability of the in vivo IVIM parameters, which for 
the [500,1000] and [300,1000] distributions was 6.32 % and 3.99 % for D, and 15.3 % and 
10.8 % for f, respectively. The values were similar to the ones depicted by the low-
perfusion model at SNR = 40 (Figures 4.5 and 4.6), with small improvements seen with 
the use of [300,1000] over the [500,1000] distribution. 
The IVIM parameter histograms were compared to the ones derived with PVE masks for 
eight volunteer cases (n = 8). No significant differences were found between the mean, 
median, 10th and 90th percentiles of the IVIM parameters derived with the different 
masks, for either [300,1000] or [500,1000] distributions. Example grey matter masks are 
presented in Figure 4.13 for a volunteer case. The overlaid mask regions showed that the 
sulcal CSF was successfully removed with the binary grey matter mask.  
For comparing the in vivo and simulated data results, the D* was computed for the grey 
matter using the full b-value distribution. The D* was estimated to be 9.40 × 10-3 (± 0.87 
× 10-3) mm2/s. This agreed with the D* used for the low-perfusion simulations, although 
was slightly higher than the simulated D* (7.00 × 10-3 mm2/s). 
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Figure 4.14 IVIM parameter maps derived with different b-value distributions. An 
example volunteer case with IVIM D (top) and f (bottom) parameter maps derived with b-
value distributions [300,1000], [500,1000], [700,1000] and [900,1000]. 
Finally, IVIM parameter maps for a volunteer case are presented in Figure 4.14. The f 
maps derived with the [300,1000] and [500,1000] distributions were qualitatively 
similar, although differences in the magnitude of values could be observed, as depicted 
by the in-vivo and simulation results. The IVIM maps derived with higher b-values 
appeared increasingly noisier. 
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4.4 Discussion 
The use of a simple fitting approach with a minimum number of b-values was 
investigated to assess the feasibility of a rapid clinical application for determination of 
the IVIM perfusion fraction parameter. The accuracy and reliability of the IVIM 
parameters from different b-value distributions were assessed using model simulations 
and confirmed using in vivo imaging. The model data simulations demonstrated that the 
optimal b-value distributions for different tissue regions are dependent on the SNR level 
and the degree of perfusion influencing the diffusion signal. Based on these results and 
the relative errors of f and D, optimal b-value distributions were suggested for each 
tissue type. 
The three perfusion models were influenced by bias and noise to a different extent. Bias 
was found to be the dominant cause of higher relative errors for the lower perfusion 
models and low b-value distributions. The bias was found to be independent of the 
simulated f value, but dependent on the b-value. In a study by Conklin et al. (93), a 
similar effect was demonstrated with lower perfusion fraction values estimated with the 
use of a b-value distribution [300,900], compared to distributions including more 
intermediate b-values.  
The other cause for the higher relative errors was noise, which affected the estimation of 
perfusion fraction at higher b-value distributions. This was likely introduced by the 
increased variability from extrapolating the linear fit back to the y-axis from the higher 
b-values. For the low-perfusion model, representing perfusion in the brain, the effects of 
bias and noise were found to be minimised with the use of b-value distribution 
[500,1000] at SNR = 40. This was also the case at higher SNR, due to the intrinsic bias 
seen with the use of low b-value distributions.  
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Similar characteristics were observed in vivo for the volunteer cohort, with regards to 
the estimation of the IVIM parameters. Higher f values were estimated with the 
[500,1000] distribution in comparison to the [300,1000] distribution, and the opposite 
was seen for the estimation of D.  The mean f values derived in vivo were 0.141 ± 0.02 
with [500,1000], and 0.104 ± 0.01 with [300,1000] distributions. For the low-perfusion 
model (at SNR = 40 and f = 0.14), the mean f values (error %) for [500,1000] and 
[300,1000] distributions were estimated to be 0.129 (-8.2 %) and 0.109 (-21.6 %), 
respectively.  
The magnitude of differences between the b-value distributions was somewhat greater in 
vivo compared to the simulated data. The D*/D ratio in vivo was estimated to be in the 
range of 9.31 to 12.6, which was in agreement with the ratio used in the model 
simulations (D*/D = 10). However, the variability of the in vivo ratios would have 
influenced the magnitude of bias, and in particular for regions where D*/D < 10, where 
the signal decay starts to approach mono-exponential behaviour. The contributions from 
any potential partial volume effects due to the presence of CSF were minimised with the 
exclusion of sulcal CSF. This was confirmed by the comparison of IVIM values derived 
with the binary and PVE masks, which showed no difference in the distribution of the 
extracted IVIM values. The PVE masks were strictly generated and no voxels presenting 
tissue but grey matter were included. The variability in the D*/D ratio, together with the 
effect of noise, were then likely to account for the greater differences seen in vivo. 
Nonetheless, the observations in vivo and simulated data confirm the presence of bias in 
low-perfused tissues. Therefore, consideration of b-values is particularly important when 
analysing brain data and other low-perfused tissues, where bias is likely to have a larger 
influence on the estimated IVIM parameters. 
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The medium- and high-perfusion models, representing tissues found in the abdomen 
resulted in a substantial decrease in bias when estimating the perfusion fraction. 
Therefore, the more important factor for the optimal b-value distribution was the 
variability arising from noise. The estimation of f was found to be more sensitive to noise 
in comparison to D, although the increase in SNR level considerably improved the 
reproducibility of both parameters. The smaller contribution from bias meant that the 
lower b-value distributions had lower relative errors for estimation of the IVIM 
parameters in contrast to the low-perfusion model. This resulted in the optimal b-value 
distributions for the medium-and high-perfusion models to be [300,1000] and [200,1000], 
respectively. 
The recommended b-values from this study can be used to inform analysis of pre-existing 
data of different tissue types. Previously, thresholds of b = 100 s/mm2 (101, 103) for 
abdominal organs and b = 200 s/mm2 (28, 102) for the brain have been suggested, when 
using the segmented fitting approach. In our study, the use of b-values < 500 s/mm2 for 
the low-perfusion model demonstrated high biases in estimation of both the D and f 
parameters, resulting in higher inaccuracies for any relatively low-perfused regions. For 
the higher perfused regions, our results agree with the previously suggested thresholds 
and the use of a low b-value threshold should provide results with minimal influence 
from bias. 
Previously reported IVIM parameters for different pathologies were listed in Table 2.2. 
For highly perfused regions, such as reported for cirrhotic liver (89, 111, 141), 
hepatocellular carcinomas (30, 133), prostate cancer (143, 144) and many of the pancreas 
related pathologies (132, 134, 135), our results suggest that the use of a low b-value can 
reduce the variability in estimating the perfusion fraction. In lower perfused tissues, 
such as reported for breast cancer (90, 140), a higher b-value is recommended to reduce 
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the effect of bias. A breast cancer study by Cho et al. (90) performed segmented fitting 
with b = 150 s/mm2 as the threshold, which led to a negative bias in the estimation of the 
f values, similar to what was shown in our low-perfusion model simulations with the use 
of low b-values.  
The other low-perfused region of clinical interest is the brain. Previous IVIM studies of 
brain gliomas have been inconclusive with the reported f values (27, 136-138). A range of 
values were reported for low- (f = 0.06 – 0.49) and high-grade (f = 0.11 – 0.40) gliomas 
with the use of the same threshold value b = 200 s/mm2. Interestingly, the two studies 
including b-values ≥ 1500 and up to 3500 s/mm2 (137, 138), reported relatively high f 
values (≥ 0.29), whereas the studies including b-values ≤ 1300 s/mm2 (27, 136) reported 
much lower values (≤ 0.13). Tri-exponential fitting has been previously used for data 
with high b-values (> 1000 s/mm2) in the brain (163), suggesting that using a bi-
exponential fitting for higher b-value data might result in under fitting and thus 
potential positive bias in estimation of the IVIM parameters. On the other hand, both 
the IVIM model and the tri-exponential model are unable to account for the non-
Gaussian diffusion and noise observed at high b-values (65). An alternative method was 
introduced by Iima et al. (164), who combined the IVIM and kurtosis models and 
investigated its use for low-perfused breast tissue up to b-values = 2500 s/mm2. Using 
this methodology, the IVIM effect at low b-values and the non-Gaussian behaviour at 
high b-values were accounted for. Other challenges with the use of higher b-values 
include the lower SNR level, resulting in increased variability of the data, if not adjusted 
for e.g. with the use of higher NSA. In the context of these issues, the use of the standard 
IVIM model at b-values above 1000 s/mm2 might not be desirable. Therefore, although 
the use of b = 200 s/mm2 as a threshold in these studies was likely to have introduced 
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bias to the reported f values, the use of the high b-values was the more likely cause of 
the large differences seen between the studies. 
The increase from SNR = 40 to SNR = 55, corresponding to approximately an acquisition 
with one and two signal averages, increased the reproducibility for all the b-value 
distributions and the resulting IVIM parameters. The improvement was less marked in 
going from an SNR 55 to 80. Therefore, aiming for an SNR = 55 may be a reasonable 
compromise between reproducibility and length of acquisition, if the biological effects 
being investigated are large enough, such as seen between the low- and high-grade 
gliomas (27, 28). Presence of small biological changes in tissue might require the use of 
higher SNR levels, where detection of the tissue properties can be improved with the 
better reproducibility of the f parameter. 
4.5 Study Limitations 
The study presented in this chapter had some limitations. First, only three separate 
tissue models were investigated. While this provides a general guide on the use of 
optimal b-values, variation in tissues creates a more complex scenario, as shown by the 
in vivo results. However, the in vivo results presented here were in agreement with the 
simulated data, confirming the presence of effects such as bias in low-perfused tissues.  
Pathologies in the abdomen and the surrounding tissue have been found relatively high 
perfused, implying that the recommended b-value is likely to perform well for the whole 
imaged region. However, in abdominal MR imaging, motion effects need to be 
considered, and the image quality assessed to ensure sufficiently high quality for IVIM 
analysis. Although imaging in the brain might not be affected by motion to the same 
extent as in the abdomen, data quality remains an important requirement for reliable 
IVIM analysis. Therefore, an estimate of SNR can provide good guidance on the 
robustness of the results and aid in choosing the optimal b-values for IVIM. 
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4.6 Conclusion 
In conclusion, this study demonstrated that IVIM parameters D and f can be estimated 
reliably with three b-values using the linear fitting step of the segmented IVIM 
approach. In this context, the fitting stability of the IVIM was therefore not of critical 
concern, as the pseudo-diffusion coefficient D* was not estimated. Our results showed 
that the optimal b-value distribution depends on the diffusion and perfusion 
characteristics of the tissue and the compromise between bias and variability. The in 
vivo results confirmed the presence of bias in the low perfused brain tissue and 
underlined the importance of using high enough b-values to minimise its influence.  
Recommendations for b-values were made based on the model simulations, which can be 
used as a guide in future studies or for pre-existing data. With different clinical centres 
still utilising different b-value distributions, the results from this study can also aid in 
the interpretation of differences seen between IVIM parameters of similar tissues. 
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5. Comparison Study of IVIM and DSC Perfusion 
Parameters in Childhood Brain Tumours 
5.1 Introduction 
Diffusion- and perfusion-weighted MR imaging methods are becoming increasingly 
prevalent in clinical practice due to their ability to provide information about tissue 
microstructures, such as cellularity and vascularity, respectively (115, 165).  Diffusion-
weighted imaging (DWI) has the clinical advantage of being non-invasive, whereas the 
gold standard perfusion imaging method, dynamic susceptibility contrast (DSC-MRI), 
requires the use of an intravenous contrast agent.  In paediatric patients, administering 
contrast can be difficult or contraindicated in such cases as renal failure and allergy. The 
recent reports of gadolinium deposits in the brain have also posed questions on the 
safety of gadolinium based contrast agents (112, 113). 
A potential alternative measure to DSC derived cerebral blood volume (CBV) could be 
the perfusion fraction derived with the intravoxel incoherent motion (IVIM) model (119). 
Previous studies in the brain have suggested links between the IVIM perfusion 
parameters (f, D*) and the classical perfusion parameters from DSC-MRI (Chapter 2, 
section 2.3.2.3). However, while f has been shown to correlate well with the DSC-CBV, 
comparisons of D* to mean transit time (MTT) and fD* to cerebral blood flow (CBF) have 
been rarely reported, and provided contradictory results (28, 87). This suggests that the 
bi-exponential behaviour in the brain might not be sufficiently pronounced for the robust 
computation of D* and/or arise from the difficulties in measuring arterial input function 
(AIF) required for the computation of DSC-CBF and DSC-MTT (121).  
The comparison of IVIM and DSC parameters has been reported for a mixture of 
different tumours (27, 28, 93, 122, 123). However, no studies of IVIM or its 
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comparison to DSC in paediatric brain tumours has been reported to date. Low-grade 
gliomas in children commonly have low perfusion, yet are treated with regimes aimed to 
be anti-angiogenic i.e. inhibit growth of new blood vessels (166). This presents a notable 
challenge in monitoring the pharmacodynamic effects (the biochemical or physiologic 
effect of a drug on an organism) of a treatment. A non-invasive measure of perfusion 
could therefore provide an alternative way to assess the treatment effects.  
The successful use of IVIM for such a purpose was presented by Kim et al. (122), who 
used the IVIM perfusion fraction to differentiate recurrent tumour from treatment 
effects in adult glioblastomas, and reported a significant correlation between IVIM-f and 
DSC-CBV. Other previous studies have mainly focused on adult low- and high-grade 
gliomas, which have shown promising results in their differentiation with the IVIM-f 
(27, 28, 93, 137). However, the brain tumours in paediatrics often present histologically 
different and more heterogeneous than those in adults (167). In paediatrics, the most 
common low-grade glioma is the pilocytic astrocytoma (grade I), whereas in adults this is 
the diffuse astrocytoma (grade II) (168). Therefore, considering these differences, the 
assessment of IVIM and DSC-MRI in paediatric brain tumours could further evaluate 
the association of the two methods and potentially provide IVIM as a valuable 
alternative method for the non-invasive measurement of perfusion in childhood tumours. 
This leads to the primary aim of this chapter, which is to investigate the relationship 
between IVIM and DSC-MRI in tumorous and healthy paediatric brain tissues. This 
builds on the low-perfused model simulations reported in Chapter 3, which showed that 
the IVIM perfusion fraction can be robustly measured in low-perfused tissues. The 
assessment of IVIM-f and DSC-CBV forms an important part of the biological validation 
of perfusion fraction as a potential imaging biomarker and probes the biophysical origins 
of the IVIM perfusion fraction.  
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5.2 Methods 
5.2.1 MR Imaging 
The data for IVIM-DSC comparison was acquired with MR imaging performed on a 
Philips Achieva 3.0 Tesla (T) TX (Philips Healthcare, Best, the Netherlands) MRI 
scanner with a 32-multichannel receive head coil at Birmingham Children’s Hospital 
(BCH). Additional diffusion-weighted MR data (not included in the IVIM-DSC 
comparison) was acquired with [1] Siemens Symphony 1.5 Tesla (T) (Siemens 
Healthcare, Erlangen, Germany) and [2] Siemens Avanto 1.5 Tesla (T) (Siemens 
Healthcare, Erlangen, Germany) MRI scanners at the Great Ormond Street Hospital 
(GOSH).  
5.2.1.1 Diffusion-weighted Imaging 
The DW-MRI protocol parameters are reported in Table 5.1 for the data acquisition from 
the two clinical centres. For the BCH protocol, a sensitivity-encoded (SENSE) approach 
with a single-shot, spin echo planar imaging sequence was used. For each subject, 11 
exponentially spaced b-values (0, 20, 40, 80, 110, 140, 170, 200, 300, 500, 1000 s/mm2) 
were acquired in three orthogonal directions, of which a geometrical average diffusion-
weighted image (or trace) was derived, using 30 contiguous axial slices and NSA = 1. The 
spectral presaturation with inversion recovery (SPIR) was used for fat suppression and 
the scan duration was 2.12 minutes. For the GOSH protocol, imaging was performed 
with 3 b-values (0, 500, 1000 s/mm2) acquired in three orthogonal directions, of which a 
trace image was derived. For scanner [1] NSA = 2 and 20 contiguous axial slices, and 
scanner [2] NSA = 3 and 19 contiguous axial slices were used. 
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Table 5.1 The DW-MRI protocol parameters for BCH and GOSH protocols (scanners [1] and 
[2] specified where different parameters were used). 
Centre No. of  
b-values  
TR/TE FOV Matrix size Slice 
thickness 
In-plane 
resolution 
BCH 11 4,000/91 240 × 240 96 × 96 3.5 2.5 × 2.5 
GOSH 3 3,700/108 [1] 
2,700/96 [2] 
230 × 230 256 × 256 [1] 
128 × 128 [2] 
5.0 0.90 × 0.90 [1] 
1.80 × 1.80 [2] 
Note: field-of-view, slice thickness and in-plane resolution reported in units of mm and 
TR/TE in units of ms. 
5.2.1.2 Dynamic Susceptibility Contrast Imaging 
The DSC protocol was acquired subsequently to the DW-MRI protocol from the same 
spatial location including FOV, matrix size and slice thickness. The protocol used FE-
EPI sequence with TR/TE = 1,865/40 ms and a flip angle of 20. The temporal resolution 
was 1.86 s, and this was repeated 60 times. The contrast agent (Dotarem, Guerbet, 
France) was administered in two equal doses via a power injector through a cannula 
inserted in an antecubital vein. The first dose was administered prior to the DSC 
examination to minimise T1 effects (114), while the second dose was administered at 
time point 5 during the DSC examination. The total dose of contrast agent was 0.1 
mmol/kg, with an injection rate of 3 mL/s. Both contrast doses were followed by 
injections of saline (volume of up to 10 mL, depending on patient’s weight) delivered at 
the same rate as the contrast. 
5.2.1.3 T2-weighted Imaging 
A T2-weighted turbo spin echo (TSE) scan was acquired with the same coverage as for 
DWI and DSC to outline the regions-of-interest for the comparison study. The protocol 
was performed with a TR/TE = 4,000/100 ms, FOV 240 × 240 mm, matrix size 288 × 288, 
slice thickness 3.5 mm and in-plane resolution of 0.83 mm2. 
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5.2.2 Patient Population 
The IVIM-DSC comparison study included 11 paediatric brain tumour patients (age 1.42 
to 9.26 years, mean 5.18 years) acquired at the BCH. The patient details are listed in 
Table 5.2. Informed parental consent was obtained for all subjects and ethical approval 
was granted as stated in the thesis declaration. 
 
Table 5.2 Patient cohort demographics for the IVIM-DSC comparison study. 
Case Sex (F/M) Age (years) Diagnosis 
1 M 9.26 Rosette-forming glioneuronal tumour 
2 F 5.91 Optic pathway glioma 
3 M 6.59 Optic pathway glioma 
4 M 4.20 Optic pathway glioma 
5 M 6.76 Optic pathway glioma 
6 M 1.42 Thalamic optic pathway glioma 
7 F 1.65 Optic pathway glioma 
8 M 8.31 Supratentorial glioneuronal tumour 
9 M 2.99 Suprasellar pilomyxoid astrocytoma 
10 M 3.36 Optic pathway glioma 
11 F 6.30 Optic pathway glioma 
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Table 5.3 Patient cohort demographics for computation of IVIM maps. 
Case Sex (F/M) Diagnosis Grade 
1 F Pilocytic astrocytoma I 
2 F Pilocytic astrocytoma I 
3 F Choroid plexus papilloma I 
4 F Atypical choroid plexus papilloma II 
5 F Choroid plexus carcinoma III 
 
Data from the GOSH (n = 5) was used for the computation of IVIM maps in paediatric 
low-grade gliomas and choroid plexus tumours. The patient details are listed in Table 
5.3. Informed parental consent was obtained for all subjects and the same ethical 
approval applied as stated above. 
5.2.3 Data Analysis 
The image analysis was implemented using in-house Python software (Anaconda, 
Continuum Analytics, v. 2.7.1.0) with the LmFit library (150). For both DW-MRI and 
DSC-MRI images, an averaging filter of size 3 × 3 was used to smooth the images. 
5.2.3.1 IVIM Model Fitting 
Non-linear least-squares minimisation was performed with the Levenberg-Marquardt 
(153) algorithm for the IVIM fitting of the signal data. The fitting was performed on a 
voxel-by-voxel basis using the segmented approach, which had the best overall 
performance for low-perfused tissues, as described in Chapter 3. 
For the GOSH image data, the segmented approach was used to define D and f from the 
fitting of b-values: 500 and 1000 s/mm2, as described in Chapter 4. The fitting of 
diffusion signal in the brain with b-value = 500 s/mm2 was determined previously in 
Chapter 4 to produce the most accurate and least biased measure of f. 
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The following boundaries were applied to the IVIM parameters: 0 < D < 0.1 mm2/s, 0 < 
D* 1 mm2/s and 0 < f < 1.  The boundaries were chosen to eliminate any non-
physiological results (88).  
5.2.3.2 DSC Analysis 
Tracer tissue concentration-time course data was derived from the signal-time course 
data for each voxel using the relationship between T2* signal intensity and tracer tissue 
concentration (120). This assumes that the gadolinium contrast concentration [Gd] is 
approximately linearly proportional to the observed change in the T2* relaxation rate 
(1/∆R2*), which is proportional to the negative logarithm of the relative signal intensity: 
[𝐺𝑑] ∝ Δ𝑅2
∗ = −
1
TE
ln (
𝑆𝑡
𝑆0
) [5.1] 
where TE is the echo time, St the signal at time t during passage of the contrast bolus, 
and S0 the baseline signal intensity. 
The relative cerebral blood volume (CBV) maps were determined using the area below 
the tracer concentration-time curve. The blood brain barrier breakdown and the 
resulting T1-weighted leakage and T2*-weighted imaging (T2/T2*WI) residual effects were 
corrected using preload-dosing (PLD) and baseline subtraction (BLS) techniques, 
respectively (114, 169). The reported CBV values are in arbitrary units of mL/100 mL. 
5.2.4 Statistical Analysis 
All statistical analysis was performed in SPSS Statistics (IBM, Chicago, IL, v.22). 
The analysis workflow for the comparison study of IVIM-f and DSC-CBV is presented in 
Figure 5.1. ROIs were drawn manually on co-registered T2-weighted images over 
multiple slices (3 to 5) for healthy-appearing grey matter (ROI = 596 ± 54 voxels), white 
matter (ROI = 545 ± 36 voxels), and tumours (ROI = 626 ± 202 voxels), with exclusion of 
large areas of cyst (Figure 5.2). The ROIs were transferred to the analysed IVIM-f and 
DSC-CBV perfusion maps for the correlation analysis. The correlation between the  
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Figure 5.1 The IVIM-DSC analysis workflow. The workflow used for the analysis and 
comparison of IVIM-f and DSC-CBV parameters. 
parameters was assessed using the Pearson correlation coefficient, r. The correlation 
study was performed voxel-wise and using histogram derived parameters (mean, 
median, 25th/75th/90th percentiles, kurtosis and skewness). The histogram parameters 
were also used for a relative or normalised tumour value (tumour/healthy grey matter) 
correlation analysis. Histograms were constructed using the same number of bins for 
both imaging methods. Number of bins was based on the square root rule, where the 
number of bins is equal to the square root of total number of data points or voxels from 
the ROI. The bin widths were determined between the max. value (f or CBV) and zero for 
each patient. 
The correlation between the parameters was assessed using the Pearson correlation 
coefficient, r. The correlation study was performed voxel-wise and using histogram 
derived parameters (mean, median, 25th/75th/90th percentiles, kurtosis and skewness). 
The histogram parameters were also used for a relative or normalised tumour value 
(tumour/healthy grey matter) correlation analysis. Histograms were constructed using 
the same number of bins for both imaging methods. Number of bins was based on the 
square root rule, where the number of bins is equal to the square root of total number of 
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data points or voxels from the ROI. The bin widths were determined between the 
maximum value (f or CBV) and zero, for each patient case separately. 
Statistical power was computed for the sample size (n = 11) to determine whether a large 
enough sample size was used to provide valid conclusions. Power of the study is the 
likelihood that the observed effect is real and is often set to be 0.8, corresponding to an 
80 % chance. The sample size of 11 in this study had a power of 80 % to detect 
correlation of more or equal to 0.750, with a statistical significance of 0.05 using the 
Pearson’s correlation. 
For the data acquired at GOSH, ROIs were drawn manually on the IVIM parameter 
maps to determine representative value ranges in the different tumours and grey matter 
regions (ROI = 160 ± 70 voxels). The diffusion-weighted images of b = 0 were used as a 
guideline. Large areas of cysts were excluded and areas close to the edge of the tumours 
were avoided to reduce partial volume effects. 
 
 
Figure 5.2 Regions-of-interests (ROIs) for the data analysis (BCH data). Examples of 
(a) tumour, (b) grey matter and (c) white matter ROIs used in the data analysis, shown on 
the T2-weighted images. Both (a) and (b) present cases of optic pathway gliomas and (c) a 
case of glioneuronal tumour. 
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5.3 Results 
5.3.1 Voxel-wise and Histogram Parameter Comparison  
The median IVIM-f and DSC-CBV values for grey matter, white matter and tumour 
regions are listed in Table 5.4. Relatively lower variability was observed in the different 
tissue regions with the IVIM-f parameter compared to the DSC-CBV parameter. 
Table 5.4 Median values (± standard deviation) of IVIM-f and DSC-CBV (n = 11). 
Region IVIM-f DSC-CBV 
Grey matter 0.115 ± 0.010 4.38 ± 0.96 
White matter 0.090 ± 0.009 1.94 ± 0.53 
Tumour 0.087 ± 0.032 1.94 ± 1.10 
 
Voxel-wise correlations between IVIM-f and DSC-CBV were computed for the grey 
matter, white matter and tumour tissue regions. The voxel-wise correlation coefficients 
are listed in Table 5.5. Significant correlations were observed in all tissue regions, 
although not for each one of the cases. Significance was achieved in 10 out of 11 grey 
matter, and 8 out of 11 white matter and tumour regions. Comparison in the grey matter 
demonstrated the strongest correlations (r = 0.139 – 0.716, P < 0.001), followed by more 
moderate correlations in white matter (r = 0.171 – 0.298, P < 0.001) and tumour (r = 
0.081 – 0.567, P ≤ 0.001) regions.  
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Table 5.5 Voxel-wise correlations of IVIM-f and DSC-CBV in grey matter, white matter and 
tumour regions. 
  White Matter   Grey Matter  Tumour 
Case  r P-value   r P-value  r P-value 
1  0.171** < 0.001   0.139** < 0.001  0.033 0.292 
2  0.298** < 0.001   0.577** < 0.001  0.329** < 0.001 
3  0.092 0.114   0.522** < 0.001  0.193** < 0.001 
4  0.200** < 0.001   0.364** < 0.001  0.102** < 0.001 
5  0.180** < 0.001   0.331** < 0.001  0.383** < 0.001 
6  0.198** < 0.001   0.716** < 0.001  0.349** < 0.001 
7  0.096 0.064   0.473** < 0.001  0.340** < 0.001 
8  0.214** < 0.001   0.539** < 0.001  0.016 0.791 
9  0.232** < 0.001   0.049 0.400  0.081** 0.001 
10  0.199** < 0.001   0.716** < 0.001  0.428** 0.001 
11  -0.025 0.607   0.627** < 0.001  0.567** < 0.001 
** corresponds to a significance level of P < 0.001. 
Low voxel-wise correlations were observed for cases 1 and 9, in both grey matter and 
tumour regions-of-interest. The DW-MRI data for case 1 was acquired with an increased 
number of slices. Although the positioning appears qualitatively similar and the IVIM-f 
and DSC-CBV maps produced comparable parameter distributions, the voxel-wise 
comparison might have been affected by a small shift due to the DW-MRI positioning. 
For case 9, the T2 images were slightly mal-aligned to the DWI and DSC images, 
potentially due to patient movement between the scans. The low-correlations for the 
tumour cases included two cases of glioneuronal tumours and a suprasellar pilomyxoid 
astrocytoma. These tumours often appear heterogeneous, and are therefore more prone 
to mismatch between voxels due to patient movement. The other tumour regions 
demonstrated moderate correlations, with a more homogeneous appearance. 
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Figure 5.3 Voxel-wise comparison of IVIM-f and DSC-CBV parameters. Voxel-wise 
comparison and distributions of the perfusion parameters in white matter (a-b), grey matter 
(c-d), and tumour (e-f) for an example case. Each data point on the scatter plots represents a 
voxel. 
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Figure 5.4 Correlation between histogram skewness and kurtosis of IVIM-f and 
DSC-CBV (n = 11). Plots presenting the correlation in (a-b) white matter, (c-d) grey matter, 
and (e-f) tumour using histogram parameters skewness (left) and kurtosis (right). 
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Figure 5.5 Correlation between histogram skewness and kurtosis of IVIM-f and 
DSC-CBV from combined grey and white matter regions (n = 22). Plots presenting the 
correlation for histogram (a) skewness and (b) kurtosis, with the data points corresponding to 
grey and white matter histogram values.  
Voxel-wise correlation and distribution plots for an example patient case are presented 
in Figure 5.3 for white matter, grey matter and tumour regions. The white matter 
example (Figure 5.3a) showed a narrower range of values (f = 0.05 - 0.15) in comparison 
to the grey matter (f = 0.02 - 0.26). The distributions of IVIM-f and DSC-CBV 
parameters had similar shapes and widths, in all three tissue regions. However, a shift 
was observed in the distributions, which were normalised separately to the maximum 
values of IVIM-f and DSC-CBV. The IVIM-f values were relatively shifted towards 
higher values in comparison to the DSC-CBV values. 
Correlation between the histogram parameters of IVIM-f and DSC-CBV was established 
for skewness and kurtosis (Figure 5.4). No correlation was observed for the other 
histogram parameters including mean, median and 25th/75th/90th percentiles. However, 
due to the small sample size (n = 11), a correlation of more than r ≥ 0.750 was required 
for a power of 80 %. Therefore, only the results for skewness and kurtosis of grey matter, 
and kurtosis of tumour can be considered statistically valid. The skewness of tumour 
demonstrated significant correlation (r = 0.681, P = 0.021), but had statistically low 
power of 67 %.  
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Due to the rather small sample size, correlation of combined grey and white matter (n = 
22) was also assessed with the histogram parameters. This approach was previously 
used by Wirestam et al. (125).  Significant correlations were established for the skewness 
and kurtosis parameters, which are presented in Figure 5.5. The method provided 
correlations of r = 0.754 (P < 0.001) and r = 0.580 (P = 0.005) for skewness and kurtosis, 
respectively, which both had statistical power above 80 %. 
5.3.2 Relative Value Comparison 
Correlations with histogram parameters were also computed using normalised tumour 
values. The tumour values were normalised to the healthy appearing grey matter 
values, which is the commonly used method in the clinical practice of DSC-MRI (28, 120, 
121). Using this methodology for both DSC-CBV and IVIM-f, a significant correlation 
was observed with the histogram skewness, but not with kurtosis (Table 5.6, Figure 5.6). 
The mean relative values demonstrated a significant correlation, but had statistically 
low power of 59 %, and a larger sample size would be required to validate this 
observation. 
Table 5.6 Correlation results of relative histogram parameters of IVIM-f and DSC-CBV. 
Histogram parameter r P-value 
Mean 0.628* 0.039 
Median 0.294 0.380 
Skewness 0.775* 0.005 
Kurtosis 0.215 0.525 
25th percentile 0.253 0.453 
75th percentile 0.134 0.694 
90th percentile 0.215 0.525 
* corresponds to a significance level of P < 0.05. 
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Figure 5.6 Comparison between normalised tumour values of IVIM-f and DSC-CBV 
(n = 11). Plots presenting the correlation for relative tumour histogram (a) mean and (b) 
skewness values. 
Two patient cases are presented in Figure 5.7 with the derived IVIM and DSC 
parametric maps. The glioneuronal tumour (Figure 5.7a) appeared heterogeneous with 
some cystic regions, whereas the optic pathway glioma (Figure 5.7b) presented as a more 
homogeneous lesion. Both tumours appeared low-perfused in the parameter maps. The 
glioneuronal tumour case demonstrated poor voxel-wise correlation between IVIM-f and 
DSC-CBV, whereas moderate correlation was observed for the optic pathway glioma. 
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Figure 5.7 Characterisation of brain tumours with IVIM and DSC. Example cases of 
(a) glioneuronal tumour and (b) hypothalamic glioma shown on b0 images and the parametric 
maps of IVIM-D and f, and DSC-CBV. The yellow boxes indicate the locations of the 
pathologies. 
5.3.3 Age Effect on Perfusion 
The effect of age on the level of perfusion was assessed for the median IVIM-f and DSC-
CBV values in the healthy brain tissues (Figure 5.8). No significant correlations were 
observed in this cohort, but a general trend of increasing perfusion with age could be 
seen for the grey matter (Figure 5.8a). In white matter, the changes in perfusion with 
age appeared to be more modest. The median values in Figure 5.8 were derived from the 
same ROIs as used in the correlation analysis. 
 
Figure 5.8 The effect of age on perfusion in paediatrics. The plots describe the median 
IVIM-f and DSC-CBV values in (a) grey matter and (b) white matter as a function of age. 
Chapter 5. Comparison Study of IVIM and DSC Perfusion Parameters in Childhood Brain 
Tumours 
 128  
5.3.4 IVIM Maps of Low-Grade Gliomas and Choroid Plexus Tumours 
Data acquired from patients at GOSH was analysed with the IVIM model to inspect low-
grade gliomas acquired at a different centre, and choroid plexus tumours, which have 
previously been reported to demonstrate elevated cerebral blood volume levels (170). The 
IVIM diffusion coefficient and perfusion fraction values for these tumours are reported 
in Table 5.7, and characteristic parameter maps are presented in Figure 5.9 and Figure 
5.10 for low-grade gliomas and the choroid plexus tumours, respectively. 
The low-grade gliomas appeared low-perfused on the IVIM-f maps relative to the grey 
matter, similarly to the cases acquired at the local institution. Although different sets of 
b-values were used for the two cohorts, the f values were found to be comparable. The 
choroid plexus tumours presented in Figure 5.10 showed interesting perfusion 
characteristics. The grade I choroid plexus tumour demonstrated slightly elevated f 
values compared to the low-grade gliomas, whereas the D values were similar. The 
higher grade (II and III) tumours showed highly increased perfusion (f > 0.2) with more 
restricted diffusion.  
 
Table 5.7 IVIM parameters extracted from the tumour regions for the GOSH data. 
Case Diagnosis Grade IVIM-D IVIM-f 
1 Pilocytic astrocytoma I 1.41 ± 0.10 0.0750 ± 0.03 
2 Pilocytic astrocytoma I 1.66 ± 0.12 0.103 ± 0.03 
3 Choroid plexus papilloma I 1.37 ± 0.08 0.192 ± 0.03 
4 Atypical choroid plexus papilloma II 1.28 ± 0.13 0.240 ± 0.04 
5 Choroid plexus carcinoma III 0.71 ± 0.01 0.252 ± 0.07 
Note: D values are reported in units of × 10-3 mm2/s. 
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Figure 5.9 IVIM maps of low-grade gliomas. Example cases of two pilocytic astrocytoma 
tumours computed using the 3 b-value IVIM approach. The yellow boxes indicate the 
locations of the pathologies. 
 
Figure 5.10 IVIM maps of choroid plexus tumours of grades I to III. Example cases of 
choroid plexus papilloma (I), atypical choroid plexus papilloma (II) and choroid plexus 
carcinoma (III) computed using the 3 b-value IVIM approach. The yellow boxes indicate the 
locations of the pathologies. 
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5.4 Discussion 
Comparison of the IVIM derived f parameter and the DSC-MRI derived CBV parameter 
was performed to assess the relationship of the two parameters in low-perfused 
paediatric brain tissues. Significant correlations were established using a voxel-wise 
comparison and histogram parameters in white matter, grey matter and tumour regions. 
Significant correlations were also observed with the use of normalised tumour values, as 
commonly used in the reporting of DSC-CBV, for the mean and skewness histogram 
parameters. 
The IVIM perfusion fraction values of healthy brain tissue were found to be higher in 
comparison to previous adult studies (fGM = 0.115 ± 0.01; fWM = 0.090 ± 0.009). Previous 
reports include ones by Grech-Sollars et al. (79) (fGM = 0.10 ± 0.002; fWM = 0.080 ± 0.002), 
Wu et al. (87) (fGM = 0.14 ± 0.02; fWM = 0.07 ± 0.01) and Bisdas et al. (136) (fWM = 0.065 ± 
0.037). Although some variation exists between these studies, the higher values in our 
study are not fully accounted for by the variability. Therefore, the more likely reason for 
the greater values is the elevated perfusion observed in children compared to adults (95, 
171). The grey matter volume, proportional to the cerebral blood flow (95), has been 
found to first increase and then decrease with age in the first two decades of life (172). In 
white matter, the increase in volume has been found to be linear in the same period, but 
to a lesser extent. The cohort used in this study showed a moderate increase in perfusion 
with age in the grey matter, and more modest change in the white matter. Another 
cause of elevated perfusion in our cohort could be a result anaesthesia (173), which is 
often used in younger children during MR imaging. The developmental microstructural 
changes and the potential effect of anaesthetic make it difficult to compare the values 
across the cohort, and particularly with the previous adult studies. 
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The DSC-CBV values in our cohort were found to be CBVGM = 4.38 ± 0.96 mL/100 mL 
and CBVWM = 1.94 ± 0.53 mL/100 mL. These values were in good agreement with a study 
by Wu et al. (87) (CBVGM = 4.4 ± 0.5 mL/100 mL and CBVWM = 1.9 ± 0.2 mL/100 mL), but 
appeared slightly elevated compared to a study by Sourbron et al. (174) (CBVGM = 2.6 ± 
0.8 mL/100 mL and CBVWM = 1.3 ± 0.4 mL/100 mL). Other adult studies have shown the 
grey matter CBV to vary between 3 to 7 mL/100 mL (175-177). Similarly to the IVIM-f, 
the differences were likely to arise due to the influence of age, but also from the 
differences in data analysis used in the computation of CBV values. 
Discrimination of adult low- and high-grade gliomas has been possible in previous 
studies using IVIM-f  (27, 28, 137) and DSC-CBV (115, 178). The low-grade tumours in 
our cohort appeared generally hypo-perfused compared to the grey matter with both 
IVIM and DSC-MRI. This agrees with the previous adult studies, apart from the studies 
by Hu et al. (137) and Lin et al. (138), who reported higher f values for the low-grade 
gliomas. However, these studies reported the use of IVIM including high b-values (> 
1000 s/mm2), producing a more challenging scenario for the accurate estimation of IVIM 
parameters, as discussed in Chapter 4. 
The voxel-wise correlations between IVIM-f and DSC-CBV were significant for most of 
the grey matter, white matter and tumour regions. A few of the cases with lower 
correlations were found to be influenced by motion or misalignment of the slices, which 
had a direct effect on the voxel-wise comparison. In general, the correlations were more 
moderate in the white matter and tumour tissues, most likely due to the lower overall 
perfusion and small range of values seen in these regions. In a previous study by Wu et 
al. (87), voxel-wise correlations were only found in grey matter, but not in white matter. 
In our study, the range of f-values produced in the white matter was narrow, which 
would have reduced the correlation strength. Also, the measurement of both perfusion 
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parameters is more difficult in low-perfused tissues, with the measurements having 
inherently lower accuracy. This was shown for IVIM-f in Chapter 3 with the low-
perfused tumour simulations, where the IVIM fitting was less robust compared to the 
grey matter model. The measurement of IVIM-f is also affected by higher variability at 
the lower f value region, as shown in Chapter 4. With regards to bias, the use of b-value 
= 300 s/mm2 in the brain was likely to introduce some bias to the f values. However, as 
demonstrated previously, the bias was independent of the magnitude of f, but dependent 
on the b-value, and therefore the bias would have influenced the fitting performed across 
the brain. Therefore, this was not likely to affect the correlation between IVIM and DSC 
measurements.  
An interesting observation was made in the previous studies by Wu et al. (87) and 
Conklin et al. (93), where a reduction in the correlation strength was seen when CBV > 
10, which was attributed to voxels containing larger vessels. Similar behaviour was also 
observed in our study (Figure 5.3). Coherent flow in larger vessels does not comply with 
the randomly oriented microvasculature as assumed by the IVIM model. This means 
that the contribution from the larger vessels is likely to go towards the perfusion free 
diffusion component D, with the increase in phase accumulation rather than the signal 
decay.  This has an important consequence for the comparison of IVIM and DSC in such 
regions, and indicates the inherent differences in the properties of the two measures.  
To mitigate some of the motion effects likely influencing the voxel-wise correlations, 
histogram parameters were derived for the brain tissue regions. However, no 
correlations were observed between the histogram “value” parameters e.g. mean or 
percentiles. Instead, significant correlations were observed using skewness and kurtosis, 
signifying the similarities between the shapes of the perfusion parameter distributions. 
Although the strong correlations between the distribution shapes suggests that similar 
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tissue properties contribute towards both f and CBV, it is well known that the two 
measures are not comparable as exact values (102). This likely resulted in a shift 
between the f and CBV histograms in the different tissue regions and likely accounted 
for the poor correlations of the histogram values such as the mean and median. 
The final correlations were performed using normalised tumour values, as used in the 
clinical practice of DSC-MRI to provide semi-quantitative CBV values (120, 121). The 
normalisation to a healthy tissue aims to reduce the variability of tumour CBV between 
patient cases by accounting for the variability in contrast bolus arrival due to 
microstructural differences. Using this approach, significant correlations were 
established between the mean and the skewness histogram parameters. The significant 
correlation between the histogram skewness indicated similarities in the distributions of 
the perfusion parameters, which suggested that a correlation should also exist between 
the medians. This was found to not be the case, similarly to the percentile measures. The 
magnitude of skewness for the IVIM-f and DSC-CBV were found to increase in a similar 
fashion in both grey matter and tumour regions, although lower skewness was observed 
for the IVIM-f. The skewness was found to be more variable between the IVIM-f and 
DSC-CBV measures in the low-perfused tissues of tumour and white matter, potentially 
influenced by the aforementioned issues in the measurement of both parameters. 
Therefore, the distributions of the parameters were not similar enough to produce 
agreement between the medians. However, the significant correlation between the 
relative mean parameters in this study and previous studies is promising and should be 
further confirmed in a larger cohort. 
Data from GOSH was included in this Chapter to assess the applicability of the 3 b-
value fitting (Chapter 4) and whether low-grade gliomas appeared low-perfused, 
similarly to the cases in our cohort. The two cases presented appeared relatively low-
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perfused and further confirmed this observation in paediatric patients. No IVIM studies 
to date have presented the finding of low-perfusion in paediatric low-grade gliomas. This 
is important for the use of IVIM-f as a potential biomarker in tumour grading, and 
further studies are required for its validation in larger paediatric cohorts including high-
grade gliomas. 
The other cases included in this study were the choroid plexus tumours of different 
grades. As reported previously in the literature (170), these type of tumours have shown 
higher levels of perfusion. While the low-grade gliomas in this study appeared low-
perfused, the IVIM-f values in the choroid plexus tumours were estimated relatively 
high as expected given their vascular origin. Interestingly, the IVIM-f increased with 
grade in the choroid plexus tumours, and differences in their appearance could be 
observed for the benign grade I and the more malignant grade II and III tumours.  
The vasculature in tumours is known to be unevenly distributed with irregular 
branching of the tumour vessels and no well-defined hierarchy (179). As a result, the 
blood flow in tumours is not constant along a single direction, and may follow different 
paths and even change direction through the same vessel. In contrast, the vasculature in 
healthy tissues is arranged in a hierarchy of well-differentiated components. The 
complex nature of the underlying vasculature of these tumours and the origins of the 
increase seen in the IVIM perfusion fraction pose interesting questions requiring further 
studies to investigate the physiologic origins of the IVIM perfusion fraction. 
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5.5 Study Limitations 
Some limitations were present in this study. The IVIM model used here did not consider 
differences in relaxation times, which have been shown to affect the perfusion-related 
parameters in the liver (180). However, while statistical support for the extended IVIM 
model has been shown in the liver, this was not the case for the lower perfused organs, 
namely spleen and kidney (181). Therefore, these effects are likely to be negligible in the 
low-perfused tissues investigated here. 
The greatest limitation perhaps of this study was the small cohort size. However, the 
significant correlations observed in the voxel-wise comparison and the histogram 
parameters with statistically sufficient power suggest that promising results could be 
expected in a larger cohort. An additional limitation in our study was the influence of 
developing brain on the perfusion, which provided a more complex scenario compared to 
the previous adult studies. A larger cohort is required for the assessment of the influence 
of age on both the IVIM and DSC perfusion parameters. 
Finally, the IVIM fitting used for the GOSH data was found to be limited by the smaller 
voxel size and potentially lower SNR in regions of white matter in comparison to the 
data from the local institution. The fitting in these cases was found to result in negative 
values for perfusion fraction, which were set to zero to ensure biologically valid 
parameters. This would however result in a positive bias to results over a region of 
interest containing such voxels. Therefore, as shown in the previous Chapters, the 
consideration of SNR level and hence the use of a sufficient voxel size are essential for 
the application of IVIM, particularly where this is dependent on only three b-values. 
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5.6 Conclusion  
The results presented in this Chapter agree with the previous studies and support the 
link between the IVIM-f and DSC-CBV parameters. The voxel-wise correlations in the 
grey matter were significant, demonstrating a promising association of the parameters. 
However, the measurement of the parameters was technically challenging in the lower 
perfused tissues, i.e. the white matter. Some key differences also exist between what is 
measured by each parameter, which leads to scenarios where the relationship between 
the two parameters is likely to reduce. Such scenarios were found in both low- and high-
perfused tissues. At low perfusion, the challenge was the inherently lower accuracy of 
both methods and higher variability of the IVIM-f. Also, bias was introduced in low-
perfused tissues with IVIM fitting resulting in negative f values, and with DSC-CBV 
from T1 effects in contrast enhancing tissues which are only partially allowed for. In 
regions of relatively high perfusion with larger vessels, a plateau was observed for the 
CBV values, and IVIM was hypothesised to measure only the perfusion arising from the 
microvascular capillary network due to the limited timescale used in DW-MRI. 
Differences also exist in what both parameters measure of the underlying tissue. IVIM 
measures the inherent perfusion influenced diffusion of water, while DSC relies on the 
timings and concentration of the administered contrast. Therefore, while the correlations 
suggested that the IVIM-f and DSC-CBV arise from similar tissue properties, the 
limitations of both methods result in differences in certain tissue regions. 
Overall, the presented study suggests that the non-invasive DW-MRI could provide a 
contrast-free perfusion biomarker for the assessment of childhood brain tumours, which 
can be made more robust by the appropriate acquisition and analysis of data. Used in 
conjunction with the IVIM D, this could result in a more comprehensive investigation of 
the underlying tissue microenvironment in a single MRI protocol.  
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6. MIROR Clinical Decision Support System: 
Implementation of Diffusion Module and 
Investigation of Childhood Solid Tumours  
Some aspects of the work presented here were published in [P03], [P04] and [P07]. 
This Chapter was part of a larger collaborative project, with the contributions from 
others detailed in the Declarations section at the beginning of this thesis. In the text, 
where clarity was required, the initials of the contributor were also included. 
6.1 Introduction 
New MRI applications are continuously developed with the aim to improve clinical 
decision making in scenarios such as diagnosis and treatment response. This has led to 
the discovery of specific imaging biomarkers, which often require computationally 
intensive quantitative image analysis techniques (59, 182-184). Nevertheless, the 
clinical interpretation remains largely qualitative and subjective by expert review. 
Therefore, improvements are required in the presentation and accessibility of the 
advanced features, and the versatile amount of quantitative information derived from 
different MR modalities to promote their clinical uptake. 
In the past decade, clinical decision support systems (CDSSs) have gained more 
attention with the aim to reduce the translational gap between research and clinical use 
of the advanced analytical methods (185-188). The idea of a translational gap was 
introduced in Chapter 1 in the context of imaging biomarkers, and involves the crucial 
final step of integrating the new biomarker into a routine clinical practice. The CDSSs 
approach this challenge by providing a platform for extracting relevant features from the 
image data, with the aim to reduce any user prone or expertise related errors. 
Furthermore, the CDSSs allow the incorporation of evidence-based medicine or practice 
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of medicine based on the best available scientific evidence, which has been found to 
improve clinical outcomes (189). Therefore, the availability of a user-friendly, flexible 
and evidence-based CDSS could accelerate the clinical uptake of more advanced imaging 
methods, and allow the simultaneous assessment of modular data in a scientifically 
informative and convenient manner. 
In this Chapter, aspects of a collaborative project in designing and developing a modular 
medical image region of interest analysis tool and repository (MIROR) platform are 
described (Figure 6.1). MIROR is currently developed and used at Birmingham 
Children’s Hospital to determine its role in facilitating non-invasive diagnosis of 
childhood brain and abdominal tumours. The project involved both experts in MRI data 
processing and clinicians, to ensure the fit for purpose of MIROR to clinical practice. 
Here, the development of a diffusion MRI module for MIROR including both the ADC 
and IVIM analysis pathways is described, with the aim to provide a tool for integration 
of the analysis into routine clinical practice. 
The second aim of this Chapter was to test the implemented diffusion module in a cohort 
of childhood abdominal lesions. Malignant abdominal tumours are usually diagnosed 
with a combination of conventional imaging techniques and histology (82). However, 
histological diagnosis requires the invasive procedure of biopsy with risks of morbidity 
and sampling errors in large abdominal lesions (190, 191). Conclusive diagnosis based on 
conventional imaging alone can be difficult with similar morphological appearances of 
some childhood tumours (7). Therefore, diagnosis based on an advanced MR imaging 
modalities would be of important clinical value. 
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Figure 6.1 Hierarchical structure of MIROR. The workflow of clinical imaging data from 
storage to diagnostic evaluation, adapted from reference (192) with the permission of the 
author. PACS corresponds to the picture archiving and communications system, which 
provides storage and access to images from multiple modalities. 
Promising results have been shown with the use of diffusion-weighted MR imaging and 
the apparent diffusion coefficient (ADC) in paediatric abdominal tumours (41, 193). ADC 
has been able to discriminate benign from malignant solid tumours, likely reflecting the 
more restricted diffusion and hence higher cellularity found in malignant lesions (14, 
16). However, discrimination between individual tumour types with ADC was not 
possible in the previous studies. The ADC approach for heterogeneous tissues such as 
those found in abdominal tumours can be relatively simplistic and does not maximise 
the information that can be potentially extracted from the DW-MRI (11). Therefore, the 
use of the intravoxel incoherent motion (IVIM) model could provide additional 
parameters of clinical value. Previously, an adult study showed the IVIM parameters to 
be helpful in discriminating common malignant pancreatic tumours, as well as benign 
from malignant lesions (132). In another study, significantly better discrimination of 
low- and high-grade hepatocellular carcinoma (HCC) was achieved with the use of the 
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IVIM derived diffusion coefficient compared to the ADC (30). Therefore, the application 
of IVIM should be investigated in paediatric abdominal tumours to evaluate its 
diagnostic value.  
The heterogeneous nature of abdominal tumours can be difficult to characterise based on 
imaging measures such as the mean value of a region-of-interest alone. In a previous 
study, the use of histograms in paediatric Wilms’ tumours was able to identify distinct 
cellular regions based on ADC values, and to determine predominant histological cell 
types (194). The use of histogram parameters based on IVIM parametric values was also 
shown to discriminate recurrent tumours from treatment effects in adult glioblastomas 
(122) and showed significant differences among tumour subtypes in breast cancer (195). 
Therefore, in this study, histograms were derived for the whole tumour regions to allow 
the inspection of the distribution of parametric values. 
Overall, the aim of this study was to develop a diffusion module to the MIROR platform, 
and to evaluate the diagnostic performance of IVIM in a cohort of childhood abdominal 
tumours using the implemented diffusion module.  
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6.2 Methods 
6.2.1 Development of Diffusion Module for MIROR 
6.2.1.1 MIROR Framework  
A short summary of the design and development of MIROR is provided here for the 
completeness, with a more comprehensive study presented in ref. (192). The MIROR 
framework was implemented by N.Z. 
The MIROR platform has a modular and open architecture (196) to ensure seamless 
incorporation of new workflows to facilitate the new developments made in MR data 
analysis. Such an approach was chosen to allow the development of independent 
modules in their own life cycles, before the addition to the final product. MIROR was 
designed to use the evidence-adaptive CDSS approach, based on the American medical 
informatics association (AMIA) recommendations (189). This means that the clinical 
knowledge base of MIROR is derived from and continually reflects the most up-to-date 
evidence from the research literature and practice-based sources (197). Quantitative and 
statistical analysis modules for MIROR were developed based on literature and local 
practice based research.  
The MIROR repository is an evolving database, which stores the analysed diagnostic 
data from routine clinical practice. The experimental based knowledge and evidence 
from the outcomes of the MIROR repository can then inform clinical investigation, 
reflect on clinical practise, and develop the quantitative analysis modules further. The 
practice-based evidence can advise the choice of MRI protocol and parametric maps to be 
used for future analysis and clinical evaluations.  
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6.2.1.2 Implementation of Diffusion Module to MIROR 
 
Figure 6.2 Design of the MIROR diffusion module. The workflow of the diffusion 
module and the connection to the MIROR ROI and statistical analysis modules. T 
corresponds to a chosen threshold value used in the segmented IVIM fitting. 
The platform used in this study was MeVisLab (MeVis Medical Solutions AG - 
Fraunhofer MEVIS, v. 2.7.1) (198, 199). MeVisLab is a research based rapid prototyping 
platform for medical image processing. The diffusion analysis module, with IVIM and 
ADC fitting algorithms, was developed using Python (v.2.7), which was embedded within 
MeVisLab. The user interface and the connections of modules in MeVisLab were defined 
using an abstract module definition language (MDL).  
The workflow of the diffusion module is described in Figure 6.2. In the current version, 
the diffusion module only accepts images in digital imaging and communications in 
medicine (DICOM) format. The workflow starts by converting an ML (MeVis Image 
Processing Library) image to a native python numerical data structure, followed by the 
detection of the imported DICOM files. A function then determines which manufacturer 
diffusion-weighted MR scans have been imported by reading the DICOM tag. Based on 
the manufacturer, the b-values are extracted from the correct DICOM tag location. If 
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non-enhanced DICOM files are imported, the image files are sorted based on the DICOM 
instance number tag. The next step involves the determination of diffusion analysis, 
which is feasible for the available image data.  
The segmented fitting approach was chosen for the IVIM analysis to increase the 
stability of the bi-exponential fitting and reliability of the IVIM parameters, as reported 
by previous studies (84, 85, 88, 90). This approach allows the computation of IVIM 
diffusion coefficient (D) and perfusion fraction (f) parameters on data with limited 
number of b-values. Based on the set threshold (determining high b-values for the linear 
fitting step), if two or more b-values are available > bthreshold, the computation of D and f 
parameters is performed. This validity criteria for determining D and f by using two b-
values was studied in Chapter 4, which showed that robust estimates for the parameters 
can be derived (Figure 4.9). The criteria for computation of the pseudo-diffusion 
parameter (D*) requires at least two b-values < bthreshold (excluding b0), as well as the 
validity of criteria for D and f parameters. The bi-exponential fitting step was 
implemented using the Levenberg-Marquardt algorithm, the functionality of which 
needed to be developed in-house as no third-party fitting modules were available. For all 
diffusion data with at least 2 b-values, where one of them is b0, computation of ADC is 
performed. Finally, the resulting diffusion parametric maps are stored in the MIROR 
repository. 
The diffusion module connects to the other modules of the MIROR framework. This 
allows the use of previously drawn regions-of-interest (ROIs) and the extraction of the 
data for statistical analysis from the diffusion maps saved in the MIROR repository. The 
results from the statistical analysis, including histograms, are then saved in the MIROR 
repository, allowing the building of the database for different tumour types. This ensures 
that the prediction outcome for new input cases achieves the maximal statistical power. 
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6.2.2 Patient Study of Retroperitoneal Lesions 
6.2.2.1 MR Imaging 
All MR imaging was performed on a Siemens Avanto 1.5 Tesla (T) (Siemens Healthcare, 
Erlangen, Germany) MRI scanner with a 4-channel receive body coil at Birmingham 
Children’s Hospital. The imaging protocol included fat-suppressed axial and coronal pre- 
and post-gadolinium T1-weighted turbo spin echo (TR/TE 760 to 817/7.7 ms), axial T2-
weighted turbo spin echo (TR/TE 3000 to 5640/67 to 87 ms) and diffusion-weighted 
imaging.  
The DW-MRI protocol used a spin-echo planar imaging (EPI) sequence with 6 b-values 
(0, 50, 100, 150, 600, 1000 s/mm2), EPI factor = 174, three signal averages (NSA = 3), 
TR/TE 3,200 to 9,900/92 ms, parallel imaging (GRAPPA) with an acceleration factor = 2 
and 75 % partial Fourier encoding. The fat suppression was performed with a frequency-
selective preparation pulse. The diffusion weighting was applied in three orthogonal 
directions, of which a trace image was derived in the axial acquisition plane. Depending 
on the patient size, the field-of-view (FOV) was 221 to 350 × 172 to 317 mm, matrix size 
122 to 192 × 128 to 192, slice thickness 5 mm with no gap between slices, number of 
slices from 35 to 75, and voxel size of 1 to 2.34 mm2 × 5 mm. The DWI protocol 
acquisition time ranged from 4 minutes 52 seconds to 7 minutes 35 seconds. 
6.2.2.2 Patient Population 
A computerised search of medical records identified 55 patients who underwent 
abdominal MR imaging between June 2012 and September 2016, where the DW-MRI 
protocol was part of standard care. All cases were reviewed in the local tumour study 
board for suspected malignancy. Informed parental consent was obtained for all subjects. 
The following exclusion criteria were applied to the cohort: having received treatment 
prior to imaging (chemotherapy or surgery); non-solid pathology (n = 1); incomplete MRI 
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or small lesions (single slice largest area < 3 cm2 or total volume < 6 cm3, n = 12). The 
final population included 42 patients, and comprised of 10 benign and 32 malignant 
cases (Figure 6.3).  
The patient cohort demographics are summarised in Table 6.1. The cohort comprised of 
16 female (mean age 3.6 ± 4.2 years) and 26 male (mean age 3.3 ± 3.0 years) patients. 
The age range for the whole group was 0-14 years, with mean age 3.7 ± 2.8 years. The 
malignant tumour types are listed in Table 6.1. The benign lesions consisted of indolent 
abdominal mass (n = 1), ganglioneuroma (n = 3), haematocolpos (n = 1), lipoma (n = 1), 
haemangioma (n = 1), mesoblastic nephroma (n = 1), osteomyelitis (n = 1) and vascular 
malformation (n = 1). The maximum diameter of the malignant tumours was 32.1 cm 
(range 8.5  53.1 cm) and benign lesions 16.8 cm (range 7.2  47.7 cm).  
 
 
Figure 6.3 Patient selection. Flow diagram describing the patient selection process, with 
inclusion and exclusion criteria. 
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Table 6.1 Patient cohort demographics. 
Lesion type Cases Sex (F/M) Mean age, range (yrs) 
Benign 10 3/7 4.0 (0-10) 
Clear cell sarcoma 1 0/1 3.5 
Ewing’s sarcoma 1 0/1 9.3 
Germ cell tumour 1 0/1 2.4 
Hepatoblastoma 4 2/2 0.9 (0-2) 
Nephroblastomatosis 1 0/1 0.1 
Neuroblastoma 11 5/6 1.9 (0-6) 
Ovarian immature teratoma 1 1/0 11.8 
Rhabdoid tumour 2 1/1 0.9 (0-1) 
Rhabdomyosarcoma 2 0/2 5.8 (5-7) 
Wilms’ tumour 8 4/4 6.1 (1-14) 
Total 42 16/26 3.7 (0-14) 
 
6.2.2.3 Data Analysis 
Post-processing of the diffusion-weighted MR data was performed using the diffusion 
module developed for MIROR, as described in the previous section. This allowed the 
generation of ADC and IVIM D, D* and f parameter maps. ADC parameter maps were 
computed using b-values 0 and 1000 s/mm2. A threshold of b = 150 s/mm2 was chosen for 
IVIM based on the local clinical abdominal MR protocol, a previously reported consensus 
statement (101), and the study presented in Chapter 4. 
IVIM and ADC parameter values were extracted from the parameter maps using the 
MIROR region-of-interest (ROI) drawing module. Whole tumour areas were included in 
the ROIs, including cystic and necrotic areas. ROIs were drawn by a junior clinician 
(K.M) and inspected by an experienced radiologist (10 years of experience, K.F.). The 
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whole tumour approach was shown previously to result in better inter-observer 
reproducibility compared to single section or slice ROI analysis (200, 201). The ROIs 
were drawn manually on diffusion-weighted b0 images with the aid of conventional MRI 
for the tumour outline at each consecutive slice, excluding peritumoural oedema. 
Peritumoural oedema refers to the excess fluid found around a tumour, collecting in 
tissues and causing swelling. On each slice, sections of tumour > 50 % of the more 
central adjacent slice and ≥ 3 cm were included to minimise any partial volume effects. 
A MIROR histogram module was applied to the extracted data to construct histograms. 
For each patient case, mean, median, 5th/25th/75th/90th percentiles, skewness, kurtosis 
and entropy were calculated based on normalised histograms. Histograms were 
normalised to their maximum values to dissociate histogram parameters from 
differences in lesion sizes and to compute average histograms for individual tumour 
types. The histogram analysis was chosen to allow the analysis of different proportions 
of histological tissue types and necrosis within tumours. 
6.2.2.4 Statistical Analysis 
All statistical analysis was performed using SPSS Statistics (IBM, Chicago, IL, v.23). 
Non-parametric statistics were performed for the histogram derived data. These 
included the Kruskal-Wallis and Dunn’s tests, which were used to compare the ADC and 
IVIM parameters from the malignant tumours and to determine which tumours gave 
rise to the difference, respectively. Mann-Whitney U test was used to establish 
differences between the malignant and benign lesions. Bonferroni correction was used to 
adjust the P-values for the Dunn’s test, when several statistical tests were performed 
simultaneously. In SPSS, this is performed by multiplying the P-values with the number 
of comparisons made. 
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Receiver operating characteristic (ROC) curves were used to determine how well the 
diffusion parameters discriminated individual tumour types, and benign from malignant 
lesions. The area under the ROC curve (AUC) was measured to assess the diagnostic 
performance of the diffusion parameters. The cutoff values for the diagnostic tests and 
the diffusion parameters were determined using the maximum Youden index (or 
Youden’s J statistic), estimated for all points on the ROC curves from the corresponding 
sensitivity and specificity values: 
Youden index = sensitivity + specificity − 1 [6.1] 
The Youden index defines the maximum potential effectiveness of a biomarker, and 
determines the cutoff value that optimises the biomarkers differentiating ability, when 
sensitivity and specificity are given equal weight (202). 
All tests performed were two-sided. P-value < 0.05 was considered to indicate significant 
difference. 
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6.3 Results 
6.3.1 MIROR Diffusion Module 
An example IVIM f parametric map computed with the implemented diffusion module is 
presented in Figure 6.4 in the MIROR (v. 2.0) user interface developed by N.Z. (with 
contributions from E.M.M.). The b0 anatomical image was included in the interface for 
easier inspection of the drawn region-of-interest (ROI), which was imported separately 
using the MIROR ROI module. Based on the ROI, a histogram was constructed from the 
extracted IVIM f values, allowing the computation of the histogram statistics. 
 
 
Figure 6.4 MIROR user interface patient view (v. 2.0). The figure shows a malignant 
tumour case, with the imported ROI (drawn in MIROR ROI module), the overlaid ROI on the 
IVIM f parametric map, the resulting f value histogram, a 3D presentation of the ROI or 
tumour surface and the image statistics based on the histogram of the whole tumour region. 
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The next part of the workflow involved the connection of the diffusion module to the 
analysis module (N.Z.), which pulls the previously stored information from the MIROR 
repository (Figure 6.5). This functionality was implemented in the MIROR v.2.1. This 
allowed the comparison of the input case histogram to mean histograms of different 
tumour types or benign lesions, based on a chosen diffusion parameter (IVIM or ADC) 
As part of the MIROR v. 2.1.1, a more sophisticated layout of the diffusion module was 
implemented. This allowed the visualisation of all the diffusion maps as well as their 
corresponding histograms and histogram based statistics. 
 
 
Figure 6.5 MIROR analysis interface (v. 2.1). The figure shows a malignant 
neuroblastoma ADC histogram (green), overlaid on a mean ADC neuroblastoma histogram 
(red, top left), and on a mean ADC benign lesion histogram (red, top right) with grey plots 
indicating the standard deviation. The boxplots describe the histogram values for malignant 
and benign abdominal lesions, from the MIROR repository with the index describing the 
statistics of the input case. 
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6.3.2 Diagnosis of Childhood Retroperitoneal Lesions 
The implemented diffusion module for MIROR was tested and evaluated for its clinical 
value in a cohort of childhood retroperitoneal lesions in the renal bed. MRI data sets 
were imported to MIROR from the local PACS. The IVIM and ADC analyses were fully 
computed within MIROR. 
6.3.2.1 Discrimination between Tumour Types 
The median diffusion parameter values derived for each malignant and benign lesion are 
presented in Figure 6.6. The benign lesions were combined into one group, which had the 
widest distribution of values, compared to the malignant lesions. Relative to the other 
parameters, the widest distribution of median values for benign cases was seen with the 
f parameter (Figure 6.6d).  
The comparison between tumour types included cohorts of hepatoblastoma, 
neuroblastoma and Wilms’ tumours. Other tumour types were excluded due to their 
small sample sizes. The histogram values for these tumour types are summarised in 
Table 6.2.  
The results from the comparison between the ADC, D, D* and f histogram parameters of 
the malignant tumour types are listed in Table 6.3.  The Kruskal-Wallis test revealed 
significant differences in the histogram parameters of D* (P = 0.007 to 0.021) and f (P < 
0.001 to 0.008). For both D* and f these included histogram parameters: mean, median 
and 75th/90th percentiles. Additionally, D* skewness and f 25th percentile, kurtosis and 
entropy showed significant differences. No differences were observed for ADC and D 
histogram parameters. 
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Figure 6.6 Distributions of median diffusion parameter values for different tumour 
types. Box plots describing the ADC (a) and IVIM D (b), D* (c) and f (d) parameter 
distributions. Top and bottom of the boxes represent 25 % and 75 % percentiles of data 
values, respectively, and the horizontal lines in boxes represent the median. The whiskers 
extend to the most extreme data points not considered outliers, with outliers indicated by red 
circles. For data where n = 1, a dash is shown for the median value, and for n = 2, dots 
indicate the medians of the two cases. 
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Table 6.2 Histogram parameters of ADC, D, D* and f for the individual malignant tumour types. 
  Mean Median 5th % 25th % 75th % 90th % Kurtosis Skewness Entropy 
HB 
n = 4 
ADC 1181±71 1104±77 767±110 972±66 1301±96 1632±96 2.19±4.0 × 10-2 3.1 × 10-2±1.6 × 10-3 6.91±2.2× 10-1 
D 962±61 938±51 386±131 791±60 1096±65 1356±71 2.21±6.5 × 10-3 3.4 × 10-2±3.4 × 10-4 7.01±8.4 × 10-2 
D* 18723±1878 16144±1933 5068±589 11042±1295 24000±2616 33940±3412 2.22±3.0 × 10-2 7.3 × 10-3±4.3 × 10-4 9.78±1.8 × 10-1 
f 16.6±1.53 14.3±1.43 4.00±0.94 9.00±1.17 20.8±1.78 31.3±2.48 2.15±2.8 × 10-2 2.2 × 10-1±8.4 × 10-3 3.60±7.0 × 10-2 
NB 
n = 11 
ADC 1164±190 1070±201 625±124  825±139 1416±271 1770±352 2.22±7.5 × 10-2 3.3 × 10-2±5.7 × 10-3 7.09±3.9 × 10-1 
D 885±88 817±85 374±102 616±76 1098±114 1413±157 2.15±5.7 × 10-2 3.0 × 10-2±6.4 × 10-3 7.04±2.3 × 10-1 
 D* 19348±1213 16957±1318 5120±608 10651±1457 24127±1762 35328±2118 2.22±1.6 × 10-2 7.3 × 10-3±1.9 × 10-4 9.30±5.6 × 10-1 
 f 21.1±1.85 17.1±1.75 3.82±0.47 9.72±1.09 28.6± .04 43.1±4.27 2.20±1.9 × 10-2 2.1 × 10-1±6.4 × 10-3 3.88±1.2 × 10-1 
W 
n = 8 
ADC 1033±191 939±178 643±103 795±138 1180±243 1511±317 2.19±5.4 × 10-2 3.5 × 10-2±2.9 × 10-3 6.95±3.2 × 10-1 
D 935±94 847±85 586±42 722±63 1060±120 1368±167 2.19±3.1 × 10-2 3.4 × 10-2±1.7 × 10-3 6.86±2.0 × 10-1 
 D* 14944±791 13004±787 4762±729 9429±655 18147±1104 25530±1683 2.21±1.2 × 10-2 7.8 × 10-3±3.8 × 10-5 9.84±7.5 × 10-2 
 f 11.0±0.80 9.00±0.50 2.75±0.41 6.50±0.50 13.1 ± 0.92 20.3 ± 2.69 2.07±3.6 × 10-2 1.9 × 10-1±2.9 × 10-2 3.60±7.0 × 10-2 
Note: HB = hepatoblastoma, NB = neuroblastoma, W = Wilms’ tumour. Data presented corresponds to mean values ± standard deviations. 
The units for mean, median and percentiles of ADC, D and D* are in × 10-6 mm2/s and f as a percentage (%). 
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Table 6.3 Comparison of malignant tumour types and their ADC, D, D* and f histogram 
parameters. 
 
Parameter 
Kruskal-Wallis test (P-value) Dunn’s test (P-value) 
ADC D D* f ADC D D* f 
Mean 0.470 0.277 0.013* < 0.001* - - NB-W = 0.010 NB-W < 0.001 
Median 0.273 0.198 0.013* < 0.001* - - NB-W = 0.010 NB-W < 0.001 
5th percentile 0.201 0.088 0.944 0.110 - - - - 
25th percentile 0.151 0.142 0.413 0.003* - - - NB-W = 0.002 
75th percentile 0.244 0.340 0.015* < 0.001* - - NB-W = 0.012 NB-W < 0.001 
90th percentile 0.392 0.405 0.007* 0.001* - - NB-W = 0.005 NB-W < 0.001 
Kurtosis 0.395 0.445 0.651 0.008* - - - NB-W = 0.006 
Skewness 0.183 0.344 0.021* 0.651 - - NB-W = 0.017 - 
Entropy 0.462 0.466 0.974 0.001* - - - NB-W < 0.001 
Note: HB = hepatoblastoma, NB = neuroblastoma, W = Wilms’. * indicates P value of a 
significant difference. Bonferroni correction factor = 3 was applied to the Dunn’s test results. 
The Dunn’s test revealed that the D* values of neuroblastoma were significantly higher 
in comparison to Wilms’ tumours (P = 0.005 to 0.012) and skewness was significantly 
higher for Wilms’ compared to neuroblastoma (P = 0.017). Similarly, the f values in 
neuroblastoma were significantly higher in comparison to Wilms’ tumours (P < 0.001 to 
0.002) and higher kurtosis (P = 0.006) and entropy (P < 0.001) were seen for 
neuroblastoma. 
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Figure 6.7 Average perfusion fraction f histograms. Histograms shown for (a) 
hepatoblastoma (n = 4), neuroblastoma (n = 11) and Wilms’ tumour (n = 8). The (b-d) 
histograms show the major tumour types, with standard deviation between individual cases 
indicated by grey shading. 
Normalised f histograms, averaged for the individual malignant tumour types are shown 
in Figure 6.7. The median f values (%) were 14.3 ± 1.43 for hepatoblastoma, 17.1 ± 1.75 
for neuroblastoma and 9.00 ± 0.50 for Wilms’ tumour. The Wilms’ tumour and 
neuroblastoma histogram shapes demonstrate the differences seen in kurtosis and 
entropy between the tumour types. Kurtosis, which is an interpretation of tail extremity 
or “tailedness” (203), was found to be higher, as shown with the heavy-tailed distribution 
relative to normal distribution, in neuroblastoma. The higher entropy of neuroblastoma 
was observed as a more irregularly distributed histogram with greater deviation seen 
between some of the cohort cases.  
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ROC analysis was performed with D* and f histogram parameters to study the 
diagnostic performance of discriminating Wilms’ tumours from neuroblastoma. The 
results from ROC analysis are presented in Table 6.4. The D* histogram parameters 
mean, median, 75th/90th percentiles and skewness could discriminate the two tumour 
types with AUC values > 0.900 (range, 0.909 – 0.935; P = 0.002 to 0.004). The f 
histogram parameters mean, median, 5th/2th/75th/90th percentiles, kurtosis and entropy 
could discriminate Wilms’ tumours from neuroblastoma, with mean, median 
25th/75th/90th and entropy demonstrating AUC values > 0.900 (range, 0.938 – 1.00; P < 
0.001 to 0.029). 
Representative parametric maps of Wilms’ tumour and neuroblastoma are shown in 
Figures 6.8 and 6.9, respectively. The ADC and D maps were similar in appearance, 
although the D values were generally lower. For both Wilms’ and neuroblastoma, the D* 
maps appeared the most heterogeneous, indicating greater variability of values, which 
accounted for the higher histogram entropies. In reference to the healthy kidneys seen 
on the f maps, lower vascular character was suggested for the Wilms’ case, while more 
variability was observed for neuroblastoma. 
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Table 6.4 Diagnostic performance of D* and f histogram parameters in discriminating Wilms’ tumour from neuroblastoma. 
 Mean Median 5th % 25th % 75th % 90th % Kurtosis Skewness Entropy 
D* AUC 0.909 0.909 0.506 0.675 0.909 0.935 0.571 0.909 0.532 
Confidence interval 0.739, 1.00 0.739, 1.00 0.177, 0.836 0.408, 0.942 0.739, 1.00 0.807, 1.00 0.285, 0.858 0.739, 1.00 0.254, 0.811 
Sensitivity % 90.9 90.9 81.8 81.8 90.9 90.9 63.6 90.9 45.5 
Specificity % 100 100 57.1 71.4 100 100 85.7 100 100 
P-value 0.004* 0.004* 0.964 0.221 0.004* 0.002* 0.618 0.004* 0.821 
Cutoff value 17826 15636 5471 9612 22044 32376 2.22 7.60 × 10-3 9.62 
f AUC 1.00 1.00 0.784 0.938 1.00 0.966 0.886 0.523 0.977 
Confidence interval 1.00, 1.00 1.00, 1.00 0.574, 0.994 0.835, 1.00 1.00, 1.00 0.889, 1.00 0.676, 1.00 0.245, 0.801 0.920, 1.00 
Sensitivity % 100 100 50.0 75.0 100 87.5 87.5 50.0 87.5 
Specificity % 100 100 90.9 90.9 100 100 100 72.7 100 
P-value <0.001* <0.001* 0.039* 0.001* <0.001* 0.001* 0.005* 0.869 0.029* 
Cutoff value 14.7 11.0 2.50 7.50 17.5 24.50 2.10 2.01 × 10-1 3.35 
Note: * indicates P value of a significant difference. AUC is the area under the ROC curve. The units for mean, median and percentiles of 
D* cutoff values are in × 10-6 mm2/s and f as a percentage (%). The specificity, sensitivity and cutoff values are from the Youden analysis. 
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Figure 6.8 Histologically verified low risk Wilms’ tumour. (a) T2-weighted and (b) b = 
150 s/mm2 axial images, and (c-f) parametric maps (ADC, D, D* and f, respectively). Whole 
tumour ROI is shown drawn on the parametric maps. 
 
Figure 6.9 Histologically verified neuroblastoma (grade IV). (a) T2-weighted and (b) b 
= 150 s/mm2 images and (c-f) parametric maps (ADC, D, D* and f, respectively). Whole ROI 
is shown drawn on the parametric maps. 
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Figure 6.10 Investigation of higher f values observed in neuroblastoma. (a) 
Parametric maps of f, D and ADC, with a high f value (> 40 %) region indicated with a red 
circle, and (b) the large signal drop observed at low b-values for this region. The voxel-wise 
correlations for f-D (c) and f-ADC (d) for a single slice tumour ROI, with yellow box indicating 
the region where neuroblastoma differed the most from Wilms’ (f = 20-40 %) and red circle 
indicating the parametric values resulting from the signal drop at very high f values. 
The greatest difference in the f values between neuroblastoma and Wilms’ tumours was 
observed to occur when f = 20 – 40 % (Figure 6.7). This region was investigated for a few 
example cases (n = 4), with a neuroblastoma case presented in Figure 6.10. No 
correlation was established between IVIM and ADC parameters in the corresponding 
image regions, as indicated by the yellow boxes in Figures 6.10c-d. In a region where f 
was > 40 % (Figure 6.10a-b), a large signal drop was observed at the lower b-values. 
These regions are indicated by the red circles in Figures 6.10c-d, where very high f 
values resulted in relatively low D and high ADC values. Voxel-wise correlations in 
neuroblastoma and Wilms’ for the whole range of f values demonstrated negative 
correlation for D and f (r = -0.165 to -0.307; P < 0.001), while ADC and f (r = 0.310 to 
0.487; P < 0.001) showed a positive correlation.  
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6.3.2.2 Discrimination between Benign and Malignant Lesions 
Discrimination between benign and malignant lesions was possible with D, D* and ADC 
parameters (Table 6.5). The ADC, D, D* and f for benign lesions were as follows: ADC = 
1597 ± 484 (× 10-6 mm2/s), D = 1552 ± 622 (× 10-6 mm2/s), D* = 11610 ± 3385 (× 10-6 
mm2/s) and f = 16 ± 6.7 %. Both D and ADC were found to be significantly lower and D* 
significantly higher in malignant tumours. Most ADC histogram parameters 
demonstrated significantly lower values in malignant tumours (P = 0.001 to 0.007), as 
well as higher kurtosis, skewness and entropy (P < 0.001 to 0.036). The D parameter 
could discriminate malignant tumours with lower median, 25th percentile (P = 0.045 to 
0.049) and higher skewness (P = 0.018). The opposite was observed with the D* 
parameter, which demonstrated higher median (P = 0.039) and entropy (P = 0.002) 
values in malignant tumours. The f histogram parameters were found to not show any 
significant differences between the benign and malignant lesions. The histogram 
parameters for the benign and malignant groups are summarised in Table 6.6. 
 
Table 6.5 Comparison of benign (n = 10) and malignant (n = 32) lesions with ADC, D, D* 
and f histogram parameters. 
 
Parameter 
Mann-Whitney test (P-value) 
ADC D D* f 
Mean 0.007* 0.070 0.127 0.390 
Median 0.001* 0.049* 0.039* 0.320 
5th percentile 0.005* 0.056 0.135 0.919 
25th percentile 0.002* 0.045* 0.092 0.248 
75th percentile 0.007* 0.052 0.127 0.494 
90th percentile 0.202 0.112 0.259 0.760 
Kurtosis < 0.001* 0.740 0.247 0.631 
Skewness < 0.001* 0.018* 0.647 0.122 
Entropy 0.036* 0.081 0.002* 0.965 
Note: * indicates P value of a significant difference. 
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Table 6.6 Histogram parameters of ADC, D, D* and f for the malignant and benign tumour groups. 
  Mean Median 5th % 25th % 75th % 90th % Kurtosis Skewness Entropy 
Malignant 
n = 32 
ADC 1149±279 1057±285 678±202 864±243 1348±343 1694±406 2.18±8.9×10-2 3.2×10-2±6.8×10-3 7.00±3.9×10-1 
D 949±271 879±273 476±222 712±239 1124±332 1427±403 2.15±1.2×10-1 3.1×10-2±1.0×10-2 6.96±5.2×10-1 
D* 17380±3196 15014±3287 4904±1575 9915±2723 21722±4422 31425±6177 2.26±1.5×10-2 7.6×10-3±6.7×10-4 9.42±8.8×10-1 
f 17.1±6.49 13.8±5.73 3.51±1.61 8.54±3.47 22.1±9.76 34.0±14.3 2.13±9.1×10-2 2.0×10-1±3.3×10-2 3.55±4.3×10-1 
Benign 
n = 10 
ADC 1581±442 1592±483 1044±342  1363±427 1812±507 1977±511 1.99±1.4×10-1 -5.0×10-3±2.4×10-3 6.58±5.8×10-1 
D 1361±557 1357±622 795±447 1118±571 1615±614 1820±586 2.08±1.7×10-1 -8.6×10-3±3.3×10-2 6.76±4.8×10-1 
 D* 14854±4076 12320±3384 3779±1782 8541±2137 18461±5829 27531±8919 2.19±5.9×10-2 2.4×10-3±1.6×10-2 8.47±1.0 
 f 16.6±6.66 14.3±6.74 3.22±1.75 9.01±4.15 21.9±6.76 37.6±21.1 2.11±8.3×10-2 2.2×10-1±1.7×10-2 3.46±5.5×10-1 
Note: Data presented corresponds to mean values ± standard deviations. The units for mean, median and percentiles of ADC, D and D* 
are in × 10-6 mm2/s and f as a percentage (%). 
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The median values of each parameter for each of the benign cases are plotted in Figure 
6.11. The ADC and D value plots indicated how the benign and malignant lesions are 
separated into two distinct groups.   Although the values of ADC and D were similar, 
some differences were observed.  The separation of the two groups was clearer with the 
use of D values, but two benign cases (vascular malformation and lipoma) were found to 
have lower diffusion coefficients than the malignant group. The separation of the two 
groups with the D* values was not as clear and large overlap of values with benign and 
malignant cases could be observed. This was also seen with the f values, but to a greater 
extent. 
The performance of the histogram parameters in differentiating benign from malignant 
cases was evaluated using the ROC analysis. The results from the ROC analysis are 
reported in Table 6.7 for ADC, D and D* parameters, which showed significant 
differences between benign and malignant lesions. ROC curves for median histogram 
values and histogram parameters that resulted in the highest AUC values for ADC, D 
and D* parameters are shown in Figure 6.12. The most accurate cutoff levels based on 
the median histogram parameters were 1219 × 10-6 mm2/s, 1242 × 10-6 mm2/s and 11104 
× 10-6 mm2/s for ADC, D and D* parameters, respectively. These corresponded to 
sensitivity and specificity of 80.0 % and 81.3 % for ADC, 66.7 % and 87.9 % for D and 
55.6 % and 93.8 % for D*. The median ADC parameter was found to have better 
diagnostic performance than D or D* in discriminating benign from malignant lesions 
with AUC values 0.825 (P = 0.002), 0.717 (P = 0.048) and 0.736 (P = 0.032), respectively. 
The best diagnostic performance was achieved with histogram skewness for ADC (AUC 
= 0.919; P < 0.001) and D (AUC = 0.758; P = 0.019), and entropy for D* (AUC = 0.840; P 
= 0.002). The optimal cutoff values were 3.30 × 10-2, 3.56 × 10-2 and 9.32 for ADC 
skewness, D skewness and D* entropy, respectively. 
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Figure 6.11 The median values of benign and malignant cases. Median values of ADC (a), D (b), D* (c) and f (d) plotted for each of 
the benign case and median values of cohorts of the malignant lesions. 
Chapter 6. MIROR Clinical Decision Support System: Implementation of Diffusion Module and Investigation of Childhood Solid Tumours 
 165  
Table 6.7 Diagnostic performance of histogram parameters in discriminating benign from malignant lesions. 
Parameters Mean Median 5th % 25th % 75th % 90th % Kurtosis Skewness Entropy 
ADC AUC 0.781 0.825 0.788 0.819 0.778 0.638 0.875 0.919 0.722 
Confidence interval 0.601, 0.962 0.659, 0.991 0.488, 0.987 0.646, 0.992 0.610, 0.946 0.439, 0.836 0.738, 1.00 0.823, 1.00 0.513, 0.931 
Sensitivity % 70.0 80.0 70.0 70.0 70.0 90.0 80.0 70.0 60.0 
Specificity % 87.5 81.3 90.6 93.7 81.2 43.7 93.7 100 87.5 
P value 0.008* 0.002* 0.007* 0.003* 0.009* 0.194 <0.001* <0.001* 0.036* 
Cutoff 1439 1219 951 1310 1565 1605 2.10 3.30 × 10-2 6.55 
D AUC 0.700 0.717 0.710 0.721 0.714 0.677 0.539 0.758 0.694 
Confidence interval 0.451, 0.950 0.458, 0.977 0.451, 0.970 0.459, 0.983 0.487, 0.941 0.471, 0.883 0.296, 0.782 0.495, 1.00 0.493, 0.894 
Sensitivity % 66.7 66.7 77.8 66.7 66.7 88.9 33.3 77.8 77.8 
Specificity % 84.8 87.9 27.7 90.9 81.8 51.5 90.9 87.9 66.7 
P value 0.068 0.048* 0.055 0.045* 0.052 0.108 0.724 0.019* 0.078 
Cutoff 1232 1242 587 1117 1375 1421 1.93 3.56 × 10-2 6.98 
D* AUC 0.681 0.736 0.681 0.701 0.681 0.639 0.628 0.569 0.840 
Confidence interval 0.442, 0.919 0.528, 0.945 0.481, 0.880 0.495, 0.907 0.435, 0.926 0.387, 0.891 0.383, 0.874 0.342, 0.797 0.711, 0.969 
Sensitivity % 55.6 55.6 88.9 66.7 55.6 44.4 55.6 77.8 88.9 
Specificity % 87.5 93.8 469 81.2 87.5 90.6 90.6 46.9 75.0 
P value 0.101 0.032* 0.101 0.068 0.101 0.208 0.244 0.529 0.002* 
Cutoff 13700 11104 5206 8473 16642 23690 2.19 7.61 × 10-3 9.32 
Note: * indicates P value of a significant difference. AUC is the area under the ROC curve. The units for mean, median and percentiles of 
ADC, D and D* cutoff values are in × 10-6 mm2/s. The specificity, sensitivity and cutoff values are from the Youden analysis. 
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Figure 6.12 Clinical performance of diffusion parameters in discriminating benign 
from malignant lesions. ROC curves for median (a) ADC, D and D*, and the ROC curves 
with the highest AUC values for each parameter: (b) ADC skewness, (c) D skewness and (d) 
D* entropy. 
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6.4 Discussion 
In this study, a diffusion module was implemented into a clinical decision support 
system, MIROR, which was tested in a cohort of childhood abdominal lesions. The 
module was built to allow the analysis of diffusion-weighted image data from the major 
MR manufacturers, and was built to be non-region specific and compatible to different 
data sets. The results from the diffusion analysis were stored in the MIROR repository to 
build a database of information, which was allowed by the connections built around the 
different modules of MIROR.  
The application of IVIM analysis in the patient cohort revealed promising results in the 
use of histogram parameters for discriminating between malignant neuroblastoma and 
Wilms’ tumours as well as differentiating benign from malignant lesions. Distinctive 
IVIM D* and f parameters were revealed for Wilms’ tumours and neuroblastomas, while 
no significant differences were observed with the use of D or ADC histogram parameters. 
The diffusion coefficients (D, D* and ADC) could discriminate benign from malignant 
lesions. These results suggest that the complex, heterogeneous structures of 
retroperitoneal tumours can be characterised using histogram analysis, which has the 
potential to facilitate their non-invasive diagnosis. 
New challenges have arisen for clinicians with the movement towards quantitative 
imaging methods and analysis as part of clinical practice (188, 204, 205). The complex 
interpretation of the vast amount of information and data resulting from the advanced 
imaging techniques does not often ease the diagnosis of diseases. This has promoted the 
role and use of CDSSs (188). MIROR, the CDSS developed in this study, was designed to 
guide clinicians through the analysis of advanced MR imaging techniques to allow new 
methodologies to receive clinical acceptance through a translational approach. 
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The diffusion module of MIROR was tested and validated by its application to a cohort of 
childhood abdominal lesions.  The use of IVIM histogram analysis for this type of cohort 
has not been previously reported, although the histogram approach has been 
increasingly used for heterogeneous and complex tissue types (206). In previous 
paediatric abdominal studies, the mean or median ADC values have often been reported 
based on single section or slice, which does not address the heterogeneity seen in many 
of these tumours (41, 193). 
The results from our study indicate that the IVIM derived histogram parameters may 
facilitate discrimination between malignant neuroblastoma and Wilms’ tumours. 
Comparison of these tumours indicated significant differences in the tumour perfusion 
characteristics. The perfusion influenced parameters D* and f were found to be 
significant predictors of tumour type, while both ADC and D parameters were unable to 
discriminate between them. Although these tumours generally display different 
characteristic features, both in terms of clinical presentation (207) and on conventional 
imaging (208, 209), differentiation of the tumours may cause diagnostic confusion in the 
case of intrarenal neuroblastoma (210, 211), or if the tumour involves the adrenal gland 
(212). Neuroblastomas commonly encase vascular structures (207), which could be 
observed as an increase in D* and f parameters. The lack of correlation between IVIM 
and ADC parameters in regions where f = 20-40 %, suggested that the higher parameter 
values resulted from pathological origins. This finding is of clinical importance as it 
could potentially be applied to other tumours, which are more difficult to discriminate, 
such as Wilms’ from renal rhabdoid tumour, clear cell sarcoma of the kidney or benign 
mesoblastic nephroma. This is particularly relevant given the recommendation to avoid 
pre-treatment biopsy in these tumours(213). 
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In addition to the higher values of IVIM perfusion parameters, higher skewness for D* 
and higher entropy for f were observed in neuroblastoma. This is suggestive of a more 
irregular and heterogeneous vasculature of neuroblastoma compared to Wilms’ tumours. 
Diagnostic performance with sensitivity and specificity above 85 % was achieved with 
many of the histogram parameters of both D* and f. 
Cellularity and vascularity have been hypothesised to increase in similar manner, 
corresponding to a decrease in ADC or D and increase in the f parameter. Interestingly, 
the voxel-wise correlations in neuroblastoma and Wilms cases demonstrated this to be 
true for D and f, with negative correlation demonstrated, whereas positive correlation 
was observed between ADC and f. This agrees with the IVIM model and the proposed 
“true” tissue diffusion coefficient D (24), and the contribution of both diffusion and 
vascular characteristics to the measure of ADC. 
A review of our results in a clinical context revealed the interesting observations that 
tumours following an unusual clinical course often had f values differing from others in 
the same tumour group. Tumours behaving particularly aggressively tended to have 
higher f values, whereas those following a more indolent course had lower f values. The 
mean f value for Wilms’ tumours in our cohort was 11.0  0.8 %; the patient with the 
highest mean f value (14.4 %) died following a very aggressive disease process with 
multiple relapses. Rhabdoid tumours are typically aggressive malignancies with poor 
survival. The two patients in our cohort with rhabdoid tumours had mean f values of 
23.2 % and 8.4 %. The former case died three months after presentation, whereas the 
latter remains in remission two years following the completion of treatment. This is 
suggestive of f being a potential prognostic biomarker, with high-risk tumours having 
higher f values. This is biologically plausible with increased tumour vascularity reflected 
through an increase in the f parameter. Although our numbers were too small to draw 
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firm conclusions, this interesting observation deserves further exploration in a larger 
cohort. 
The second investigation involved the discrimination of benign from malignant lesions. 
This was possible with the use of D, D* and ADC histogram parameters, with highest 
diagnostic performance observed with the ADC. It is possible that the ADC parameter 
performed better due to the combination of diffusion and perfusion characteristics into a 
single parameter. Interestingly, ADC and D were both lower in malignant tumours, 
while D* was found to be higher. The f parameter failed to reach significance in 
discrimination of benign from malignant tumours. A wide range of f values were 
observed for the benign cohort, which may reflect differences in vasculature rather than 
cellularity, particularly as benign lesions evaluated included a liver haemangioma and 
vascular malformation. The highest f value was observed for lipoma (mean f = 26.0 %), 
followed by the ganglioneuroma cases (f = 20.3 – 22.1 %) and vascular malformation (f = 
18.4 %). Lipomas are formed of adipose tissue (body fat) and are generally considered to 
be low-perfused. However, the high f values seen for the lipoma case indicated the 
presence of a vascular component. This was confirmed by the diagnostic report, which 
described veins running through the lesion. Therefore, although the f parameter may not 
determine benign from malignant cases, it may be useful in evaluation the vascular 
environment within the lesions. 
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6.5 Study Limitations 
This study had some limitations. Firstly, the sample size of the cohort was relatively 
small. Further validation with a richer data set in real time and in a clinical setting will 
be performed as part of future studies to reinforce the credibility and efficiency of the 
MIROR platform. In terms of the comparison of individual tumour types, the 
preliminary results were promising and suggested that discrimination is possible. 
Secondly, no T2 correction was applied to the perfusion fraction, and therefore the values 
may have been affected by the T2 relaxation times of blood and tissue. Thirdly, the group 
sizes were unbalanced for discrimination of benign from malignant tumours and the 
group of benign tumours was very heterogeneous as reflected in their DWI 
characteristics. Further larger and multi-centre studies are required to confirm these 
results. 
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6.6 Conclusion 
The development and implementation of a diffusion module was completed as part of the 
multi-modular, non-region-specific design and architecture of the MIROR platform. This 
aimed to reduce the translational gap between the research and clinical use of IVIM, and 
made the analysis available for clinical practice at the local institution. The module 
underwent testing and validation with the application to a cohort of childhood 
retroperitoneal lesions. The use of multi-b-value DW-MRI allowed the computation of 
IVIM parameters, and the whole tumour ROI approach ensured that the heterogeneity 
of the tumours was taken into consideration. The results suggested that IVIM 
parameters and their histogram analysis can provide useful insight into the complex 
structures of such tumours. The use of these parameters in combination could facilitate 
the non-invasive diagnosis of individual tumour types. Although further investigation is 
needed, the perfusion fraction demonstrated potential in being a diagnostic and 
prognostic imaging biomarker of disease.  
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7. Conclusions and Future Work 
This thesis investigated the use of the intravoxel incoherent motion (IVIM) model as a 
potential imaging biomarker in childhood cancers. The technical validation of the IVIM 
model suggested that the analysis is robust in the low-perfused tissues of the brain, but 
highlighted the requirement for sufficient data quality and in particular signal-to-noise 
ratio (SNR), whilst showing that a constrained fitting model is optimal in most 
instances. Furthermore, the application of IVIM was successful with the use of a rapid 
acquisition protocol using only three b-values. The fitting thresholds used here 
emphasised the influence of bias and variability on the IVIM parameters in different 
tissue types, and provided guidelines for the interpretation of the differences seen in 
previous studies, including its use for future studies. As part of the biological validation, 
significant correlations between the IVIM perfusion fraction and dynamic susceptibility 
contrast (DSC) derived cerebral blood volume were established for the first time in a 
paediatric brain tumour cohort. As a final part of this thesis, the IVIM model was 
successfully implemented into a clinical decision support system (MIROR) platform. 
Using this platform, the IVIM perfusion fraction was found to discriminate between 
childhood abdominal tumours, thereby proposing it as a potential diagnostic imaging 
biomarker.  
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The following list presents the conclusions from this work and suggests directions for 
future studies: 
I. The technical validation in Chapter 3 was performed to assess the reliability of 
using the IVIM model in the brain and low-perfused tissues observed in the 
childhood brain tumours. The constrained IVIM fitting improved the robustness 
of the estimated parameters, with higher overall accuracy and reproducibility. 
The investigation of IVIM parameter space revealed that an important SNR 
requirement exists for the application of IVIM, in both grey matter and low-
perfused tissues such as white matter and low-grade gliomas. The modelling 
results from this Chapter warrant further investigation of the influence of SNR 
on the estimation of the IVIM parameters, and in particular measurements in 
vivo would be of interest to validate these observations.  
II. Chapter 4 investigated the use of a rapid acquisition protocol to acquire the 
clinically relevant IVIM diffusion coefficient and perfusion fraction parameters. 
The optimal b-value varied, depending on the underlying tissue characteristics, 
based on both simulated and in vivo data. This had an important consequence on 
the threshold used in the constrained or segmented fitting of IVIM, which in 
many studies might have been too low to separate the perfusion influence from 
the diffusion coefficient. This would have led to biased estimation of the IVIM 
parameters, particularly in the brain. In this Chapter, suggestions for the b-
values to be used were given for different tissue types to minimise bias and 
variability of the estimated IVIM parameters. Subsequently, guidelines were 
provided for the interpretation of studies from different centres, which often 
utilise different b-value distributions, and to aid future studies or the analysis of 
pre-existing data. Therefore, and going forward, more work is needed to 
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standardise the multi b-value DW-MRI protocols and hence provide consensus for 
their optimal use in different imaging regions. Such work is critical for the future 
clinical uptake of IVIM. 
III. Based on the biomarker roadmap introduced in Chapter 1, the contributions from 
Chapters 3 & 4 are within the single centre technical validation with assessment 
of precision and bias (Domain 2). Protocols from these studies with regards to b-
values were also included in the local MRI scanner, making them available for 
clinical research at the local institution. The single-centre study here and the 
current literature provide valuable contributions towards the use of IVIM as an 
imaging biomarker. However, the future studies should aim to extend this to 
multi-centre studies, of which only a few exist to date. Such studies are essential 
for the assessment of reproducibility across different centres, and are required to 
cross the first translational gap towards the use of IVIM as an imaging 
biomarker. 
IV. The focus in Chapter 5 was moved to the biological validation of IVIM, and in 
particular the perfusion fraction parameter. The use of DW-MRI and IVIM-f has 
many advantages, with no requirements for tracer delivery and by providing a 
single acquisition protocol for measures of diffusion and perfusion. For most 
cases, the perfusion fraction showed significant point-wise correlations to the 
“gold standard” cerebral blood volume (CBV) from dynamic susceptibility contrast 
(DSC) imaging. However, the correlation of the two parameters decreased in 
regions of very low perfusion, with the inherently lower accuracy of both methods, 
and high perfusion, where differences exist in what the two methods are able to 
measure. Therefore, while the perfusion fraction appeared to provide a measure 
of the underlying tissue vascularity, it is unlikely to provide the same exact 
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measure as DSC-CBV. Further studies determining the relationship of tissue 
properties to IVIM perfusion fraction, potentially with a histopathological 
comparison, would be of great interest. Defining the limits for the aforementioned 
low and high perfusion regions would also be of value, to validate the range of 
perfusion where IVIM-f and DSC-CBV can provide a similar measure. 
V. The implementation of IVIM on the MIROR platform was considered an 
important step towards making the analysis available for clinical practice at the 
local institution. The implementation, described in Chapter 6, filled the third 
requirement of technical validation of IVIM in terms of the software availability. 
Although the IVIM computational performance was sufficient for the generation 
of the parameter maps, future collaboration should focus on the optimisation of 
the algorithm in terms of the speed at which it can process images. Following the 
optimisation, the MIROR platform could be used in future multi-centre IVIM 
studies, with the diffusion module designed to be adaptable for the input data and 
by providing standardised software for analysis of data from different centres.  
VI. The clinical validation of IVIM was performed using the MIROR platform and a 
cohort of childhood retroperitoneal lesions. The IVIM perfusion fraction 
discriminated between common Wilms’ tumours and neuroblastomas, which was 
not possible using the ADC parameter. This is promising for the use of IVIM 
perfusion fraction as a diagnostic imaging biomarker. Studies in larger cohorts of 
tumours, as well as studies comparing tumours that are difficult to differentiate 
on conventional MR imaging, should be investigated to further evaluate its 
potential. This would promote the clinical value of IVIM and increase its uptake 
for clinical practice. 
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The work in this thesis provides an important contribution towards the validation of 
IVIM as an imaging biomarker. The findings demonstrate its technical reliability and 
clinical validity, and highlight the future potential of its use as a clinical tool, albeit 
further work is required to complete its validation.  
 
 
A large number of publications to-date have focused on the reliability of IVIM post-
processing, and while standardisation is still required, the focus should now move onto 
its clinical validation in larger clinical trials. With very promising results demonstrated 
in previous smaller studies of various diseases and organs, this would provide the final 
key requirement for IVIM as an imaging biomarker and pave its way towards clinical 
practice. 
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